<SEC-DOCUMENT>0001193125-23-008474.txt : 20230113
<SEC-HEADER>0001193125-23-008474.hdr.sgml : 20230113
<ACCEPTANCE-DATETIME>20230113170508
ACCESSION NUMBER:		0001193125-23-008474
CONFORMED SUBMISSION TYPE:	POS EX
PUBLIC DOCUMENT COUNT:		20
FILED AS OF DATE:		20230113
DATE AS OF CHANGE:		20230113
EFFECTIVENESS DATE:		20230113

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BLACKROCK DEBT STRATEGIES FUND, INC.
		CENTRAL INDEX KEY:			0001051003
		IRS NUMBER:				223564108
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		POS EX
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-267429
		FILM NUMBER:		23529461

	BUSINESS ADDRESS:	
		STREET 1:		100 BELLEVUE PARKWAY
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19809
		BUSINESS PHONE:		800-441-7762

	MAIL ADDRESS:	
		STREET 1:		100 BELLEVUE PARKWAY
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19809

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BLACKROCK DEBT STRATEGIES FUND
		DATE OF NAME CHANGE:	20070611

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DEBT STRATEGIES FUND
		DATE OF NAME CHANGE:	20030428

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DEBT STRATEGIES FUND II INC
		DATE OF NAME CHANGE:	19971208
</SEC-HEADER>
<DOCUMENT>
<TYPE>POS EX
<SEQUENCE>1
<FILENAME>d447340dposex.htm
<DESCRIPTION>BLACKROCK DEBT STRATEGIES FUND, INC.
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:cik0001051003="http://www.blackrock.com/20230113" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:cef="http://xbrl.sec.gov/cef/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>BlackRock Debt Strategies Fund, Inc.</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body><div style='display: none'><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P01_13_2023To01_13_2023">0001051003</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="P01_13_2023To01_13_2023">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="cik0001051003-20230113.xsd" /><link:linkbaseRef xlink:type="simple" xlink:href="cik0001051003-20230113_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="cik0001051003-20230113_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="cik0001051003-20230113_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /></ix:references><ix:resources><xbrli:context id="P01_13_2023To01_13_2023" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001051003</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-13</xbrli:startDate> <xbrli:endDate>2023-01-13</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_13_2023To01_13_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001051003</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis" >dei:BusinessContactMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-13</xbrli:startDate> <xbrli:endDate>2023-01-13</xbrli:endDate> </xbrli:period> </xbrli:context></ix:resources></ix:header></div><div><div style="background-color:white;display: inline;"><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">As filed with the Securities and Exchange Commission on January 13, 2023 </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:right">Securities Act File No.&#160;<ix:nonNumeric name="dei:EntityFileNumber" contextRef="P01_13_2023To01_13_2023">333-267429</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:right">Investment Company Act File <div style="white-space:nowrap;display:inline;">No.&#160;<ix:nonNumeric name="dei:InvestmentCompanyActFileNumber" contextRef="P01_13_2023To01_13_2023">811-08603</ix:nonNumeric></div> </div><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><div style="margin-top:4pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman;font-weight:bold;text-align:center">U.S. SECURITIES AND EXCHANGE COMMISSION </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549 </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <div style="white-space:nowrap;display:inline;"><ix:nonNumeric name="dei:DocumentType" contextRef="P01_13_2023To01_13_2023">N-2</ix:nonNumeric></div> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registration Statement </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center"><div style="font-style:italic;display:inline;">under </div></div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:6%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:88%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">the Securities Act of 1933</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:right;"><div style="font-weight:bold;display:inline;"></div><ix:nonNumeric name="dei:DocumentRegistrationStatement" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-true">&#9746;</ix:nonNumeric><div style="font-weight:bold;display:inline;"></div><div style="font-weight:bold;display:inline;"></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center;"><div style="font-weight:bold;display:inline;"><div style="white-space:nowrap;display:inline;">Pre-Effective</div> Amendment No.</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:right;"><div style="font-weight:bold;display:inline;"></div><ix:nonNumeric name="dei:PreEffectiveAmendment" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric><div style="font-weight:bold;display:inline;"></div><div style="font-weight:bold;display:inline;"></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center;"><div style="font-weight:bold;display:inline;">Post-Effective Amendment No. <ix:nonNumeric name="dei:PostEffectiveAmendmentNumber" contextRef="P01_13_2023To01_13_2023">1</ix:nonNumeric></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:right;"><div style="font-weight:bold;display:inline;"></div><ix:nonNumeric name="dei:PostEffectiveAmendment" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-true">&#9746;</ix:nonNumeric><div style="font-weight:bold;display:inline;"></div><div style="font-weight:bold;display:inline;"></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center;"><div style="font-size:10pt;display:inline;"><div style="font-weight:bold;display:inline;">and/or</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center;"><div style="font-size:18pt;display:inline;"><div style="font-weight:bold;display:inline;">Registration Statement</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Under</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">the Investment Company Act of 1940</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:right;"><div style="font-weight:bold;display:inline;"></div><ix:nonNumeric name="dei:InvestmentCompanyActRegistration" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-true">&#9746;</ix:nonNumeric><div style="font-weight:bold;display:inline;"></div><div style="font-weight:bold;display:inline;"></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center;"><div style="font-weight:bold;display:inline;">Amendment No.&#160;<ix:nonNumeric name="dei:InvestmentCompanyRegistrationAmendmentNumber" contextRef="P01_13_2023To01_13_2023">10</ix:nonNumeric></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:right;"><div style="font-weight:bold;display:inline;"></div><ix:nonNumeric name="dei:InvestmentCompanyRegistrationAmendment" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-true">&#9746;</ix:nonNumeric><div style="font-weight:bold;display:inline;"></div><div style="font-weight:bold;display:inline;"></div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P01_13_2023To01_13_2023">BlackRock Debt Strategies Fund, Inc.</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified In Charter) </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="P01_13_2023To01_13_2023">100 Bellevue Parkway</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="P01_13_2023To01_13_2023">Wilmington</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="P01_13_2023To01_13_2023" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="P01_13_2023To01_13_2023">19809</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices) </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, including Area Code: (<ix:nonNumeric name="dei:CityAreaCode" contextRef="P01_13_2023To01_13_2023">800</ix:nonNumeric>) <div style="white-space:nowrap;display:inline;"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="P01_13_2023To01_13_2023">882-0052</ix:nonNumeric></div> </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:ContactPersonnelName" contextRef="P01_13_2023To01_13_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">John M. Perlowski, President</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">BlackRock Debt Strategies Fund, Inc. </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="P01_13_2023To01_13_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">55 East 52nd Street</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="P01_13_2023To01_13_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">New York</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="P01_13_2023To01_13_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis" format="ixt-sec:stateprovnameen">New York</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="P01_13_2023To01_13_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">10055</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Name and Address of Agent For Service) </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><div style="font-style:italic;display:inline;">Copies of information to: </div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Margery K. Neale, Esq. </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Elliot J. Gluck, Esq. </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Willkie Farr&#160;&amp; Gallagher LLP </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">787 Seventh Avenue </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">New York, New York 10019 </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-weight:bold;display:inline;">Approximate Date of Commencement of Proposed Public Offering:</div> <ix:nonNumeric name="dei:ApproximateDateOfCommencementOfProposedSaleToThePublic" contextRef="P01_13_2023To01_13_2023">From time to time after the effective date of this Registration Statement.</ix:nonNumeric> </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, check the following box&#160;&#160;<ix:nonNumeric name="dei:DividendOrInterestReinvestmentPlanOnly" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric> </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any securities being registered on this Form will be offered on a delayed or continuous basis in reliance on Rule 415 under the Securities Act of 1933 (&#8220;Securities Act&#8221;), other than securities offered in connection with a dividend reinvestment plan, check the following box&#160;&#160;<ix:nonNumeric name="dei:DelayedOrContinuousOffering" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-true">&#9746;</ix:nonNumeric> </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this Form is a registration statement pursuant to General Instruction A.2 or a post-effective amendment thereto, check the following box&#160;&#160;<ix:nonNumeric name="cef:PrimaryShelfFlag" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-true">&#9746;</ix:nonNumeric> </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this Form is a registration statement pursuant to General Instruction B or a post-effective amendment thereto that will become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box&#160;&#160;<ix:nonNumeric name="dei:EffectiveUponFiling462e" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric> </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction B to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box&#160;&#160;<ix:nonNumeric name="dei:AdditionalSecuritiesEffective413b" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric> </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It is proposed that this filing will become effective (check appropriate box): </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:EffectiveWhenDeclaredSection8c" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-true">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">when declared effective pursuant to Section&#160;8(c) of the Securities Act </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If appropriate, check the following box: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:NewEffectiveDateForPreviousFiling" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This [post-effective] amendment designates a new effective date for a previously filed [post-effective amendment] [registration statement]. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:AdditionalSecurities462b" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is: <div style="text-decoration:underline;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:NoSubstantiveChanges462c" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is: <div style="text-decoration:underline;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:ExhibitsOnly462d" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-true">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is: <ix:nonNumeric name="dei:ExhibitsOnly462dFileNumber" contextRef="P01_13_2023To01_13_2023">333-267429</ix:nonNumeric>. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check each box that appropriately characterizes the Registrant: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;"><ix:nonNumeric name="cef:RegisteredClosedEndFundFlag" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-true">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Registered <div style="white-space:nowrap;display:inline;">Closed-End</div> Fund <div style="white-space:nowrap;display:inline;">(closed-end</div> company that is registered under the Investment Company Act of 1940 (the &#8220;Investment Company Act&#8221;)). </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;"><ix:nonNumeric name="cef:BusinessDevelopmentCompanyFlag" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Business Development Company <div style="white-space:nowrap;display:inline;">(closed-end</div> company that intends or has elected to be regulated as a business development company under the Investment Company Act). </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;"><ix:nonNumeric name="cef:IntervalFundFlag" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Interval Fund (Registered <div style="white-space:nowrap;display:inline;">Closed-End</div> Fund or a Business Development Company that makes periodic repurchase offers under Rule <div style="white-space:nowrap;display:inline;">23c-3</div> under the Investment Company Act). </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;"><ix:nonNumeric name="cef:PrimaryShelfQualifiedFlag" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-true">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">A.2 Qualified (qualified to register securities pursuant to General Instruction A.2 of this Form). </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:EntityWellKnownSeasonedIssuer" contextRef="P01_13_2023To01_13_2023" format="ixt-sec:yesnoballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Well-Known Seasoned Issuer (as defined by Rule 405 under the Securities Act). </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Emerging Growth Company (as defined by Rule <div style="white-space:nowrap;display:inline;">12b-2</div> under the Securities and Exchange Act of 1934). </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;"><div style="display:inline;">&#9744;</div></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">If an Emerging Growth Company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left;"><ix:nonNumeric name="cef:NewCefOrBdcRegistrantFlag" contextRef="P01_13_2023To01_13_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">New Registrant (registered or regulated under the Investment Company Act for less than 12 calendar months preceding this filing). </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div></div></div> <div><div style="background-color:white;display: inline;"><div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div><div></div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EXPLANATORY NOTE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Post-Effective Amendment No. 1 to the Registrant&#8217;s Registration Statement on Form N-2 (File <span style="white-space:nowrap">Nos.&#160;333-267429</span> and <span style="white-space:nowrap">811-08603)</span> is being filed pursuant to Rule 462(d) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), solely for the purpose of filing exhibits to the Registration Statement. Accordingly, this Post-Effective Amendment No.&#160;1 consists only of a facing page, this explanatory note and Part C of the Registration Statement setting forth the exhibits to the Registration Statement. This Post-Effective Amendment No.&#160;1 does not modify any other part of the Registration Statement. Pursuant to Rule 462(d) under the Securities Act, this Post-Effective Amendment No.&#160;1 shall become effective immediately upon filing with the Securities and Exchange Commission. The contents of the Registration Statement are hereby incorporated by reference. </p>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">PART C </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Other Information </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;25.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements And Exhibits </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The agreements included or incorporated by reference as exhibits to this Registration Statement contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties were made solely for the benefit of the other parties to the applicable agreement and (i)&#160;were not intended to be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate; (ii)&#160;may have been qualified in such agreement by disclosures that were made to the other party in connection with the negotiation of the applicable agreement; (iii)&#160;may apply contract standards of &#8220;materiality&#8221; that are different from &#8220;materiality&#8221; under the applicable securities laws; and (iv)&#160;were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Registrant acknowledges that, notwithstanding the inclusion of the foregoing cautionary statements, it is responsible for considering whether additional specific disclosures of material information regarding material contractual provisions are required to make the statements in this Registration Statement not misleading. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:96%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(1)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Financial Statements</td></tr></table>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:96%"></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/000119312522065641/d296099dncsr.htm">Part A: The annual report to the Fund&#8217;s shareholders for the fiscal year ended December&#160;31, 2021 (the &#8220;2021 Annual Report&#8221;) is incorporated by reference.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/000119312522236278/d366274dncsrs.htm">Part A: The semi-annual report to the Fund&#8217;s shareholders for the fiscal period ended June&#160;30, 2022 (the &#8220;2022 Semi-Annual Report&#8221;) is incorporated by reference.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001051003/000119312522065641/d296099dncsr.htm">Part B: Audited financial statements and financial highlights for the fiscal year ended December&#160;31, 2021 and related Report of Independent Registered Public Accounting Firm are incorporated herein by reference to the 2021 Annual Report. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/000119312522236278/d366274dncsrs.htm">Part B: Unaudited financial statements and financial highlights for the fiscal period ended June&#160;30, 2022 are incorporated herein by reference to the 2022 Semi-Annual Report.</a></td></tr></table>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:96%"></td></tr>
<tr style="font-size:1pt">
<td style="height:18pt"></td>
<td style="height:18pt" colspan="2"></td></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(2)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Exhibits</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:7%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td style="width:91%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(a)(1)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/0000950130-98-000097.txt">Articles of Incorporation, dated January<span style="text-decoration:underline"></span>&#160;12, 1998, are incorporated by reference to Exhibit (a)<span style="text-decoration:underline"></span>&#160;to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> filed on January<span style="text-decoration:underline"></span>&#160;12, 1998.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(a)(2)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/000134100414000523/exa2.htm">Articles of Amendment, dated September<span style="text-decoration:underline"></span>&#160;14, 2006, are incorporated by reference to Exhibit (a)(2) to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-196682)</span> filed on June<span style="text-decoration:underline"></span>&#160;11, 2014.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(a)(3)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/000134100414000523/exa3.htm">Articles Supplementary, dated September<span style="text-decoration:underline"></span>&#160;17, 2010, are incorporated by reference to Exhibit (a)(2) to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-196682)</span> filed on June<span style="text-decoration:underline"></span>&#160;11, 2014.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(a)(4)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/000134100414000523/exa4.htm">Articles of Amendment, dated December<span style="text-decoration:underline"></span>&#160;9, 2013, are incorporated by reference to Exhibit (a)(2) to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-196682)</span> filed on June<span style="text-decoration:underline"></span>&#160;11, 2014.</a></td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-1 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:7%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td style="width:91%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(b)(1)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/000119312510213634/dex31.htm">Amended and Restated Bylaws, dated September<span style="text-decoration:underline"></span>&#160;17, 2010, are incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s Report on Form <span style="white-space:nowrap">8-K</span> as filed with the Securities and Exchange Commission on September<span style="text-decoration:underline"></span>&#160;21, 2010.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(b)(2)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/000119312522244995/d320889dex99b2.htm">Amendment No.<span style="text-decoration:underline"></span>&#160;1 to the Amended and Restated Bylaws is incorporated by reference to Exhibit (b)(2) to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-267429)</span> filed on September<span style="text-decoration:underline"></span>&#160;14, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(c)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Inapplicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(d)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Portions of Articles of Incorporation and the Amended and Restated Bylaws of the Registrant defining the Rights of Stockholders are incorporated by reference to Exhibits <a href="http://www.sec.gov/Archives/edgar/data/1051003/0000950130-98-000097.txt">(a)(1)</a> and <a href="http://www.sec.gov/Archives/edgar/data/1051003/000134100414000523/exa2.htm">(b)(1)</a>.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(e)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/000134100414000523/exe.htm">Automatic Dividend Reinvestment Plan is incorporated by reference to Exhibit (e)<span style="text-decoration:underline"></span>&#160;to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-196682)</span> filed on June<span style="text-decoration:underline"></span>&#160;11, 2014.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(f)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Inapplicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(g)(1)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/000134100414000523/exg1.htm">Investment Management Agreement between the Registrant and BlackRock Advisors, LLC is incorporated by reference to Exhibit (g)(1) to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File <span style="white-space:nowrap">No.&#160;333-196682)</span> filed on June&#160;11, 2014. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(g)(2)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/000119312522244995/d320889dex99g2.htm"><span style="white-space:nowrap">Sub-Investment</span> Advisory Agreement between the Registrant and BlackRock International Limited is incorporated by reference to Exhibit (g)(2) to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-267429)</span> filed on September<span style="text-decoration:underline"></span>&#160;14, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(g)(3)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99g4.htm">Amended and Restated Master Advisory Fee Waiver Agreement is incorporated by reference to Exhibit (g)(4) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust, filed on January&#160;12, 2022</a>.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(g)(4)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99g5.htm">Amendment No.&#160;1 to Amended and Restated&#160;Master Advisory&#160;Fee&#160;Waiver Agreement&#160;is incorporated by reference to Exhibit (g)(5) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust, filed on January&#160;12, 2022</a>.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(g)(5)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99g6.htm">Amendment No.&#160;2 to Amended and Restated&#160;Master Advisory&#160;Fee&#160;Waiver Agreement is incorporated by reference to Exhibit (g)(6) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust, filed on January&#160;12, 2022</a>.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(g)(6)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99g7.htm">Amendment No.&#160;3 to Amended and Restated&#160;Master Advisory&#160;Fee&#160;Waiver Agreement is incorporated by reference to Exhibit (g)(7) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust, filed on January&#160;12, 2022</a>.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(g)(7)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99g8.htm">Amendment No.&#160;4 to Amended and Restated&#160;Master Advisory&#160;Fee&#160;Waiver Agreement is incorporated by reference to Exhibit (g)(8) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust, filed on January&#160;12, 2022</a>.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(g)(8)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99g9.htm">Amendment No.&#160;5 to Amended and Restated&#160;Master Advisory&#160;Fee&#160;Waiver Agreement is incorporated by reference to Exhibit (g)(9) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust, filed on January&#160;12, 2022</a>.</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-2 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:7%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td style="width:91%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(g)(9)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1832871/000119312522204326/d791219dex99g8.htm">Form of Amendment No.<span style="text-decoration:underline"></span>&#160;6 to Amended and Restated Master Advisory Fee Waiver Agreement is incorporated by reference to Exhibit (g)(8) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock 2037 Municipal Target Term Trust, filed on July<span style="text-decoration:underline"></span>&#160;28, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(h)(1)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d447340dex99h1.htm">Form of Distribution Agreement is filed herewith. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(h)(2)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d447340dex99h2.htm">Form of <span style="white-space:nowrap">Sub-Placement</span> Agent Agreement is filed herewith. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(i)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99i.htm">Form of BlackRock Fixed-Income Complex Third Amended and Restated Deferred Compensation Plan is incorporated by reference to Exhibit (i)&#160;to the Registration on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust, filed on January&#160;12, 2022</a>.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(j)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99j.htm">Form of Master Custodian Agreement is incorporated by reference to Exhibit (j)&#160;to the Registration on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust, filed on January&#160;12, 2022</a>.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(k)(1)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99k1.htm">Form of Amended and Restated Transfer Agency and Service Agreement is incorporated by reference to Exhibit (k)(1) to the Registration on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust, filed on January&#160;12, 2022</a>.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(k)(2)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99k2.htm">Form of Administration and Accounting Services Agreement is incorporated by reference to Exhibit (k)(2) to the Registration on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust, filed on January&#160;12, 2022</a>.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(k)(3)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/000119312513361455/d584134dex9913a.htm">Amendment No. 1 to the Amended and Restated Credit Agreement and Amendment No. 2 to the Amended and Restated Credit Agreement between the Registrant and State Street Bank and Trust Company are incorporated by reference to Exhibits 13(a)-(c) to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-14</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-190188)</span> filed on September<span style="text-decoration:underline"></span>&#160;9, 2013.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(k)(4)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/000134100414000523/exk4.htm">Amendment No.<span style="text-decoration:underline"></span>&#160;3 to the Amended and Restated Credit Agreement between the Registrant and State Street Bank and Trust Company is incorporated by reference to Exhibit (k)(4) to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-196682)</span> filed on June<span style="text-decoration:underline"></span>&#160;11, 2014.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(k)(5)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1259708/000134100414000355/exh992_k4.htm">Form of Amendment No.&#160;4 to the Amended and Restated Credit Agreement between the Registrant and State Street Bank and Trust Company is incorporated by reference to Exhibit (k)(4) to <span style="white-space:nowrap">Pre-Effective</span> Amendment No.&#160;1 to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File <span style="white-space:nowrap">No.&#160;333-196682)</span> filed on October&#160;9, 2014.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(k)(6)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/000119312522313179/d320889dex99k6.htm">Form of Amendment No.&#160;5 to the Amended and Restated Credit Agreement between the Registrant and State Street Bank and Trust Company is incorporated herein by reference to Exhibit (k)(6) of the Registrant&#8217;s Registration Statement on Form N-2 (File No. 333-267429) filed on December 28, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(k)(7)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Form of Ninth Amended and Restated Securities Lending Agreement between the Registrant and BlackRock Investment Management, LLC is filed herewith.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">(k)</span>(8)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1528988/000119312522063292/d294767dex99k4.htm">BlackRock <span style="white-space:nowrap">Closed-End</span> Rule <span style="white-space:nowrap">12d1-4</span> Fund of Funds Investment Agreement between the Registrant and Advisors Disciplined Trust, dated as of January<span style="text-decoration:underline"></span>&#160;19, 2022 is incorporated by reference to Exhibit (k)(4) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Utilities, Infrastructure<span style="text-decoration:underline"></span>&#160;&amp; Power Opportunities Trust, filed on March<span style="text-decoration:underline"></span>&#160;3, 2022</a>.</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-3 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:7%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td style="width:91%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(k)(9)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1528988/000119312522063292/d294767dex99k5.htm">BlackRock <span style="white-space:nowrap">Closed-End</span> Rule <span style="white-space:nowrap">12d1-4</span> Fund of Funds Investment Agreement between the Registrant, Rydex Dynamic Funds, Rydex Series Funds, Rydex Variable Trust, Guggenheim Funds Trust, Guggenheim Variable Funds Trust, Guggenheim Strategy Funds Trust, Transparent Value Trust, Guggenheim Active Allocation Fund, Guggenheim Energy<span style="text-decoration:underline"></span>&#160;&amp; Income Fund, Guggenheim Strategic Opportunities Fund, Guggenheim Taxable Municipal Bond<span style="text-decoration:underline"></span>&#160;&amp; Investment Grade Debt Trust and Guggenheim Unit Investment Trusts (Guggenheim Defined Portfolios), dated as of January<span style="text-decoration:underline"></span>&#160;19, 2022 is incorporated by reference to Exhibit (k)(5) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Utilities, Infrastructure<span style="text-decoration:underline"></span>&#160;&amp; Power Opportunities Trust, filed on March<span style="text-decoration:underline"></span>&#160;3, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(k)(10)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1528988/000119312522063292/d294767dex99k6.htm">BlackRock <span style="white-space:nowrap">Closed-End</span> Rule <span style="white-space:nowrap">12d1-4</span> Fund of Funds Investment Agreement between the Registrant, FT Series and First Trust Exchange-Traded Fund VIII dated as of January<span style="text-decoration:underline"></span>&#160;19, 2022 is incorporated by reference to Exhibit (k)(6) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Utilities, Infrastructure<span style="text-decoration:underline"></span>&#160;&amp; Power Opportunities Trust, filed on March<span style="text-decoration:underline"></span>&#160;3, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(k)(11)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1528988/000119312522063292/d294767dex99k7.htm">BlackRock <span style="white-space:nowrap">Closed-End</span> Rule <span style="white-space:nowrap">12d1-4</span> Fund of Funds Investment Agreement between the Registrant, RiverNorth Funds, RiverNorth/DoubleLine Strategic Opportunity Fund, Inc., RiverNorth Specialty Finance Corporation, RiverNorth Opportunistic Municipal Income Fund, Inc., RiverNorth Managed Duration Municipal Income Fund, Inc., RiverNorth Managed Duration Municipal Income Fund II, Inc., RiverNorth Flexible Municipal Income Fund, Inc. and RiverNorth Flexible Municipal Income Fund II, Inc. dated as of January<span style="text-decoration:underline"></span>&#160;19, 2022 is incorporated by reference to Exhibit (k)(7) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Utilities, Infrastructure<span style="text-decoration:underline"></span>&#160;&amp; Power Opportunities Trust, filed on March<span style="text-decoration:underline"></span>&#160;3, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(k)(12)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1528988/000119312522063292/d294767dex99k8.htm">BlackRock <span style="white-space:nowrap">Closed-End</span> Rule <span style="white-space:nowrap">12d1-4</span> Fund of Funds Investment Agreement between the Registrant, Thrivent Mutual Funds and Thrivent Series Fund, Inc. dated as of January<span style="text-decoration:underline"></span>&#160;26, 2022 is incorporated by reference to Exhibit (k)(8) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Utilities, Infrastructure<span style="text-decoration:underline"></span>&#160;&amp; Power Opportunities Trust, filed on March<span style="text-decoration:underline"></span>&#160;3, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(l)(1)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/000119312522313179/d320889dex99l1.htm">Opinion and Consent of Counsel is incorporated herein by reference to Exhibit (l)(1) of the Registrant&#8217;s Registration Statement on Form N-2 (File No. 333-267429) filed on December 28, 2022. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(l)(2)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d447340dex99l2.htm">Opinion and Consent of Counsel to the Registrant is filed herewith. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(m)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Inapplicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(n)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/000119312522313179/d320889dex99n.htm">Independent Registered Public Accounting Firm Consent is incorporated herein by reference to Exhibit (n) of the Registrant&#8217;s Registration Statement on Form N-2 (File No. 333-267429) filed on December 28, 2022. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(o)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Inapplicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(p)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Inapplicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(q)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Inapplicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(r)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000119312523004873/d421862dex99r.htm">Code of Ethics of the Registrant, BlackRock Advisors, LLC, BlackRock International Limited and BlackRock (Singapore) Limited is incorporated herein by reference to Exhibit (r) of Post-Effective Amendment No. 1 to the Registration Statement on Form N-2 of BlackRock Floating Rate Income Trust (File No. 333-266318), filed on January 9, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(s)(1)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/000119312522244995/d320889dexfilingfees.htm">Calculation of Filing Fee Tables (Shelf Registration Statement) is incorporated herein by reference to Exhibit (s) of the Registrant&#8217;s Registration Statement on Form N-2 (File No. 333-267429) filed on September 14, 2022. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(s)(2)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1051003/000119312522313179/d320889dexfilingfees.htm">Calculation of Filing Fee Tables Calculation of Filing Fee Tables (Shelf Registration Statement) is incorporated by reference to Exhibit (s) to Pre-Effective Amendment No. 1 to the Registrant&#8217;s Registration Statement on Form N-2 (File No. <span style="white-space:nowrap">333-267429),</span> filed on December 28, 2022. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(s)(3)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d447340dex99s3.htm">Calculation of Filing Fee Tables (Final Prospectus Dated January 13, 2023) is filed herewith. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(t)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000119312522200963/d383966dex99t.htm">Power of Attorney is incorporated by reference to Exhibit (t)&#160;to the Registration on Form <span style="white-space:nowrap">N-2</span> of BlackRock Floating Rate Income Trust, filed on July&#160;25, 2022</a>.</td></tr>
</table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;26.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Marketing Arrangements </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information contained under the section entitled &#8220;Plan of Distribution&#8221; in the Prospectus is incorporated by reference, and any information concerning any underwriters will be contained in the accompanying Prospectus Supplement, if any. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-4 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;27. Other Expenses Of Issuance And Distribution </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the estimated expenses to be incurred in connection with the offering described in this Registration Statement: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:84%"></td>

<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Registration fee</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">16,538.95</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NYSE listing fee</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">2,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting fees and expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">4,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">80,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FINRA fee</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">22,386</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">125,424.95</td>
<td style="white-space:nowrap;vertical-align:bottom">(1)&#160;</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Estimate is based on the aggregate estimated expenses to be incurred during a three year shelf offering&#160;period. </p></td></tr></table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;28.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Persons Controlled By Or Under Common Control With The Registrant </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;29.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Number Of Holders Of Shares </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;15, 2022:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:72%"></td>

<td style="vertical-align:bottom;width:24%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Title&#160;Of&#160;Class</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number&#160;Of&#160;Record&#160;Holders</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Shares of Beneficial Interest</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">240</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;30.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Indemnification </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">Section&#160;2-418</span> of the General Corporation Law of the State of Maryland, Article V of the Registrant&#8217;s Charter, Article IV of the Registrant&#8217;s Bylaws and the Investment Management Agreement each provides for indemnification. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Article V of the Registrant&#8217;s Charter provides as follows: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(4) Each director and each officer of the Corporation shall be indemnified and advanced expenses by the Corporation to the full extent permitted by the General Laws of the State of Maryland now or hereafter in force, including the advance of expenses under the procedures and to the full extent permitted by law subject to the requirements of the Investment Company Act. The foregoing rights of indemnification shall not be exclusive of any other rights to which those seeking indemnification may be entitled. No amendment of these Articles of Incorporation or repeal of any provision hereof shall limit or eliminate the benefits provided to directors and officers under this provision in connection with any act or omission that occurred prior to such amendment or repeal. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(5) To the fullest extent permitted by the General Laws of the State of Maryland or decisional law, as amended or interpreted, subject to the requirements of the Investment Company Act, no director or officer of the Corporation shall be personally liable to the Corporation or its security holders for money damages. No amendment of these Articles of Incorporation or repeal of any provision hereof shall limit or eliminate the benefits provided to directors and officers under this provision in connection with any act or omission that occurred prior to such amendment or repeal. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-5 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Article IV of the Registrant&#8217;s Amended and Restated Bylaws provides as follows: </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;1. <span style="text-decoration:underline">No Personal Liability of Directors or Officers</span>. No Director, advisory board member or officer of the Fund shall be subject in such capacity to any personal liability whatsoever to any Person, save only liability to the Fund or its shareholders arising from bad faith, willful misfeasance, gross negligence or reckless disregard for his or her duty to such Person; and, subject to the foregoing exception, all such Persons shall look solely to the assets of the Fund for satisfaction of claims of any nature arising in connection with the affairs of the Fund. If any Director, advisory board member or officer, as such, of the Fund, is made a party to any suit or proceeding to enforce any such liability, subject to the foregoing exception, such person shall not, on account thereof, be held to any personal liability. Any repeal or modification of the Charter or this Article IV Section&#160;1 shall not adversely affect any right or protection of a Director, advisory board member or officer of the Fund existing at the time of such repeal or modification with respect to acts or omissions occurring prior to such repeal or modification. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;2. <span style="text-decoration:underline">Mandatory Indemnification</span>. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) The Fund hereby agrees to indemnify each person who is or was a Director, advisory board member or officer of the Fund (each such person being an &#8220;Indemnitee&#8221;) to the full extent permitted under the Charter. In addition, the Fund may provide greater but not lesser rights to indemnification pursuant to a contract approved by at least a majority of Directors between the Fund and any Indemnitee. Notwithstanding the foregoing no Indemnitee shall be indemnified hereunder against any liability to any person or any expense of such Indemnitee arising by reason of (i)&#160;willful misfeasance, (ii)&#160;bad faith, (iii)&#160;gross negligence, or (iv)&#160;reckless disregard of the duties involved in the conduct of the Indemnitee&#8217;s position (the conduct referred to in such clauses (i)&#160;through (iv) being sometimes referred to herein as &#8220;Disabling Conduct&#8221;). Furthermore, with respect to any action, suit or other proceeding voluntarily prosecuted by any Indemnitee as plaintiff, indemnification shall be mandatory only if the prosecution of such action, suit or other proceeding by such Indemnitee (A)&#160;was authorized by a majority of the Directors or (B)&#160;was instituted by the Indemnitee to enforce his or her rights to indemnification hereunder in a case in which the Indemnitee is found to be entitled to such indemnification. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the foregoing, unless otherwise provided in any agreement relating to indemnification between an Indemnitee and the Fund, no indemnification shall be made hereunder unless there has been a determination (i)&#160;by a final decision on the merits by a court or other body of competent jurisdiction before whom the issue of entitlement to indemnification hereunder was brought that such Indemnitee is entitled to indemnification hereunder or, (ii)&#160;in the absence of such a decision, by (A)&#160;a majority vote of a quorum of those Directors who are both Independent Directors and not parties to the proceeding (&#8220;Independent <span style="white-space:nowrap">Non-Party</span> Directors&#8221;), that the Indemnitee is entitled to indemnification hereunder, or (B)&#160;if such quorum is not obtainable or even if obtainable, if such majority so directs, a Special Counsel in a written opinion concludes that the Indemnitee should be entitled to indemnification hereunder. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) Subject to any limitations provided by the 1940 Act and the Charter, the Fund shall have the power and authority to indemnify and provide for the advance payment of expenses to employees, agents and other Persons providing services to the Fund or serving in any capacity at the request of the Fund to the full extent permitted for corporations organized under the corporations laws of the state in which the Fund was formed, provided that such indemnification has been approved by a majority of the Directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Any repeal or modification of the Charter or Section&#160;2 of this Article IV shall not adversely affect any right or protection of any person who is or was a Director, any advisory board member or any officer of the Fund existing at the time of such repeal or modification with respect to acts or omissions occurring prior to such repeal or modification. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;3. <span style="text-decoration:underline">Good Faith Defined; Reliance on Experts</span>. For purposes of any determination under this Article IV, a person shall be deemed to have acted in good faith and in a manner such person reasonably believed to be in the best interests of the Fund, or, with respect to any criminal action or proceeding, to have had no reasonable cause to believe such person&#8217;s conduct was unlawful, if such person&#8217;s action is based on the records or books of account of the Fund, or on information supplied to such person by the officers of the Fund in the course of their duties, or </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-6 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
on the advice of legal counsel for the Fund or on information or records given or reports made to the Fund by an independent certified public accountant or by an appraiser or other expert or agent selected with reasonable care by the Fund. The provisions of this Article IV Section&#160;3 shall not be deemed to be exclusive or to limit in any way the circumstances in which a person may be deemed to have met the applicable standard of conduct set forth in this Article IV. Each Director and officer or employee of the Fund shall, in the performance of his or her duties, be fully and completely justified and protected with regard to any act or any failure to act resulting from reliance in good faith upon the books of account or other records of the Fund, upon an opinion of counsel selected by the Board of Directors or a committee of the Directors, or upon reports made to the Fund by any of the Fund&#8217;s officers or employees or by any advisor, administrator, manager, distributor, dealer, accountant, appraiser or other expert or consultant selected with reasonable care by the Board of Directors or a committee of the Directors, officers or employees of the Fund, regardless of whether such counsel or expert may also be a Director. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;4. <span style="text-decoration:underline">Survival of Indemnification and Advancement of Expenses</span>. The indemnification and advancement of expenses provided by, or granted pursuant to, this Article IV shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director or officer and shall inure to the benefit of the heirs, executors and administrators of such a person. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;5. <span style="text-decoration:underline">Insurance</span>. The Directors may maintain insurance for the protection of the Fund&#8217;s property, the shareholders, Directors, officers, employees and agents in such amount as the Directors shall deem adequate to cover possible tort liability, and such other insurance as the Directors in their sole judgment shall deem advisable or is required by the 1940 Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;6. <span style="text-decoration:underline">Subrogation</span>. In the event of payment by the Fund to an Indemnitee under the Charter or these Bylaws, the Fund shall be subrogated to the extent of such payment to all of the rights of recovery of the Indemnitee, who shall execute such documents and do such acts as the Fund may reasonably request to secure such rights and to enable the Fund effectively to bring suit to enforce such rights. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Registrant has also entered into an agreement with Directors and officers of the Registrant entitled to indemnification under the charter and bylaws of the Fund pursuant to which the Registrant has agreed to advance expenses and costs incurred by the indemnitee in connection with any matter in respect of which indemnification might be sought pursuant to the charter and bylaws of the Fund to the maximum extent permitted by law. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Reference is also made to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Sections 10 and 11 of the Registrant&#8217;s Investment Management Agreement </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Section&#160;8 of the Registrant&#8217;s Distribution Agreement with the Distributor </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, the Registrant and the other funds in the BlackRock Fixed-Income Complex jointly maintain, at their own expense, E&amp;O/D&amp;O insurance policies for the benefit of its Directors, officers and certain affiliated persons. The Registrant pays a pro rata portion of the premium on such insurance policies. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;31.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Business And Other Connections Of Investment Advisor </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Advisors, LLC, a limited liability company organized under the laws of Delaware (the &#8220;Advisor&#8221;), acts as investment adviser to the Registrant. The Registrant is fulfilling the requirement of this Item 31 to provide a list of the officers and directors of the Advisor, together with information as to any other business, profession, vocation or employment of a substantial nature engaged in by the Advisor or those officers and directors during the past two years, by incorporating by reference the information contained in the Form ADV of the Advisor filed with the commission pursuant to the Investment Advisers Act of 1940 (Commission File <span style="white-space:nowrap">No.&#160;801-47710).</span> </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-7 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;32.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Location Of Accounts And Records </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Omitted pursuant to the Instruction of Item 32 of Form <span style="white-space:nowrap">N-2.</span> </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;33.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Management Services </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Not Applicable </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;34.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Undertakings </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Not applicable. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Not applicable. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The securities being registered will be offered on a delayed or continuous basis in reliance on Rule 415 under the Securities Act of 1933. Accordingly, the Registrant undertakes: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(a)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">to file, during and period in which offers or sales are being made, a post-effective amendment to this Registration Statement: </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(1)&#160;to include any prospectus required by Section&#160;10(a)(3) of the Securities Act of 1933; </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(2) to reflect in the prospectus any facts or events after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(3)&#160;to include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(b)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">that for the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(c)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(d)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">that, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-8 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(1) if the Registrant is relying on Rule&#160;430B [17 CFR 230.430B]: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(A) Each prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(B) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (x), or (xi)&#160;for the purpose of providing the information required by Section&#160;10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. <span style="font-style:italic">Provided, however</span>, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(2) if the Registrant is subject to Rule 430C [17 CFR 230.430C]: Each prospectus filed pursuant to Rule 424(b) under the Securities Act of 1933 as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(e)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">that for the purpose of determining liability of the Registrant under the Securities Act of 1933 to any purchaser in the initial distribution of securities: The undersigned Registrant undertakes that in a primary offering of securities of the undersigned Registrant pursuant to this Registration Statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to the purchaser: (1)&#160;any preliminary prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant to Rule 424 under the Securities Act of 1933; (2) free writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to by the undersigned Registrant; (3)&#160;the portion of any other free writing prospectus or advertisement pursuant to Rule 482 under the Securities Act of 1933 relating to the offering containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned Registrant; and (4)&#160;any other communication that is an offer in the offering made by the undersigned Registrant to the purchaser. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-9 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(4)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">If applicable: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(a)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">For the purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of a registration statement in reliance upon Rule 430A and contained in the form of prospectus filed by the Registrant under Rule 424(b)(1) under the Securities Act of 1933 shall be deemed to be part of the Registration Statement as of the time it was declared effective. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(b)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of the securities at that time shall be deemed to be the initial bona fide offering thereof. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(5)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant&#8217;s f pursuant to Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934 that is incorporated by reference into the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(6)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(7)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The Registrant undertakes to send by first class mail or other means designed to ensure equally prompt delivery within two business days of receipt of a written or oral request, any prospectus or Statement of Additional Information constituting Part B of this Registration Statement. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-10 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Fund has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, and the State of New York, on the 13th day of January, 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:7%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:92%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3">BLACKROCK DEBT STRATEGIES FUND, INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John M. Perlowski</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">John M. Perlowski</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">President and Chief Executive Officer</td></tr>
</table></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities indicated and on the 13th day of January 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:35%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:30%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:33%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Signature</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ John M. Perlowski</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(John M. Perlowski)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Director, President and Chief Executive Officer<br />(Principal Executive Officer)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap" align="center">January 13, 2023</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Trent Walker</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Trent Walker)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Chief Financial Officer</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">(Principal Financial and Accounting Officer)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap" align="center">January 13, 2023</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">C<small>YNTHIA</small> L. E<small>GAN</small>*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Cynthia L. Egan)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Director</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">F<small>RANK</small> J. F<small>ABOZZI</small>*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Frank J. Fabozzi)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Director</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">L<small>ORENZO</small> A. F<small>LORES</small>*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Lorenzo A. Flores)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Director</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">S<small>TAYCE</small> D. H<small>ARRIS</small>*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Stayce D. Harris)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Director</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">J. P<small>HILLIP</small> H<small>OLLOMAN</small>*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(J. Phillip Holloman)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Director</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">R. G<small>LENN</small> H<small>UBBARD</small>*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(R. Glenn Hubbard)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Director</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">W. C<small>ARL</small> K<small>ESTER</small>*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(W. Carl Kester)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Director</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-11 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:35%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:30%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:33%"></td></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">C<small>ATHERINE</small> A. L<small>YNCH</small>*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Catherine A. Lynch)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Director</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">R<small>OBERT</small> F<small>AIRBAIRN</small>*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Robert Fairbairn)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Director</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*By: /s/ Janey Ahn</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">(Janey Ahn, <span style="white-space:nowrap"><span style="white-space:nowrap">Attorney-In-Fact)</span></span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap" align="center">January 13, 2023</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-12 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EXHIBIT INDEX </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:6%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(h)(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d447340dex99h1.htm">Form of Distribution Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(h)(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d447340dex99h2.htm">Form of Sub-Placement Agent Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(k)(7)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d447340dex99k7.htm">Form of Ninth Amended and Restated Securities Lending Agreement between the Registrant and BlackRock Investment Management, LLC </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(l)(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d447340dex99l2.htm">Opinion and Consent of Counsel to the Registrant </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(s)(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d447340dex99s3.htm">Calculation of Filing Fee Tables (Final Prospectus Dated January 13, 2023) </a></td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-13 </p>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(H)(1)
<SEQUENCE>2
<FILENAME>d447340dex99h1.htm
<DESCRIPTION>FORM OF DISTRIBUTION AGREEMENT
<TEXT>
<HTML><HEAD>
<TITLE>Form of Distribution Agreement</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Exhibit (h)(1) </I></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DISTRIBUTION AGREEMENT </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
DISTRIBUTION AGREEMENT (the &#147;<U>Agreement</U>&#148;) is made as of January 13, 2023 by and between BlackRock Debt Strategies Fund, Inc., a Maryland corporation (the &#147;<U>Fund</U>&#148;), and BlackRock Investments, LLC, a Delaware limited
liability company (the &#147;<U>Distributor</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>WITNESSETH</U>: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Fund is registered under the Investment Company Act of 1940, as amended, and the rules and regulations thereunder (collectively
called the &#147;<U>Investment Company Act</U>&#148;), as a diversified, <FONT STYLE="white-space:nowrap">closed-end,</FONT> management investment company; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Fund has filed, or may from time to time file, one or more registration statements on Form
<FONT STYLE="white-space:nowrap">N-2</FONT> pursuant to the Investment Company Act and the Securities Act of 1933, as amended, and the rules and regulations thereunder (collectively called the &#147;<U>Securities Act</U>&#148;), to register
additional shares of common stock, par value $0.10 per share (&#147;<U>common shares</U>&#148;), of the Fund, which may be issued and sold from time to time through various specified transactions, including <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">at-the-market</FONT></FONT> (&#147;<U>ATM</U>&#148;) offerings pursuant to Rule 415 under the Securities Act; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Distributor is registered as a broker-dealer under the provisions of the Securities Exchange Act of 1934 (the &#147;<U>Exchange
Act</U>&#148;) and is a member in good standing of the Financial Industry Regulatory Authority, Inc. (&#147;<U>FINRA</U>&#148;); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Fund and the Distributor wish to enter into an agreement with each other with respect to ATM offerings, from time to time, of the
Fund&#146;s common shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW THEREFORE, the parties agree as follows: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1. <U>Appointment of the Distributor; ATM Offerings</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the terms and conditions of this Agreement, the Fund hereby appoints the Distributor as its principal underwriter and placement
agent for the common shares of the Fund to be offered pursuant to a Registration Statement (as defined below) through ATM offerings from time to time (the &#147;<U>Shares</U>&#148;) and the Fund agrees that it will issue such Shares as the
Distributor may sell. The Distributor agrees to use reasonable efforts to identify opportunities for the sale of Shares, but the Distributor is not obligated to sell any specific number of the Shares (though the Distributor will only be authorized
to sell on any Offering Date (as defined below) the maximum number of Shares agreed to with the Fund pursuant to Section&nbsp;1(d) hereof) or purchase any Shares for its own account. The Shares will only be sold on such days as shall be agreed to by
the Distributor and the Fund (each, an &#147;<U>Offering Date</U>&#148;). The Distributor hereby accepts such appointment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The
Distributor acknowledges that Shares will be offered and sold only as set forth from time to time in a Registration Statement including, without limitation, pricing of Shares, handling of investor funds and payment of sales commissions. </P>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Fund may suspend or terminate any ATM offering of its Shares at any time. Upon notice to
the Distributor of the terms of such suspension or termination, the Distributor shall suspend the ATM offering of Shares in accordance with such terms until the Fund notifies the Distributor that such ATM offering may be resumed; <U>provided</U>,
<U>however</U>, that such suspension or termination shall not affect or impair the parties&#146; respective obligations with respect to the Shares sold hereunder prior to the giving of such notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The price per Share shall be determined by the Fund together with the Distributor by reference to trades on the Fund&#146;s primary
exchange. In no event shall the price per Share be less than the current net asset value per Share plus the per Share amount of the commission to be paid to the Distributor (the &#147;<U>Minimum Price</U>&#148;). The Fund may establish a minimum
sales price per Share on any Offering Date in excess of the Minimum Price (the &#147;<U>Minimum Sales Price</U>&#148;), and the Fund shall communicate such Minimum Sales Price to the Distributor. The Fund shall have sole discretion to establish a
Minimum Sales Price for any Offering Date and may consider, among other factors, the degree to which the Fund&#146;s market price per Share exceeds its net asset value per Share, and the amount of assets the Fund desires to raise through ATM
offerings. The Distributor shall suspend the sale of Shares if the per share price of the Shares is less than the Minimum Price or the Minimum Sales Price. The Distributor shall, together with the Fund, determine the maximum number of Shares to be
sold by the Distributor for any Offering Date, and the Distributor shall not be authorized to sell Shares on any Offering Date in excess of such maximum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Distributor will confirm to the Fund, following the close of trading on the Fund&#146;s primary exchange on each Offering Date for the
Shares, the number of Shares sold, the time of sale, the gross sales price per Share and the compensation payable to the Distributor, or to which the Distributor is entitled with respect to such sales. The Fund reserves the right to reject any order
in whole or in part. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Settlement for sales of the Shares pursuant to this Section&nbsp;1 will occur on the second business day
following the date on which such sales are made (each such day, a &#147;<U>Settlement Date</U>&#148;). On each Settlement Date, the Shares sold through the Distributor for settlement on such date shall be delivered by the Fund to the Distributor
against payment of the gross sales proceeds for the sale of such Shares, less the Distributor&#146;s sales commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) In selling
Shares, the Distributor shall act solely as an agent of the Fund and not as principal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2. <U>Representations and Warranties
by the Fund</U>. The Fund represents, warrants to and agrees with the Distributor, as of the date hereof and as of each Offering Date and Settlement Date, that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) A shelf registration statement on Form <FONT STYLE="white-space:nowrap">N-2</FONT> (File
<FONT STYLE="white-space:nowrap">No.&nbsp;333-267429</FONT> and <FONT STYLE="white-space:nowrap">811-08603)</FONT> (the &#147;<U>Registration Statement</U>&#148;) (i) has been prepared by the Fund in conformity with the requirements of the
Securities Act and the Investment Company Act in all material respects, (ii)&nbsp;has been filed with the U.S. Securities and Exchange Commission (the &#147;<U>Commission</U>&#148;) under the Securities Act and the Investment Company Act; the
Registration Statement sets forth the terms of the offering, sale and plan of distribution of the Shares and contains additional information concerning the Fund and its business, and (iii)&nbsp;heretofore became, and is, effective; no stop order of
the Commission preventing or suspending the use of the Prospectus (as defined below), or the effectiveness of the Registration Statement, has been issued, and no proceedings for such purpose have been instituted or, to the Fund&#146;s knowledge,
have been threatened by the Commission. Except where the context otherwise requires, &#147;<U>Registration Statement</U>,&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;2&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
as used herein, means, collectively, the various parts of the Registration Statement pertaining to the offering and sale of Shares, as amended, at the time of effectiveness for purposes of
Section&nbsp;11 of the Securities Act (the &#147;<U>Effective Time</U>&#148;), as such section applies to the Distributor, including (1)&nbsp;all documents filed as a part thereof or incorporated or deemed to be incorporated by reference therein,
(2)&nbsp;any information contained or incorporated by reference in a prospectus filed with the Commission pursuant to Rule&nbsp;424(b)(2) and/or Rule&nbsp;424(b)(5) under the Securities Act, to the extent such information is deemed pursuant to
Rule&nbsp;430B or Rule&nbsp;430C under the Securities Act to be part of the Registration Statement at the Effective Time, and (3)&nbsp;any registration statement filed to register the offer and sale of Shares pursuant to Rule&nbsp;462(b) under the
Securities Act. Except where the context otherwise requires, &#147;<U>Prospectus</U>,&#148; as used herein, means a final prospectus, including the related statement of additional information, relating to the Shares, filed by the Fund with the
Commission pursuant to Rule&nbsp;424(b)(2) and/or Rule&nbsp;424(b)(5) under the Securities Act, in the form furnished by the Fund to the Distributor in connection with the offering of the Shares, together with, if applicable, any final prospectus
supplement relating to the Shares attached to or used with such final prospectus, filed by the Fund with the Commission pursuant to Rule&nbsp;424(b)(2) and/or Rule 424(b)(5) under the Securities Act, in the form furnished by the Fund to the
Distributor in connection with the offering of the Shares. Any reference herein to the Registration Statement or the Prospectus shall be deemed to refer to and include the documents, if any, incorporated by reference, or deemed to be incorporated by
reference, therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Fund is duly registered under the Investment Company Act as a
<FONT STYLE="white-space:nowrap">closed-end</FONT> management investment company. A notification of registration of the Fund as an investment company under the Investment Company Act on Form <FONT STYLE="white-space:nowrap">N-8A</FONT> (the
&#147;<U>Investment Company Act Notification</U>&#148;) has been prepared by the Fund in conformity with the Investment Company Act and has been filed with the Commission and, at the time of filing thereof and at the time of filing any amendment or
supplement thereto, conformed in all material respects with all applicable provisions of the Investment Company Act. The Fund has not received any notice in writing from the Commission pursuant to Section&nbsp;8(e) of the Investment Company Act with
respect to the Investment Company Act Notification or the Registration Statement (or any amendment or supplement to either of them). No person is serving or acting as an officer, Director (as defined below) or investment adviser of the Fund except
in accordance with the provisions of the Investment Company Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Registration Statement, the Investment Company Act Notification
and the Prospectus as from time to time amended or supplemented each complied when it became effective or was filed (as the case may be), complies as of the date hereof and, as amended or supplemented, will comply, at each time of purchase of Shares
in connection with the ATM offerings, and at all times during which a prospectus is required by the Securities Act to be delivered in connection with any sale of Shares, in all material respects, with the requirements of the Securities Act and the
Investment Company Act; the Registration Statement did not, as of the Effective Time, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not
misleading; at no time during the period that begins on the earlier of the date of the Prospectus and the date the Prospectus was filed with the Commission and ends at the later of the time of purchase of Shares in connection with the ATM offerings,
and the end of the period during which a prospectus is required by the Securities Act to be delivered in connection with any sale of Shares did or will the Prospectus, as from time to time amended or supplemented, include an untrue statement of a
material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U>, <U>however</U>, that the Fund does not make any
representation or warranty with respect to any statement contained in the Registration Statement or the Prospectus in reliance upon and in conformity with information furnished in writing by the Distributor or any
<FONT STYLE="white-space:nowrap">sub-placement</FONT> agents (as defined below), or on the Distributor&#146;s or any <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent&#146;s behalf, to the Fund expressly for use in the Registration
Statement or the Prospectus (the &#147;<U>Agent Provided Information</U>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;3&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The financial statements incorporated by reference in the Registration Statement or the
Prospectus, together with the related notes and schedules, present fairly the financial position of the Fund as of the dates indicated and the results of operations, cash flows and changes in shareholders&#146; equity of the Fund for the periods
specified and have been prepared in compliance in all material respects with the requirements of the Securities Act, the Investment Company Act and the Exchange Act, and in conformity in all material respects with U.S. generally accepted accounting
principles applied on a consistent basis during the periods involved; the other financial and statistical data contained or incorporated by reference in the Registration Statement or the Prospectus are accurately and fairly presented, in all
material respects, and prepared on a basis consistent with the financial statements and books and records of the Fund in all material respects; there are no financial statements that are required to be included or incorporated by reference in the
Registration Statement or the Prospectus by the Securities Act, the Investment Company Act or the Exchange Act that are not included or incorporated by reference as required; and the Fund does not have any material liabilities or obligations, direct
or contingent (including any <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet obligations), not described in the Registration Statement (excluding the exhibits thereto). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) As of the date of this Agreement, the Fund has an authorized and outstanding capitalization as set forth in the Registration Statement and
the Prospectus and, with respect to any issuance and sale under this Agreement, the Fund shall have as of the date of the most recent amendment or supplement to the Registration Statement or Prospectus, an authorized and outstanding capitalization
as set forth in the Registration Statement and the Prospectus; all of the issued and outstanding shares of capital stock, including the Shares, of the Fund have been duly authorized and validly issued and are fully paid and <FONT
STYLE="white-space:nowrap">non-assessable</FONT> (except as described below and in the Registration Statement), have been issued in material compliance with all applicable securities laws and were not issued in violation of any preemptive right,
resale right, right of first refusal or similar right; the Shares will be duly listed, and admitted and authorized for trading, subject to official notice of issuance, on the exchange on which the Fund&#146;s Shares are listed and primarily trade
(the &#147;<U>Stock Exchange</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Fund has been duly formed, is validly existing and is in good standing under the laws of
Maryland, with full power and authority to own, lease and operate and conduct its business as described in the Registration Statement and the Prospectus and to issue, sell and deliver the Shares as contemplated herein. The Fund is duly qualified to
do business as a foreign entity and is in good standing in each jurisdiction where the conduct of its business requires such qualification, except where the failure to be so qualified and in good standing would not, individually or in the aggregate,
have a material adverse effect on the business, properties, financial condition or results of operations of the Fund. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Shares have
been duly and validly authorized and, when issued and delivered against payment therefor as provided herein, will be duly and validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> (except as described below and in the
Registration Statement) and free of statutory and contractual preemptive rights, resale rights, rights of first refusal and similar rights; the Shares, when issued and delivered against payment therefor as provided herein, will be free of any
restriction upon the voting or transfer thereof pursuant to the Fund&#146;s Articles of Incorporation, as amended or supplemented, the Fund&#146;s Bylaws, as amended or supplemented, or any agreement or other instrument to which the Fund is a party.
The capital stock of the Fund, including the Shares, conforms in all material respects to each description thereof, if any, contained or incorporated by reference in the Registration Statement or the Prospectus; and the certificates for the Shares,
if any, are in due and proper form. The Fund is in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;4&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
material compliance with the rules of the Stock Exchange, including, without limitation, the requirements for continued listing of the Shares on the Stock Exchange and the Fund has not received
any written notice from the Stock Exchange regarding the delisting of the Shares from the Stock Exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) No approval, authorization,
consent or order of or filing with any federal, state, local or foreign governmental or regulatory commission, board, body, authority or agency, or of or with any self-regulatory organization or other
<FONT STYLE="white-space:nowrap">non-governmental</FONT> regulatory authority (including, without limitation, the Stock Exchange), or approval of the shareholders of the Fund that has not already been obtained, is required in connection with the
issuance and sale of the Shares or the consummation by the Fund of the transactions contemplated hereby, other than (i)&nbsp;the registration of the Shares under the Securities Act, which has been effected, (ii)&nbsp;the listing of the Shares with
the Stock Exchange, upon official notice of issuance, (iii)&nbsp;any necessary qualification under the securities or blue sky laws of the various jurisdictions in which the Shares are being offered by the Fund or (iv)&nbsp;any necessary
qualification pursuant to the rules of FINRA. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3. <U>Duties of the Fund</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Fund shall take, from time to time, but subject always to any necessary approval of the Board of Directors of the Fund (each a
&#147;<U>Director</U>,&#148; and together the &#147;<U>Board</U>&#148;) or of its shareholders, all necessary action to fix the number of authorized Shares, to the end that the Fund will have a number of authorized but unissued Shares at least equal
to the number of Shares registered for sale under the Securities Act and available for sale pursuant to the Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
For purposes of the ATM offerings of Shares, the Fund will furnish to the Distributor copies of its most recent amendment to its Registration Statement for a particular ATM offering, its most recent Prospectus and all amendments and supplements
thereto, and other documentation the Distributor may reasonably request for use in the ATM offerings of Shares. The Distributor is authorized to furnish to prospective investors only such information concerning the Fund and the ATM offerings of
Shares as may be contained in the Registration Statement, the Prospectus, the Fund&#146;s publicly available formation documents, or any other documents (including sales material), if expressly approved by the Fund for such purpose. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Fund shall furnish to the Distributor copies of all financial statements of the Fund which the Distributor may reasonably request for
use in connection with its duties hereunder, and this shall include, upon request by the Distributor, one certified copy of all financial statements prepared for the Fund by independent public accountants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Fund shall use its best efforts to qualify and maintain, to the extent required by applicable law, the qualification of Shares for
sale under the securities laws of such jurisdictions as the Distributor and the Fund may approve. Any such qualification may be withheld, terminated or withdrawn by the Fund at any time in its discretion. The expense of qualification and maintenance
of qualification shall be borne by the Fund. The Distributor shall furnish such information and other material relating to its affairs and activities as may be required by the Fund in connection with such qualification. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Fund will furnish, in reasonable quantities upon request by the Distributor, copies of its annual and interim reports. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Fund will furnish the Distributor with such other documents as it may reasonably require, from time to time, for the purpose of
enabling it to perform its duties as contemplated by this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;5&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4. <U>Duties of the Distributor</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Distributor shall devote reasonable time and effort to its duties hereunder. The services of the Distributor to the Fund hereunder are
not to be deemed exclusive and nothing herein contained shall prevent the Distributor from entering into like arrangements with other investment companies so long as the performance of its obligations with respect to the Fund hereunder is not
impaired thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In performing its duties hereunder, the Distributor shall comply with the requirements of all applicable laws
relating to the sale of securities in all material respects. Neither the Distributor nor any <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent having an agreement to offer and sell Shares pursuant to Section&nbsp;5 hereof nor any other
person is authorized by the Fund to give any information or to make any representations, other than those contained in its Registration Statement, Prospectus and any sales literature specifically approved for such use by the Fund. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Distributor shall adopt and follow procedures, as approved by the officers of the Fund, for the confirmation of sales to selected
dealers, the collection of amounts payable by selected dealers on such sales, and the cancellation of unsettled transactions, as may be necessary to comply with the requirements of FINRA applicable to sales of Shares, as such requirements may from
time to time exist. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Distributor shall prepare or review, and file with federal and state agencies or other organizations as
required by federal, state, or other applicable laws and regulations, all sales literature (advertisements, brochures and shareholder communications) prepared in connection with the ATM offerings for the Fund. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Distributor agrees to supply the following additional services, together with such other services as set forth throughout this
Agreement: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">handling inquiries from <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents regarding the Fund;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">assisting in the enhancement of communications between <FONT STYLE="white-space:nowrap">sub-placement</FONT>
agents and the Fund; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">communicating the Minimum Price or Minimum Sales Price to any
<FONT STYLE="white-space:nowrap">sub-placement</FONT> agents and instructing any <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents not to sell Shares if such sales cannot be effected at or above the Minimum Price or the Minimum Sales
Price; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">communicating the maximum amount of Shares to be sold on any Offering Date to any <FONT
STYLE="white-space:nowrap">sub-placement</FONT> agents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">notifying any <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents of any suspension or termination of
the ATM offerings of Shares, together with any corresponding resumption of the ATM offerings of Shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">coordinating delivery of any Shares sold through <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents
to such <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents on the Settlement Date against payment of the gross sales proceeds for the sale of such Shares, less any applicable <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent
selling commission; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">delivering the Fund&#146;s Prospectus to any <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">identifying potential <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;6&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">monitoring the performance of <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">providing any necessary reconciliation, accounting and recordkeeping services in respect of the ATM offerings
of Shares, including with respect to the underwriting compensation paid by the Fund to the Distributor in respect thereof; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">providing such other information, assistance and services as may be reasonably requested by the Fund.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Distributor shall report to the Board at least quarterly, or more frequently as requested by the Board,
regarding: (i)&nbsp;the nature of the services provided by the Distributor hereunder; (ii)&nbsp;the amount of compensation <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents, if any, are entitled to retain or be paid by the Distributor;
and (iii)&nbsp;the aggregate amount of underwriting compensation paid by the Fund to the Distributor in respect of the ATM offerings of Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Distributor represents and warrants to the Fund that it has all necessary licenses to perform the services contemplated hereunder and
will perform such services in compliance with all applicable rules and regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Distributor shall make such initial and
ongoing inquiry with respect to any <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents as shall be necessary to obtain appropriate assurances from any such <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents with respect to the
respective <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents&#146; licensing, performance of services in respect of the Fund, compliance programs and such other matters as may be customary, necessary or desirable in respect of such <FONT
STYLE="white-space:nowrap">sub-placement</FONT> agents&#146; participation in the ATM offerings of Shares, or as may be requested by the Fund. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5. <U>Agreements with <FONT STYLE="white-space:nowrap">Sub-Placement</FONT> Agents</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Distributor may enter into selected dealer agreements, on such terms and conditions as the Distributor determines are not inconsistent
with this Agreement, with broker-dealers to act as the Distributor&#146;s agents to effect the sale of the Shares in the ATM offerings. Such selected broker-dealers (&#147;<U><FONT STYLE="white-space:nowrap">sub-placement</FONT> agents</U>&#148;)
shall sell Shares only at market prices subject to the Minimum Price and the Minimum Sales Price. This Agreement shall not be construed as authorizing any dealer or other person to accept orders for sale on the Fund&#146;s behalf or to otherwise act
as the Fund&#146;s agent for any purpose. The Distributor shall not be responsible for the acts of other dealers or agents except as and to the extent that they shall be acting for the Distributor or under the Distributor&#146;s direction or
authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Distributor shall offer and sell Shares only to such <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents who
are acting as brokers or dealers who are members in good standing of FINRA and who agree to abide by the rules of FINRA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The
Distributor shall obtain appropriate assurance from any <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents which it engages of the compliance by such <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents with applicable federal and
state securities laws and the rules of FINRA. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6. <U>Sales Commission</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Fund shall pay the Distributor, or the Distributor shall be entitled to retain, an amount equal to 1.00% of the gross sales price per
Share of the Shares sold. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Distributor may pay to <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents such <FONT
STYLE="white-space:nowrap">sub-placement</FONT> agent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;7&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
commissions as the Distributor shall deem advisable, or may authorize such <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents to retain such
<FONT STYLE="white-space:nowrap">sub-placement</FONT> agent commissions from the gross sales proceeds from the sale of such Shares, which shall be payable or retained, as the case may be, from the commissions payable or retained, as the case may be,
to or by the Distributor under Section&nbsp;6(a) above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Fund hereby represents and warrants to the Distributor that (i)&nbsp;the
terms of this Agreement, (ii)&nbsp;the fees and expenses associated with this Agreement, and (iii)&nbsp;any benefits accruing to the Distributor or to the Fund&#146;s investment adviser or sponsor or another affiliate of the Fund in connection with
this Agreement, including but not limited to any fee waivers, conversion cost reimbursements, <FONT STYLE="white-space:nowrap">up-front</FONT> payments, signing payments or periodic payments relating to this Agreement have been fully disclosed to
the Board and that, if required by applicable law, the Board has approved or will approve the terms of this Agreement, any such fees and expenses, and any such benefits. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7. <U>Payment of Expenses</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Fund shall bear all of its own costs and expenses, including fees and disbursements of its counsel and auditors, in connection with the
preparation of its Prospectus, Statement of Additional Information, if any, the preparation and filing of any required registration statements under the Securities Act and/or the Investment Company Act, and all amendments and supplements thereto,
and in connection with any fees and expenses incurred with respect to any filing requirements of FINRA and preparing and mailing annual and interim reports and proxy materials to shareholders (including but not limited to the expense of setting in
type any such Registration Statement, Prospectus, interim reports or proxy materials). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Fund shall bear any cost and expenses of
qualification of the Shares for sale pursuant to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Distributor shall bear all expenses incurred by it in connection
with its duties and activities under this Agreement, including the compensation of <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents for sales of the Fund&#146;s Shares and fees and expenses of Distributor&#146;s counsel (except for any
FINRA filing fees or &#147;blue sky&#148; fees paid on behalf of the Fund or the Distributor by such counsel). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.
<U>Limitation of Liability; Indemnification</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Distributor shall not be liable for any error of judgment or mistake of law or
for any loss suffered by the Fund in connection with the matters to which this Agreement relates, except a loss resulting from willful misfeasance, bad faith or gross negligence on its part in the performance of its duties or from reckless disregard
by it of its obligations and duties under this Agreement. Notwithstanding anything in this Agreement to the contrary, the Distributor&#146;s cumulative liability to the Fund and any person or entity claiming through the Fund for all losses, claims,
suits, controversies, breaches and damages of any nature whatsoever arising out of or relating to this Agreement, and regardless of the form of action or legal theory, shall not exceed an amount equal to the greatest amount of fees received by the
Distributor for services provided under this Agreement during a particular six (6)&nbsp;consecutive month period. The Distributor shall not be liable for any damages arising out of any action or omission to act by any prior service provider of the
Fund or for any failure to discover any such error or omission (provided that this sentence shall not apply where the Distributor was the prior service provider). Notwithstanding anything in this Agreement to the contrary, the Distributor shall not
be liable for any consequential, incidental, exemplary, punitive, special or indirect damages, whether or not the likelihood of such damages was known by the Distributor. Notwithstanding anything in this Agreement to the contrary, the Distributor
shall not be liable for damages occurring directly or indirectly by reason of circumstances beyond its reasonable control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;8&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Fund agrees that it will indemnify, defend and hold harmless the Distributor, its several
officers, and directors, and any person who controls the Distributor within the meaning of Section&nbsp;15 of the Securities Act, from and against any losses, claims, damages or liabilities, joint or several, to which the Distributor, its several
officers, and directors, and any person who controls the Distributor within the meaning of Section&nbsp;15 of the Securities Act, may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or
actions or proceedings in respect thereof)&nbsp;(i) arise out of, or are based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, the Prospectus or in any application or other document
executed by or on behalf of the Fund or are based upon information furnished by or on behalf of the Fund filed in any state in order to qualify the Shares under the securities or blue sky laws thereof (&#147;<U>Blue Sky application</U>&#148;) or
arise out of, or are based upon, the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading; or (ii)&nbsp;arise out of, or are based upon, any breach of
the representations, warranties or covenants of the Fund contained in this Agreement, and the Fund will reimburse the Distributor, its several officers, and directors, and any person who controls the Distributor within the meaning of Section&nbsp;15
of the Securities Act, for any legal or other expenses reasonably incurred by the Distributor, its several officers, and directors, and any person who controls the Distributor within the meaning of Section&nbsp;15 of the Securities Act, in
investigating, defending or preparing to defend any such action, proceeding or claim described above in this Section&nbsp;8(b); <U>provided</U>, <U>however</U>, that the Fund shall not be liable in any case to the extent that such loss, claim,
damage or liability arises out of, or is based upon, any untrue statement, alleged untrue statement, or omission or alleged omission made in the Registration Statement, the Prospectus or any Blue Sky application with respect to the Fund in reliance
upon and in conformity with any Agent Provided Information, or arising out of the failure of the Distributor or any <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent to deliver a current Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Fund shall not indemnify any person pursuant to this Section&nbsp;8 unless the court or other body before which the proceeding was
brought has rendered a final decision on the merits that such person was not liable by reason of his or her willful misfeasance, bad faith or gross negligence in the performance of his or her duties, or his or her reckless disregard of any
obligations and duties, under this Agreement (&#147;<U>disabling conduct</U>&#148;) or, in the absence of such a decision, a reasonable determination (based upon a review of the facts) that such person was not liable by reason of disabling conduct
has been made by the vote of a majority of a quorum of the Directors of the Fund who are neither &#147;<U>interested parties</U>&#148; (as defined in the Investment Company Act) nor parties to the proceeding, or by independent legal counsel in a
written opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Distributor will indemnify and hold harmless the Fund and its several officers and Directors, and any person who
controls the Fund within the meaning of Section&nbsp;15 of the Securities Act, from and against any losses, claims, damages or liabilities, joint or several, to which any of them may become subject under the Securities Act or otherwise, insofar as
such losses, claims, damages or liabilities (or actions or proceedings in respect thereof) arise out of, or are based upon, any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, the Prospectus
or any Blue Sky application, or arise out of, or are based upon, the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, which statement or omission
was made in reliance upon and in conformity with information furnished in writing to the Fund or any of its several officers and Directors by or on behalf of the Distributor specifically for inclusion therein, and will reimburse the Fund and its
several officers, Directors and such controlling persons for any legal or other expenses reasonably incurred by any of them in investigating, defending or preparing to defend any such action, proceeding or claim. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;9&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) This Section&nbsp;8 shall survive any termination of this Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9. <U>Duration and Termination of this Agreement</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement shall become effective as of the date first above written and shall remain in force for two years thereafter and thereafter
continue from year to year, but only so long as such continuance is specifically approved at least annually (i)&nbsp;by the Directors or by the vote of a majority of the outstanding voting securities of the Fund, and (ii)&nbsp;by the vote of a
majority of those Directors who are not parties to this Agreement or interested persons of any such party cast in person at a meeting called for the purpose of voting on such approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This Agreement may be terminated at any time, without the payment of any penalty, by the Directors or by vote of a majority of the
outstanding voting securities of the Fund, or by the Distributor, on sixty days&#146; written notice to the other party. This Agreement shall automatically terminate in the event of its assignment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The terms &#147;<U>vote of a majority of the outstanding voting securities</U>,&#148; &#147;<U>assignment</U>,&#148; &#147;<U>affiliated
person</U>&#148; and &#147;<U>interested person</U>,&#148; when used in this Agreement, shall have the respective meanings specified in the Investment Company Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10. <U>Amendments of this Agreement</U>. This Agreement may be amended by the parties only if such amendment is specifically
approved (i)&nbsp;by the Directors or by the vote of a majority of the outstanding voting securities of the Fund and (ii)&nbsp;by the vote of a majority of those Directors of the Fund who are not parties to this Agreement or interested persons of
any such party cast in person at a meeting called for the purpose of voting on such approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11. <U>Governing Law</U>. This
Agreement and any claim, counterclaim or dispute of any kind or nature whatsoever arising out of or in any way relating to this Agreement, directly or indirectly, shall be governed by, and construed in accordance with, the internal laws of the State
of New York. To the extent that the applicable law of the State of New York, or any of the provisions herein, conflict with the applicable provisions of the Investment Company Act, the latter shall control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;12. <U>Customer Identification Program Notice</U>. To help the U.S. government fight the funding of terrorism and money
laundering activities, U.S. federal law requires each financial institution to obtain, verify, and record certain information that identifies each person who initially opens an account with that financial institution on or after October&nbsp;1,
2003. Consistent with this requirement, the Distributor will request (or already has requested) the Fund&#146;s name, address and taxpayer identification number or other government-issued identification number. The Distributor may also ask (and may
have already asked) for additional identifying information, and the Distributor may take steps (and may have already taken steps) to verify the authenticity and accuracy of these data elements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;13. <U>Miscellaneous</U>. The captions in this Agreement are included for convenience of reference only and in no way define or
delimit any of the provisions hereof or otherwise affect their construction or effect. If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of this Agreement shall not be
affected thereby. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;10&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;14. <U>Proprietary and Confidential Information</U>. The Distributor agrees on
behalf of itself and its employees to treat confidentially and as proprietary information of the Fund all records and other information relative to the Fund and prior, present or potential shareholders, and not to use such records and information
for any purpose other than performance of its responsibilities and duties hereunder, except after prior notification to and approval in writing by the Fund, which approval shall not be unreasonably withheld and shall not be required where the
Distributor may be exposed to civil or criminal contempt proceedings for failure to comply, when requested to divulge such information by duly constituted authorities, or when so requested by the Fund. The provisions of this Section&nbsp;14 shall
survive termination of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in this Agreement to the contrary, each party hereto agrees that:
(i)&nbsp;any Nonpublic Personal Information, as defined under Section&nbsp;248.3(t) of Regulation <FONT STYLE="white-space:nowrap">S-P</FONT> (&#147;<U>Regulation <FONT STYLE="white-space:nowrap">S-P</FONT></U>&#148;), promulgated under the
Gramm-Leach-Bliley Act (the &#147;<U>Act</U>&#148;), disclosed by a party hereunder is for the specific purpose of permitting the other party to perform the services set forth in this Agreement, and (ii)&nbsp;with respect to such information, each
party will comply with Regulation <FONT STYLE="white-space:nowrap">S-P</FONT> and the Act and will not disclose any Nonpublic Personal Information received in connection with this Agreement to any other party, except to the extent as necessary to
carry out the services set forth in this Agreement or as otherwise permitted by Regulation <FONT STYLE="white-space:nowrap">S-P</FONT> or the Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;11&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first
above written. This Agreement may be executed by the parties hereto in any number of counterparts, all of which shall constitute one and the same instrument.</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BLACKROCK DEBT STRATEGIES FUND, INC.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Name: Janey Ahn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title: &nbsp;&nbsp;Secretary</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BLACKROCK INVESTMENTS, LLC</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Name: Jonathan Diorio</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title: &nbsp;&nbsp;Managing Director</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Signature Page to BlackRock Debt Strategies Fund, Inc. Distribution
Agreement </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(H)(2)
<SEQUENCE>3
<FILENAME>d447340dex99h2.htm
<DESCRIPTION>FORM OF SUB-PLACEMENT AGENT AGREEMENT
<TEXT>
<HTML><HEAD>
<TITLE>Form of Sub-Placement Agent Agreement</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Exhibit (h)(2) </I></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">SUB-PLACEMENT</FONT> AGENT AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">BlackRock Investments, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55
East 52nd Street, New York, New York 10055 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January 13, 2023 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">UBS Securities LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1285 Avenue of the Americas </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">RE:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At-the-Market</FONT></FONT> Offerings by BlackRock Debt Strategies Fund, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From time to time
BlackRock Investments, LLC (the &#147;<I>Distributor</I>,&#148; &#147;<I>we</I>&#148; or &#147;<I>us</I>&#148;) will act as manager of registered <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">at-the-market</FONT></FONT> offerings
by BlackRock Debt Strategies Fund, Inc., a Maryland corporation (the &#147;<I>Fund</I>&#148;), of up to 16,000,000 shares (the &#147;<I>Shares</I>&#148;) of common stock, par value $0.10 per share, of the Fund (the &#147;<I>Common Shares</I>&#148;).
In the case of such offerings, the Fund has agreed with the Distributor to issue and sell through or to the Distributor, as sales agent and/or principal, the Shares (the &#147;<I>Distribution Agreement</I>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby agree to retain UBS Securities LLC (the &#147;<I>Agent</I>&#148; or &#147;<I>you</I>&#148;) as a
<FONT STYLE="white-space:nowrap">sub-placement</FONT> agent with respect to the offerings of the Shares to be issued and sold by the Fund (the &#147;<I>Offerings</I>&#148;) as the Fund and the Distributor may indicate from time to time, and you
agree to act in such capacity, all upon, and subject to, the terms and conditions set forth below: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 1.&nbsp;<U>Description of
Offerings</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;The Shares are to be sold on a daily basis or otherwise as shall be agreed to by the Fund and the Distributor on
any day (each, an &#147;<I>Offering Date</I>&#148;) that is a trading day for the exchange on which the Fund&#146;s Shares are listed and primarily trade (the &#147;<I>Stock Exchange</I>&#148;) (other than a day on which the Stock Exchange is
scheduled to close prior to its regular weekday closing time).&nbsp;Promptly after the Fund and the Distributor have determined the maximum amount of the Shares to be sold by the Distributor for any Offering Date, which shall not in any event exceed
the amount available for issuance under the currently effective Registration Statement (as defined below) (the &#147;<I>Maximum Daily Amount</I>&#148;), and the minimum price per Share below which the Shares may not be sold by the Agent on any
Offering Date (the &#147;<I>Minimum Daily Price</I>&#148;), the Distributor shall advise the Agent of the Maximum Daily Amount and the Minimum Daily Price.&nbsp;Subject to the terms and conditions hereof, the Agent shall use its reasonable best
efforts to sell all of the Shares designated in accordance with the plan of distribution set forth in the Prospectus; provided, however, that in no event shall the Agent sell Shares in excess of the Maximum Daily Amount or for a price per Share
below the Minimum Daily Price.&nbsp;The gross sales price of the Shares sold under this Section&nbsp;1(a) shall be the market price at which the Agent sells such Shares. </P>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;Notwithstanding the foregoing, the Distributor or the Fund may instruct the Agent by
telephone (confirmed promptly by <FONT STYLE="white-space:nowrap">e-mail</FONT> or telecopy) of a revised Minimum Daily Price and/or a revised Maximum Daily Amount and the Agent shall not sell Shares for a price per Share below such revised Minimum
Daily Price, or in a quantity in excess of such revised Maximum Daily Amount, after the giving of such notice.&nbsp;In addition, the Distributor or the Fund may, upon notice to the Agent by telephone (confirmed promptly by <FONT
STYLE="white-space:nowrap">e-mail</FONT> or telecopy), suspend the offering of the Shares at any time; provided, however, that such suspension or termination shall not affect or impair the parties&#146; respective obligations with respect to the
Shares sold hereunder prior to the giving of such notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;The Agent agrees not to make any sales of the Shares pursuant to this
Section&nbsp;1, other than through transactions for which compliance with Rule 153 under the Securities Act of 1933, as amended (collectively with the rules and regulations thereunder, the &#147;<I>Securities Act</I>&#148;), will satisfy the
prospectus delivery requirements of Section&nbsp;5(b)(2) of the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;The compensation to the Agent, as a <FONT
STYLE="white-space:nowrap">sub-placement</FONT> agent for each sale of the Shares pursuant to this Section&nbsp;1, shall be the Applicable Selling Agent Commission with respect to the Shares sold, multiplied by the Gross Sales Proceeds (the
&#147;<I>Agent Compensation</I>&#148;), as further described in the Addendum to this <FONT STYLE="white-space:nowrap">Sub-Placement</FONT> Agent Agreement (the &#147;<I>Agreement</I>&#148;).&nbsp;The Agent shall not be responsible for any fees
imposed by any governmental or self-regulatory organization on the Fund or the Distributor in respect of such sales.&nbsp;The Distributor may pay the Agent Compensation to the Agent, or may authorize the Agent to retain the Agent Compensation from
the Gross Sales Proceeds.&nbsp;The Agent Compensation shall be payable solely out of the compensation the Distributor receives from the Fund pursuant to the Distribution Agreement (the &#147;<I>Related Compensation</I>&#148;).&nbsp;Notwithstanding
anything to the contrary in any other provision of this Agreement (or, for the avoidance of doubt, in the Addendum hereto), the Distributor shall have no obligation to pay any portion of the Agent Compensation to the Agent, or authorize the
retention by the Agent of any portion of the Agent Compensation from the Gross Sales Proceeds, until the Distributor receives at least an equivalent amount of Related Compensation, and the Distributor&#146;s obligation to the Agent for the Agent
Compensation is limited solely to amounts payable out of the Related Compensation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;The Agent shall provide written confirmation
to the Distributor following the close of trading on the Stock Exchange on each Offering Date setting forth for each sale the number of Shares sold, the time of sale, the Gross Sales Price (as defined in the Addendum to this Agreement) per Share,
and the compensation that the Agent is owed with respect to such sales. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;Settlement for sales of the Shares pursuant to this
Section&nbsp;1 will occur on the second business day following the date on which such sales are made (each such day, a &#147;<I>Settlement Date</I>&#148;), unless otherwise agreed to in writing by the parties hereto.&nbsp;On each Settlement Date,
the Shares sold through the Agent for settlement on such date shall be delivered by the Distributor to the Agent against payment of the Gross Sales Proceeds for the sale of such Shares.&nbsp;Settlement for all such Shares shall be effected by free
delivery of the Shares to the Agent&#146;s account at The Depository Trust Company in return for payments in same day funds delivered to the account(s) designated by the Distributor.&nbsp;If the Distributor shall default on its obligation to deliver
the Shares on any Settlement Date, subject to the terms of Section&nbsp;5 herein, the Distributor shall (A)&nbsp;hold the Agent harmless against any reasonable loss, claim or damage arising from or as a result of such
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;2&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
default by the Distributor and (B)&nbsp;pay the Agent any commission to which it would otherwise be entitled absent such default.&nbsp;If the Agent breaches this Agreement by failing to deliver
proceeds on any Settlement Date for the Shares delivered by the Distributor, subject to the terms of Section&nbsp;5 herein, the Agent shall (A)&nbsp;hold the Distributor harmless against any reasonable loss, claim or damage arising from or as a
result of such default by the Agent, (B)&nbsp;deliver such proceeds to the Distributor as soon as practicable and (C)&nbsp;pay the Distributor interest based on the effective overnight Federal Funds rate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;In connection with this Agreement and the Offerings, the Distributor shall, no more than once per calendar quarter in which the Fund
and the Distributor have requested, or anticipate requesting, that the Agent sell Shares pursuant to an Offering, provide to the Agent such certificates and other documents, in any case, as the Agent may reasonably request upon reasonable notice
(but in no event upon notice of less than five business days) relating to authorization, capacity, enforceability and compliance matters.&nbsp;Any such certifications shall be made as of the end of the calendar quarter immediately preceding the
calendar quarter in which such request by the Agent is made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;In connection with this Agreement and the Offerings, the Agent will
promptly notify the Distributor of any material <FONT STYLE="white-space:nowrap">non-confidential</FONT> claim or complaint, any material enforcement action or other material proceeding by a regulatory authority with respect to the Fund, the Shares
or the Offerings against or directed at or to the Agent or its principals, affiliates, officers, directors, employees or agents, or any person who controls the Agent, within the meaning of Section&nbsp;15 of the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;In connection with this Agreement and the Offerings, the Agent will promptly notify the Distributor of any examination by any
regulatory agency or self-regulatory organization that has resulted in a material compliance deficiency in connection with the Offerings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 2.&nbsp;<U>Representations and Warranties by the Distributor</U>.&nbsp;The Distributor represents, warrants to and agrees with the
Agent, as of the date hereof and as of each Offering Date and Settlement Date, that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;Based upon the representations made by the
Fund to the Distributor in the Distribution Agreement, a registration statement on Form <FONT STYLE="white-space:nowrap">N-2</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-267429</FONT> and
<FONT STYLE="white-space:nowrap">811-08603)</FONT> (the &#147;<I>Registration Statement</I>&#148;) (i) has been prepared by the Fund in conformity with the requirements of the Securities Act and the Investment Company Act of 1940, as amended, and
the rules and regulations thereunder (collectively called the &#147;<I>1940 Act</I>&#148;) in all material respects, (ii)&nbsp;has been filed with the U.S. Securities and Exchange Commission (the &#147;<I>Commission</I>&#148;) under the Securities
Act and the 1940 Act, and (iii)&nbsp;heretofore became, and is, effective; the Registration Statement sets forth the terms of the offering, sale and plan of distribution of the Shares and contains additional information concerning the Fund and its
business; no stop order of the Commission preventing or suspending the use of the Prospectus (as defined below), or the effectiveness of the Registration Statement, has been issued, and no proceedings for such purpose have been instituted or, to the
Fund&#146;s knowledge, have been threatened by the Commission.&nbsp;Except where the context otherwise requires, &#147;<I>Registration Statement</I>,&#148; as used herein, means, collectively, the various parts of the Registration Statement at the
time of effectiveness for purposes of Section&nbsp;11 of the Securities Act (the &#147;<I>Effective Time</I>&#148;), as such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;3&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
section applies to the Distributor, including (1)&nbsp;all documents filed as a part thereof or incorporated or deemed to be incorporated by reference therein, (2)&nbsp;any information contained
or incorporated by reference in a prospectus filed with the Commission pursuant to Rule&nbsp;424(b)(2) and/or Rule 424(b)(5) under the Securities Act, to the extent such information is deemed pursuant to Rule 430B or Rule&nbsp;430C under the
Securities Act to be part of the Registration Statement at the Effective Time, and (3)&nbsp;any registration statement filed to register the offer and sale of Shares pursuant to Rule&nbsp;462(b) under the Securities Act.
&#147;<I>Prospectus</I>,&#148; as used herein, means the final prospectus, including the related statement of additional information, relating to the Shares, filed by the Fund with the Commission pursuant to Rule&nbsp;424(b)(2) and/or
Rule&nbsp;424(b)(5) under the Securities Act, in the form furnished by the Fund to the Distributor in connection with the offering of the Shares, together with, if applicable, any final prospectus supplement relating to the Shares attached to or
used with such final prospectus, filed by the Fund with the Commission pursuant to Rule&nbsp;424(b)(2) and/or Rule&nbsp;424(b)(5) under the Securities Act, in the form furnished by the Fund to the Distributor in connection with the offering of the
Shares (the &#147;<I>Prospectus Supplement</I>&#148;). Any reference herein to the Registration Statement or the Prospectus shall be deemed to refer to and include the documents, if any, incorporated by reference, or deemed to be incorporated by
reference, therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;Based upon the representations made by the Fund to the Distributor in the Distribution Agreement,
(i)&nbsp;the Fund is duly registered under the 1940 Act as a <FONT STYLE="white-space:nowrap">closed-end</FONT> management investment company; (ii)&nbsp;a notification of registration of the Fund as an investment company under the 1940 Act on Form <FONT
STYLE="white-space:nowrap">N-8A</FONT> (the &#147;<I>1940 Act Notification</I>&#148;) has been prepared by the Fund in conformity with the 1940 Act and has been filed with the Commission and, at the time of filing thereof and at the time of filing
any amendment or supplement thereto, conformed in all material respects with all applicable provisions of the 1940 Act; (iii)&nbsp;the Fund has not received any notice in writing from the Commission pursuant to Section&nbsp;8(e) of the 1940 Act with
respect to the 1940 Act Notification or the Registration Statement (or any amendment or supplement to either of them); and (iv)&nbsp;no person is serving or acting as an officer, director or investment adviser of the Fund except in accordance with
the provisions of the 1940 Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;Based upon the representations made by the Fund to the Distributor in the Distribution
Agreement, the Registration Statement, the 1940 Act Notification and the Prospectus as from time to time amended or supplemented each complied when it became effective or was filed (as the case may be), complies as of the date hereof and, as amended
or supplemented, will comply, at each time of purchase of Shares in connection with each Offering, and at all times during which a prospectus is required by the Securities Act to be delivered in connection with any sale of Shares, in all material
respects, with the requirements of the Securities Act and the 1940 Act; the Registration Statement did not, as of the Effective Time, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading; at no time during the period that begins on the earlier of the date of the Prospectus and the date such Prospectus was filed with the Commission and ends at the later of each time of purchase
of Shares in connection with each Offering, and the end of the period during which a prospectus is required by the Securities Act to be delivered in connection with any sale of Shares, did or will the Prospectus, as from time to time amended or
supplemented, include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that
the Distributor does not make any representation or warranty with respect to any statement contained in the Registration Statement or the Prospectus in reliance </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;4&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
upon and in conformity with information furnished in writing by the Agent or on the Agent&#146;s behalf to the Distributor or the Fund expressly for use in the Registration Statement or the
Prospectus (the &#147;<I>Agent Provided Information</I>&#148;).&nbsp;The Agent confirms that (i)&nbsp;the Agent&#146;s name on the front cover of the Prospectus Supplement and (ii)&nbsp;the seventh paragraph under the heading &#147;Plan of
Distribution&#148; in the Prospectus Supplement was the only information furnished in writing to the Distributor or the Fund by or on behalf of the Agent expressly for use in the Registration Statement or Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;Based upon the representations made by the Fund to the Distributor in the Distribution Agreement, the financial statements
incorporated by reference in the Registration Statement or the Prospectus, together with the related notes and schedules, present fairly the financial position of the Fund as of the dates indicated and the results of operations, cash flows and
changes in shareholders&#146; equity of the Fund for the periods specified and have been prepared in compliance in all material respects with the requirements of the Securities Act, the 1940 Act and the Securities Exchange Act of 1934, as amended
(the &#147;<I>Exchange Act</I>&#148;), and in conformity in all material respects with U.S. generally accepted accounting principles applied on a consistent basis during the periods involved; the other financial and statistical data contained or
incorporated by reference in the Registration Statement or the Prospectus are accurately and fairly presented, in all material respects, and prepared on a basis consistent with the financial statements and books and records of the Fund in all
material respects; there are no financial statements that are required to be included or incorporated by reference in the Registration Statement or the Prospectus by the Securities Act, the 1940 Act or the Exchange Act that are not included or
incorporated by reference as required; and the Fund does not have any material liabilities or obligations, direct or contingent (including any <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet obligations), not described in the Registration
Statement (excluding the exhibits thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;Based upon the representations made by the Fund to the Distributor in the
Distribution Agreement, as of the date of this Agreement, the Fund has an authorized and outstanding capitalization as set forth in the Registration Statement and the Prospectus and, with respect to any issuance and sale under this Agreement, the
Fund shall have as of the date of the most recent amendment or supplement to the Registration Statement or Prospectus, an authorized and outstanding capitalization as set forth in the Registration Statement and the Prospectus; all of the issued and
outstanding shares of capital stock, including the Common Shares, of the Fund have been duly authorized and validly issued and are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> (except as described below and in the
Registration Statement), have been issued in material compliance with all applicable securities laws and were not issued in violation of any preemptive right, resale right, right of first refusal or similar right; the Shares will be duly listed, and
admitted and authorized for trading, subject to official notice of issuance, on the Stock Exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;Based upon the
representations made by the Fund to the Distributor in the Distribution Agreement, (i)&nbsp;the Fund has been duly formed, is validly existing and is in good standing under the laws of Maryland, with full power and authority to own, lease and
operate and conduct its business as described in the Registration Statement and the Prospectus and to issue, sell and deliver the Shares as contemplated herein; and (ii)&nbsp;the Fund is duly qualified to do business as a foreign entity and is in
good standing in each jurisdiction where the conduct of its business requires such qualification, except where the failure to be so qualified and in good standing would not, individually or in the aggregate, have a material adverse effect on the
business, properties, financial condition or results of operations of the Fund. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;5&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;Based upon the representations made by the Fund to the Distributor in the Distribution
Agreement, (i)&nbsp;the Shares have been duly and validly authorized and, when issued and delivered against payment therefor as provided herein, will be duly and validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT>
(except as described below and in the Registration Statement) and free of statutory and contractual preemptive rights, resale rights, rights of first refusal and similar rights; (ii)&nbsp;the Shares, when issued and delivered against payment
therefor as provided herein, will be free of any restriction upon the voting or transfer thereof pursuant to the Fund&#146;s Articles of Incorporation, as amended or supplemented, the Fund&#146;s Bylaws, as amended or supplemented, or any agreement
or other instrument to which the Fund is a party; (iii)&nbsp;the capital stock of the Fund, including the Shares, conforms in all material respects to each description thereof, if any, contained or incorporated by reference in the Registration
Statement or the Prospectus; (iv)&nbsp;the certificates for the Shares, if any, are in due and proper form; and (v)&nbsp;the Fund is in material compliance with the rules of the Stock Exchange, including, without limitation, the requirements for
continued listing of the Common Shares on the Stock Exchange and the Fund has not received any written notice from the Stock Exchange regarding the delisting of the Common Shares from the Stock Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;The Distributor has full corporate power and authority to enter into this Agreement and the transactions contemplated
hereby.&nbsp;This Agreement has been duly authorized, executed and delivered by the Distributor.&nbsp;Assuming due authorization, execution and delivery of this Agreement by the Agent, this Agreement constitutes a valid and binding agreement of the
Distributor and is enforceable against the Distributor in accordance with its terms, except as the enforceability hereof and thereof may be limited by applicable bankruptcy, insolvency, reorganization and similar laws affecting creditors&#146;
rights generally and moratorium laws in effect from time to time and by equitable principles restricting the availability of equitable remedies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;Based upon the representations made by the Fund to the Distributor in the Distribution Agreement, no approval, authorization, consent
or order of or filing with any federal, state, local or foreign governmental or regulatory commission, board, body, authority or agency, or of or with any self-regulatory organization or other <FONT STYLE="white-space:nowrap">non-governmental</FONT>
regulatory authority (including, without limitation, the Stock Exchange), or approval of the shareholders of the Fund that has not already been obtained, is required in connection with the issuance and sale of the Shares or the consummation by the
Fund of the transactions contemplated hereby, other than (i)&nbsp;the registration of the Shares under the Securities Act, which has been effected, (ii)&nbsp;the listing of the Shares with the Stock Exchange, upon official notice of issuance,
(iii)&nbsp;any necessary qualification under the securities or blue sky laws of the various jurisdictions in which the Shares are being offered by the Distributor or (iv)&nbsp;any necessary qualification pursuant to the rules of the Financial
Industry Regulatory Authority, Inc. (&#147;<I>FINRA</I>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;6&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 3.&nbsp;<U>Representations and Warranties by the Agent</U>.&nbsp;The Agent represents,
warrants to and agrees with the Distributor, as of the date hereof and as of each Offering Date and Settlement Date, that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;The
Agent has full corporate power and authority to enter into this Agreement and the transactions contemplated hereby.&nbsp;This Agreement has been duly authorized, executed and delivered by the Agent.&nbsp;Assuming due authorization, execution and
delivery by the Distributor, this Agreement constitutes a valid and binding agreement of the Agent and is enforceable against the Agent in accordance with its terms, except as the enforceability hereof and thereof may be limited by applicable
bankruptcy, insolvency, reorganization and similar laws affecting creditors&#146; rights generally and moratorium laws in effect from time to time and by equitable principles restricting the availability of equitable remedies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;The Agent Provided Information is or will be complete and accurate in all material respects and does not or will not, as from time to
time amended or supplemented, include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;The Agent has adopted and implemented written policies and procedures reasonably designed to prevent
violation of federal and state securities laws, including policies and procedures that provide oversight of compliance by each registered representative of the Agent. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 4.&nbsp;<U>Additional Covenants</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;The Agent hereby confirms that it is actually engaged in the investment banking and securities business and is a member in good
standing with FINRA and hereby agrees that it will undertake to comply with all applicable FINRA rules (as amended from time to time, including without limitation, any successor provision) in connection with acting as
<FONT STYLE="white-space:nowrap">sub-placement</FONT> agent for the sale of the Shares.&nbsp;The Agent further agrees that in acting as <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent for the sale of the Shares, it will comply with all
applicable laws, rules and regulations, including the applicable provisions of the Securities Act and the Exchange Act, the applicable rules and regulations of the Commission thereunder, and the applicable rules and regulations of any state or any
securities exchange or self-regulatory organization having jurisdiction over the relevant Offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;The Agent hereby agrees that
in acting as <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent for the sale of the Shares, it will not use, authorize use of, refer to, or participate in the planning for use of any &#147;written communication&#148; (as defined in Rule 405
under the Securities Act) concerning any Offering, other than the Prospectus.&nbsp;The Agent further agrees that in acting as <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent for the sale of the Shares, it is not authorized by the
Distributor or the Fund or any other seller of the Shares offered pursuant to the Prospectus to give any information or to make any representation not contained in the Prospectus in connection with the sale of such Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;The Distributor shall not be under any obligation to the Agent except for obligations assumed hereunder or in writing by the
Distributor in connection with any Offering.&nbsp;Nothing contained herein or in any communication in writing from us shall constitute the Distributor and the Agent an association or partners with one another.&nbsp;If such parties should be deemed
to constitute a partnership for Federal income tax purposes, then the Agent elects to be excluded from the application of Subchapter K, Chapter 1, Subtitle A of the Internal Revenue Code of 1986, as amended, and agrees not to take any position
inconsistent with that election.&nbsp;The Agent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;7&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
authorizes the Distributor, in its discretion, to execute and file on its behalf such evidence of that election as may be required by the Internal Revenue Service.&nbsp;In connection with any
Offering, each party shall be liable for its proportionate amount of any tax, claim, demand or liability that may be asserted against it alone, based upon the claim that either of them constitutes an association, an unincorporated business or other
entity, including, in each case, its proportionate amount of any expense incurred in defending against any such tax, claim, demand or liability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;The parties acknowledge and agree that all share related numbers contained in this Agreement shall be adjusted to take into account
any stock split effected with respect to the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;The Agent shall at all times comply with the offering requirements as set
forth herein and under the heading &#147;Plan of Distribution&#148; in the Prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 5.&nbsp;<U>Indemnification and
Contribution</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;The Distributor agrees to indemnify, defend and hold harmless the Agent, its partners, directors and officers,
and any person who controls the Agent within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, and the successors and assigns of all of the foregoing persons, from and against any reasonable loss, damage,
expense, liability or claim (including the reasonable cost of investigation) which the Agent or any such person may incur under the Securities Act, the 1940 Act, the Exchange Act, the common law or otherwise, insofar as such loss, damage, expense,
liability or claim (or any actions or proceedings in respect thereof) arises out of or is based upon (i)&nbsp;any material breach of any representation, warranty, covenant or agreement of the Distributor contained in this Agreement, (ii)&nbsp;any
material violation by the Distributor of any law, rule or regulation (including any rule of any self-regulatory organization) applicable to the Offerings, or (iii)&nbsp;any untrue statement or alleged untrue statement of a material fact appearing in
the Registration Statement or the Prospectus or omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances in which they were made, not
misleading, except to the extent such statements were included in the Registration Statement or the Prospectus in reliance upon and in conformity with the Agent Provided Information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;The Agent agrees to indemnify, defend and hold harmless the Distributor, the Fund, their partners, directors and officers, and any
person who controls the Distributor or the Fund within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, and the successors and assigns of all of the foregoing persons, from and against any loss, damage,
expense, liability or claim (including the reasonable cost of investigation) which the Distributor, the Fund or any such other person may incur under the Securities Act, the 1940 Act, the Exchange Act, the common law or otherwise, insofar as such
loss, damage, expense, liability or claim (or any actions or proceedings in respect thereof) arises out of or is based upon (i)&nbsp;any material breach of any representation, warranty, covenant or agreement of the Agent contained in this Agreement
or (ii)&nbsp;any material violation by the Agent of any law, rule or regulation (including any rule of any self-regulatory organization), or (iii)&nbsp;any untrue statement or alleged untrue statement or omission or alleged omission made in the
Registration Statement or the Prospectus in reliance upon and in conformity with the Agent Provided Information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;8&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;An indemnified person under Section&nbsp;5 of this Agreement (the &#147;<I>Indemnified
Party</I>&#148;) shall give written notice to the other party (the &#147;<I>Indemnifying Party</I>&#148;) of any loss, damage, expense, liability or claim in respect of which the Indemnifying Party has a duty to indemnify such Indemnified Party
under Section&nbsp;5(a) or (b)&nbsp;of this Agreement (a &#147;<I>Claim</I>&#148;), specifying in reasonable detail the nature of the loss, damage, expense, liability or claim for which indemnification is sought, except that any delay or failure so
to notify such Indemnifying Party shall only relieve such Indemnifying Party of its obligations hereunder to the extent, if at all, that such Indemnifying Party is actually prejudiced by reason of such delay or failure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;If a Claim results from any action, suit or proceeding brought or asserted against an Indemnified Party, the Indemnifying Party shall
assume the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses. The Indemnified Party shall have the right to employ separate counsel in such action, suit or
proceeding and participate in such defense thereof, but the fees and expenses of such separate counsel shall be at the expense of the Indemnified Party unless (i)&nbsp;the Indemnifying Party has agreed in writing to pay such fees and expenses,
(ii)&nbsp;the Indemnifying Party has failed within a reasonable time to assume the defense and employ counsel or (iii)&nbsp;the named parties to any such action, suit or proceeding (including any impleaded parties) include both such Indemnified
Party and Indemnifying Party and such Indemnified Party shall have been advised by its counsel that representation of such Indemnified Party and Indemnifying Party by the same counsel would be inappropriate under applicable standards of professional
conduct (whether or not such representation by the same counsel has been proposed) due to actual or potential differing interests between the Indemnifying Party and the Indemnified Party (in which case the Indemnifying Party shall not have the right
to assume the defense of such action, suit or proceeding on behalf of such Indemnified Party). It is understood, however, that the Indemnifying Party shall, in connection with any one action, suit or proceeding or separate but substantially similar
or related actions, suits or proceedings in the same jurisdiction arising out of the same general allegations or circumstances be liable for the reasonable fees and expenses of only one separate firm of attorneys (in addition to any local counsel)
at any time for all such Indemnified Parties not having actual or potential differing interests with the Indemnifying Party or among themselves, which firm shall be designated in writing by an authorized representative of such parties and that all
such fees and expenses shall be reimbursed promptly as they are incurred. The Indemnifying Party shall not be liable for any settlement of any such action, suit or proceeding effected without its written consent, but if settled with such written
consent or if there be a final judgment for the plaintiff in any such action, suit or proceeding, the Indemnifying Party agrees to indemnify and hold harmless any Indemnified Party from and against any loss, liability, damage or expense by reason by
such settlement or judgment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;With respect to any Claim not within Paragraph (d)&nbsp;of Section&nbsp;5 hereof, the Indemnifying
Party shall have 20 days from receipt of notice from the Indemnified Party of such Claim within which to respond thereto. If the Indemnifying Party does not respond within such <FONT STYLE="white-space:nowrap">twenty-day</FONT> period, it shall be
deemed to have accepted responsibility to make payment and shall have no further right to contest the validity of such Claim. If the Indemnifying Party notifies the Indemnified Party within such <FONT STYLE="white-space:nowrap">twenty-day</FONT>
period that it rejects such Claim in whole or in part, the Indemnified Party shall be free to pursue such remedies as may be available to the Indemnified Party under applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;9&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;If the indemnification provided for in this Section&nbsp;5 is unavailable to an
Indemnified Party or insufficient to hold an Indemnified Party harmless in respect of any losses, damages, expenses, liabilities or claims referred to therein, then each applicable Indemnifying Party shall contribute to the amount paid or payable by
such Indemnified Party as a result of such losses, damages, expenses, liabilities or claims in such proportion as is appropriate to reflect (i)&nbsp;the relative benefits received by the Indemnified Party, on the one hand, and the Indemnifying
Party, on the other hand, from the offering of the Shares; or (ii)&nbsp;if, but only if, the allocation provided for in clause (i)&nbsp;is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative
benefits referred to in clause (i)&nbsp;but also the relative fault of the Indemnified Party, on the one hand, and of the Indemnifying Party, on the other, in connection with any statements or omissions or other matters which resulted in such
losses, damages, expenses, liabilities or claims, as well as any other relevant equitable considerations. The relative benefits received by the Distributor, on the one hand, and the Agent, on the other, shall be deemed to be in the same respective
proportions as the total compensation received by the Distributor from sales of the Shares bears to the total compensation received by the Agent from sales of the Shares. The relative fault of the parties hereto shall be determined by reference to,
among other things, whether the untrue statement or alleged untrue statement of a material fact or omission or alleged omission relates to information supplied by such party, on one hand, or by the other party, on the other hand, and the
parties&#146; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The amount paid or payable by a party hereto as a result of the losses, damages, expenses, liabilities and claims
referred to in this subsection shall be deemed to include any legal or other fees or expenses reasonably incurred by such party in connection with investigating, preparing to defend or defending any proceeding. The parties hereto agree that it would
not be just and equitable if contribution pursuant to this Section&nbsp;5 were determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to in this subsection (f). No
person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.&nbsp;Notwithstanding the
foregoing provisions of this subsection (f), the Agent shall not be required to contribute any amount in excess of the commissions received by it under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;The indemnity and contribution agreements contained in this Section&nbsp;5 and the covenants, warranties and representations of the
parties contained in this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the Agent, its partners, directors or officers or any person (including each partner, officer or director of such
person) who controls the Agent within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, or by or on behalf of the Distributor, its directors or officers or any person who controls the Distributor within the
meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, and shall survive any termination of this Agreement or the issuance and delivery of the Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;IN NO EVENT WILL ANY PARTY TO THIS AGREEMENT BE LIABLE TO ANY OTHER PERSON OR ANY THIRD PARTY FOR ANY CONSEQUENTIAL, INCIDENTAL,
SPECIAL OR INDIRECT DAMAGES (INCLUDING BUT NOT LIMITED TO LOST PROFITS), EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;10&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 6.&nbsp;<U>Termination</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;This Agreement shall continue in full force and effect until terminated by either party by five days&#146; written notice to the other
party; provided, that if this Agreement has become effective with respect to any Offering pursuant to this Agreement, this Agreement may not be terminated by either party with respect to such Offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;This Agreement shall remain in full force and effect unless terminated pursuant to Section&nbsp;6(a) above or otherwise by mutual
agreement of the parties; provided that any such termination by mutual agreement shall in all cases be deemed to provide that Section&nbsp;5 shall remain in full force and effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;Any termination of this Agreement shall be effective on the date specified in such notice of termination; provided that in any event
such termination shall not be effective until any earlier than the close of business on the fifth day after receipt of such notice by the Distributor or the Agent, as the case may be.&nbsp;If such termination shall occur prior to the Settlement Date
for any sale of the Shares, such sale shall settle in accordance with the provisions of Section&nbsp;1 of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION
7.&nbsp;<U>Notices</U>.&nbsp;Except as otherwise herein provided, all statements, requests, notices and agreements under this Agreement shall be in writing and delivered by hand, overnight courier, mail or facsimile and, if to the Distributor, it
shall be sufficient in all respects if delivered or sent to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Investments, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">55 East 52nd Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New York,
New York 10055 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attn: Jonathan Diorio </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and
if to the Agent, it shall be sufficient in all respects if delivered or sent to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">UBS Securities LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1285 Avenue of the Americas </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">New
York, New York 10019 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attn: Saawan Pathange </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new address for such purpose.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 8.&nbsp;<U>Parties in Interest</U>.&nbsp;The Agreement herein set forth has been and is made solely for the benefit of the
Distributor, the Fund and the Agent and, to the extent provided in Section&nbsp;5 of this Agreement, the partners, directors, officers and controlling persons (within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the
Exchange Act) referred to in such section, and their respective successors and assigns.&nbsp;No other person, partnership, association or corporation (including a purchaser, as such purchaser, from the Distributor) shall acquire or have any right
under or by virtue of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;11&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 9.&nbsp;<U>No Fiduciary Relationship</U>.&nbsp;The Distributor hereby acknowledges that
the Agent is acting solely as <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent in connection with the sale of the Shares and that the Agent is acting pursuant to a contractual relationship created solely by this Agreement entered into on
an arm&#146;s length basis, and in no event do the parties intend that the Agent act or be responsible as a fiduciary to the Distributor or the Fund, their respective management, shareholders or creditors, or any other person in connection with any
activity that the Agent may undertake or have undertaken in furtherance of the sale of the Shares, either before or after the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 10.&nbsp;<U>Entire Agreement</U>.&nbsp;This Agreement constitutes the entire agreement and supersedes all other prior and
contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 11.&nbsp;<U>Counterparts; Heading</U>.&nbsp;This Agreement may be signed by the parties in one or more counterparts which together
shall constitute one and the same agreement among the parties.&nbsp;The Section headings in this Agreement have been inserted as a matter of convenience of reference and are not a part of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 12.&nbsp;<U>Law; Construction</U>.&nbsp;This Agreement and any claim, counterclaim or dispute of any kind or nature whatsoever arising
out of or in any way relating to this Agreement (&#147;<I>Dispute</I>&#148;), directly or indirectly, shall be governed by, and construed in accordance with, the internal laws of the State of New York. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 13.&nbsp;<U>Submission to Jurisdiction</U>.&nbsp;Except as set forth below, no Dispute may be commenced, prosecuted or continued in
any court other than the courts of the State of New York located in the City and County of New York or in the United States District Court for the Southern District of New York, which courts shall have jurisdiction over the adjudication of such
matters, and each party hereto consents to the jurisdiction of such courts and personal service with respect thereto. Each party hereto hereby consents to personal jurisdiction, service and venue in any court in which any Dispute arising out of or
in any way relating to this Agreement is brought by any third party against any Indemnified Party. Each party hereto (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates) waives all right to
trial by jury in any action, proceeding or counterclaim (whether based upon contract, tort or otherwise) in any way arising out of or relating to this Agreement. Each party hereto agrees that a final judgment in any such action, proceeding or
counterclaim brought in any such court shall be conclusive and binding upon such party and may be enforced in any other courts to the jurisdiction of which such party is or may be subject, by suit upon such judgment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 14.&nbsp;<U>Successors and Assigns</U>.&nbsp;This Agreement shall be binding upon the Distributor and the Agent and their successors
and permitted assigns and any successor or permitted assign of any substantial portion of the Distributor&#146;s or the Agent&#146;s respective businesses and/or assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement may not be transferred or assigned without the consent of the <FONT STYLE="white-space:nowrap">non-transferring</FONT> or <FONT
STYLE="white-space:nowrap">non-assigning</FONT> party; provided, however, that no such consent shall be required to transfer or assign this Agreement to an entity controlling, controlled by or under common control with, the transferring or assigning
party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;12&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 15.&nbsp;<U>Severability</U>.&nbsp;Whenever possible, each provision of this Agreement
shall be interpreted in such manner as to be effective and valid under applicable law. If, however, any provision of this Agreement is held, under applicable law, to be invalid, illegal or unenforceable in any respect, such provision shall be
ineffective only to the extent of such invalidity, and the validity, legality and enforceability of the remaining provisions of this Agreement shall not be affected or impaired in any way and shall be interpreted to give effect to the intent of the
parties manifested thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 16.&nbsp;<U>Investigations and Proceedings</U>.&nbsp;The parties to this Agreement agree to cooperate
fully in any securities regulatory investigation or proceeding or any judicial proceeding with respect to each party&#146;s activities under this Agreement and promptly to notify the other party of any such investigation or proceeding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 17.&nbsp;<U>Modification, Waiver and Amendment</U>.&nbsp;No modification, alteration or amendment of this Agreement will be valid or
binding unless in writing and signed by all parties.&nbsp;No waiver of any term or condition of this Agreement will be construed as a waiver of any other term or condition; nor will any waiver of any default or breach under this Agreement be
construed as a waiver of any other default or breach.&nbsp;No waiver will be binding unless in writing and signed by the party waiving the term, condition, default or breach.&nbsp;Any failure or delay by any party to enforce any of its rights under
this Agreement will not be deemed a continuing waiver or modification hereof and such party, within the time provided by law, may commence appropriate legal proceedings to enforce any or all of such right. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;13&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing correctly sets forth the understanding between the Distributor and the Agent,
please so indicate in the space provided below for that purpose, whereupon this Agreement and your acceptance shall constitute a binding agreement between the Distributor and the Agent.&nbsp;Alternatively, the execution of this Agreement by the
Distributor and the acceptance by or on behalf of the Agent may be evidenced by an exchange of telegraphic or other written communications. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours,</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Investments, LLC</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Name:&nbsp;Jonathan Diorio</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title: &nbsp;&nbsp;Managing Director</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ACCEPTED as of the date </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">first above written </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">UBS SECURITIES LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(as <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Signature Page to BlackRock Debt Strategies Fund, Inc. <FONT STYLE="white-space:nowrap">Sub-Placement</FONT> Agent Agreement </P>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADDENDUM </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">SUB-PLACEMENT</FONT> AGENT AGREEMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BETWEEN </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BLACKROCK INVESTMENTS, LLC </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UBS SECURITIES LLC
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Compensation payable to the Agent for acting as a <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent with respect to a
specified sale of Shares pursuant to this Agreement shall be determined by multiplying the Gross Sales Proceeds by the Applicable Selling Agent Commission as set forth below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="6%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Applicable Selling</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center">Agent Commission</P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">0.80%</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Gross Sales Proceeds&#148; with respect to each sale of Shares shall be the Gross Sales Price multiplied by the number of Shares sold;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Gross Sales Price&#148; with respect to each sale of Shares sold pursuant to this Agreement shall be the gross sales price per
share of such Shares. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(K)(7)
<SEQUENCE>4
<FILENAME>d447340dex99k7.htm
<DESCRIPTION>FORM OF NINTH AMENDED & RESTATED SECURITIES LENDING AGREEMENT
<TEXT>
<HTML><HEAD>
<TITLE>Form of Ninth Amended &amp;amp; Restated Securities Lending Agreement</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit (k)(7) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>NINTH AMENDED AND RESTATED SECURITIES LENDING AGENCY AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">This Ninth Amended and Restated Agreement, dated as of January&nbsp;1, 2023, between each investment company, severally and
not jointly, identified on Schedule A, as such schedule may be amended from time to time (each a &#147;Client&#148;), acting on behalf of itself or the funds listed on Schedule A hereto and any future series of a Client (each, a &#147;Fund&#148;),
by and through BlackRock Advisors, LLC (&#147;BlackRock&#148;), not in its individual capacity but as agent and investment advisor, and BlackRock Investment Management, LLC (the &#147;Lending Agent&#148;), a Delaware limited liability company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B>WHEREAS, </B>each Client is registered as an <FONT STYLE="white-space:nowrap">open-end</FONT> management investment company
or closed end management investment company under the Investment Company Act of 1940, as amended (the &#147;1940 Act&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B>WHEREAS, </B>the Lending Agent acts as the agent for each Client and its corresponding Funds, as applicable, for the
purpose of lending securities pursuant to an Eighth Amended and Restated Securities Lending Agency Agreement dated January&nbsp;1, 2022; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B>WHEREAS, </B>the parties to this Agreement desire to amend and restate such agreement on the terms set forth herein; and
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B>WHEREAS, </B>the Directors or Trustees, as the case may be, of each Client have authorized each Client and its
corresponding Funds, as applicable, to lend securities to Approved Borrowers (as defined below); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B>WHEREAS, </B>the
Directors or Trustees, as the case may be, of each Client have approved the appointment of the Lending Agent as each Client&#146;s securities lending agent and coordinator of each Client&#146;s securities lending program, subject to the terms and
conditions set forth herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B>NOW, THEREFORE, </B>for and in consideration of the mutual promises contained herein, the
parties hereto agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.&nbsp;&nbsp;&nbsp;&nbsp;<B>Appointment</B>. The Client, on behalf of its Funds, as
applicable, appoints BlackRock Investment Management, LLC as its lending agent to perform the duties and responsibilities set forth in this Agreement in its capacity as Lending Agent, and BlackRock Investment Management, LLC accepts such
appointment. The Lending Agent will act solely as a directed agent of the Client hereunder, and the Lending Agent shall have no duties or responsibilities in respect of securities lending transactions except those expressly set forth in this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">2.&nbsp;&nbsp;&nbsp;&nbsp;<B>Authorizations</B>. The Client authorizes the Lending Agent to act as agent as
set forth in this Section. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Lending of Available Securities</B>. The Client authorizes the Lending Agent to lend, on the
Client&#146;s behalf, those securities (&#147;Available Securities&#148;) which are held in accounts maintained under the supervision of the Client&#146;s custodian (the &#147;Custodian&#148;) or any
<FONT STYLE="white-space:nowrap">sub-custodian</FONT> (each a &#147;Custody Account&#148;), other than </P></TD></TR></TABLE>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
securities which the Client&#146;s investment advisor (the &#147;Advisor&#148;), on behalf of the Client, specifically notifies the Lending Agent are not available for lending. The Client
warrants to the Lending Agent that it will give appropriate instructions to the Advisor and the Custodian sufficient to permit the Lending Agent to arrange and settle loan transactions on the Client&#146;s behalf as contemplated by this Agreement.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Lending to Approved Borrowers. </B>The Client authorizes the lending of Available Securities to any one
or more of the institutions approved by the Client, the Client&#146;s Board of Directors/Trustees and/or the Client&#146;s Advisor, in accordance with the Funds&#146; Guidelines and Procedures for Lending of Securities (&#147;Securities Lending
Guidelines&#148;) (each, an &#147;Approved Borrower&#148;). The Client&#146;s Advisor, on behalf of the Client, may request that the Lending Agent change the Approved Borrowers by delivering an updated list to the Lending Agent, provided that the
Advisor shall report to the Board of Directors/Trustees at its next quarterly meeting any addition or removal of an Approved Borrower to or from the &#147;approved list&#148; made by the Advisor since the Board of Directors/Trustees prior quarterly
meeting. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">2.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Securities Loan Agreement. </B>The Lending Agent is authorized to execute securities loan agreements
(each an &#147;SLA&#148;) as the Client&#146;s agent on a disclosed basis with Approved Borrowers. The SLA will be in substantially a form or forms set forth in Schedule B hereto, as such form or forms may be materially amended from time to time
with prior written approval of the Client. The Client specifically approves such form of agreement and agrees, upon request of the Lending Agent, to cause the Advisor to promptly furnish to the Lending Agent the Client&#146;s financial statements or
other documents or information reasonably requested by the Lending Agent in order to enable the Lending Agent to satisfy reasonable credit and legal requests by Approved Borrowers in connection with any SLA or loan transaction.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">2.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Lending under Approved Terms. </B>All loans arranged by the Lending Agent on behalf of a Client shall
comply with applicable Securities and Exchange Commission (&#147;SEC&#148;) guidelines for securities lending, any applicable SEC exemptive orders, <FONT STYLE="white-space:nowrap">no-action</FONT> positions taken by the staff of the SEC with
respect to securities lending transactions, and the investment restrictions and/or guidelines for the Client, all of which shall be provided to the Lending Agent by the Client or the Advisor, and shall be subject to the terms of an SLA substantially
similar to Schedule B. The Client may, at the request of the Lending Agent, approve changes to the approved terms by delivering an amended Schedule B to the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">-&nbsp;2&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
Lending Agent. The Lending Agent shall negotiate on behalf of the Client with each Approved Borrower all terms of a securities loan, including the amounts or fees to be received or paid pursuant
to the applicable SLA. The Lending Agent may prepare a transactional confirmation in respect of each loan effected pursuant to an SLA, setting forth the securities borrowed and the material terms of the loan, and may transmit such confirmation to
the Approved Borrower in accordance with such SLA. The Client understands and agrees that the identity of the Client will be disclosed by the Lending Agent to the Approved Borrower in accordance with the SLA. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">2.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Authorizations by Client. </B>The Client authorizes and empowers the Lending Agent to execute in the
Client&#146;s name all agreements and documents as may be necessary or appropriate in the Lending Agent&#146;s judgment to carry out the purposes of this Agreement. It is understood and agreed that the Lending Agent is authorized to supply any
information regarding the Client that is required by an SLA or under applicable law, subject to Section&nbsp;10.1 hereof. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">3.&nbsp;&nbsp;&nbsp;&nbsp;<B>Loan of Securities. </B>During the term of any securities loan, the Client shall permit the
loaned securities to be transferred, pursuant to an SLA, into the name of an Approved Borrower. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Limits on Return of Loaned Securities. </B>The Client acknowledges that, under the applicable SLA,
Approved Borrowers will not be required to return loaned securities immediately upon receipt of notice from the Lending Agent terminating the applicable loan, but instead will be required to return such loaned securities within the earlier of
(i)&nbsp;such period of time following such notice which is the standard settlement period for trades of the loaned securities entered into on the date of such notice in the principal market therefor, or from the giving of such notice or
(ii)&nbsp;the third business day following such notice. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Recall of Loaned Securities. </B>Upon receiving a notice from the Advisor that Available Securities which
have been lent to an Approved Borrower should no longer be considered Available Securities (whether because of the sale of such securities or otherwise), the Lending Agent shall notify promptly thereafter the Approved Borrower which has borrowed
such securities that the loan of such securities is terminated and that such securities are to be returned within the time specified by the applicable SLA, provided that the Lending Agent may alternatively determine that it is in the best interests
of another lending client of the Lending Agent to renew and restate such loan transaction on behalf, and in the name, of such other lending client and cause to be delivered to the Client an equivalent amount of such security from the assets of such
other lending client (in which event such renewal and restatement of the loan shall constitute separate transactions between each lending client of the Lending Agent and the borrower and shall not be construed as a transaction between such lending
clients). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">3.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Notification of Sales of Loaned Securities. </B>The Client acknowledges its obligation to the Lending
Agent, as applicable, to cause and require the Advisor to provide notification of any sale of securities which are out on loan by the close of business, in the principal market therefor, on the trade date of such sale. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">-&nbsp;3&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">3.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Termination. </B>The Lending Agent is authorized in its discretion to terminate any securities loan
entered into with an Approved Borrower without prior notice to the Client, subject to the conditions of the relevant SLA. The Advisor, on behalf of a Client, may instruct the Lending Agent to terminate any loan on any date, subject to the conditions
of the relevant SLA. The Lending Agent agrees to comply with any such instruction. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">3.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Lending Agent Subject to Supervision of Advisor. </B>The Lending Agent shall at all times be subject to
the supervision of the Advisor. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">3.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Compliance with Securities Lending Guidelines</B>. The Lending Agent hereby acknowledges receipt of the
current Securities Lending Guidelines. The Client shall promptly notify the Lending Agent of any changes to the Securities Lending Guidelines. The Lending Agent acknowledges and agrees that it shall only lend Securities on behalf of the Client and
its Funds in accordance with the conditions of the Securities Lending Guidelines applicable to the Lending Agent. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">4.&nbsp;&nbsp;&nbsp;&nbsp;<B>Loan Collateral. </B>For each loan of securities, the Approved Borrower shall pledge at all times
during the term of the loan collateral in the form of one or more of the following items: (a)&nbsp;cash in U.S. dollars or foreign currency (&#147;Cash Collateral&#148;), or (b)&nbsp;securities issued or fully guaranteed by the United States
government or any agencies or instrumentalities thereof or such other collateral as may be then permitted by applicable law, regulation and/or interpretation, and the Securities Lending Guidelines
<FONT STYLE="white-space:nowrap">(&#147;Non-Cash</FONT> Collateral&#148; and, collectively with Cash Collateral, &#147;Collateral&#148;) in the aggregate having a market value (as determined by the Lending Agent pursuant to the applicable SLA) at
least equal to the market value of the loaned securities (as determined by the Lending Agent pursuant to the applicable SLA). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Receipt of Collateral. </B>At the commencement of any loan, the Lending Agent shall instruct the Approved
Borrower to transfer to the Lending Agent the required Collateral. Collateral will be received from an Approved Borrower prior to or simultaneous with delivery of the securities loaned. If the Approved Borrower does not provide Collateral to the
Lending Agent, as previously agreed, then the Lending Agent will cancel the corresponding loan instruction prior to delivery. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">4.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Holding and Administration of Collateral</B>. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Cash Collateral. </B>All Cash Collateral shall be received, held and administered by the Lending Agent
for the benefit of the Client in the applicable account maintained for the Lending Agent. The Lending Agent is hereby authorized and directed, without obtaining any further approval from the Client or the Advisor, to invest and reinvest all Cash
Collateral in accordance with the Securities Lending Guidelines (&#147;Permitted Investments&#148;). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">-&nbsp;4&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B><FONT STYLE="white-space:nowrap">Non-Cash</FONT> Collateral. </B>All
<FONT STYLE="white-space:nowrap">Non-Cash</FONT> Collateral shall be received, held and administered by the Lending Agent for the benefit of the Client in the applicable account established for the purpose of holding
<FONT STYLE="white-space:nowrap">Non-Cash</FONT> Collateral. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Perfection. </B>The Lending Agent acknowledges that it has control of the Cash Collateral and the
security entitlements relating to the <FONT STYLE="white-space:nowrap">Non-Cash</FONT> Collateral on behalf of the Fund. The Fund has a perfected security interest in the Cash Collateral pursuant to UCC
<FONT STYLE="white-space:nowrap">Section&nbsp;9-104(a)(5)</FONT> and the security entitlements relating to the <FONT STYLE="white-space:nowrap">Non-Cash</FONT> Collateral pursuant to UCC
<FONT STYLE="white-space:nowrap">Section&nbsp;8-106(d)(3).</FONT> &#147;UCC&#148; means the Uniform Commercial Code as in effect from time to time in the State of New York; <I>provided</I>, <I>however</I>, that, at any time, if by reason of
mandatory provisions of law any or all of the perfection or priority of the Lending Agent&#146;s security interest in any item or portion of the Collateral is governed by the Uniform Commercial Code as in effect in a jurisdiction other than the
State of New York, the term &#147;UCC&#148; shall mean the Uniform Commercial Code as in effect, at such time, in such other jurisdiction for purposes of the provisions relating to such perfection or priority and for purposes of definitions relating
to such provisions. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">4.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Maintenance of Collateral Margin. </B>In respect of loans of securities entered into on behalf of the
Client, the Lending Agent will value on a daily basis under policies consistent with the valuation policies of the Client, in accordance with the applicable SLA, the loaned securities and all Collateral and, where applicable, the Lending Agent
shall, in accordance with the provisions of the applicable SLA, request the Approved Borrower to deliver sufficient additional Collateral to the Client by 12:00 noon on the next business day to satisfy the applicable margin requirement. If, as a
result of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">marking-to-market,</FONT></FONT> Collateral is required to be returned to the Approved Borrower under the SLA, the Lending Agent will return such Collateral to the Approved
Borrower. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">4.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Substitution of Collateral. </B>To the extent the Client&#146;s Board of Directors/Trustees permits the
use of <FONT STYLE="white-space:nowrap">Non-Cash</FONT> Collateral, the Client acknowledges and agrees that, pursuant to any SLA, the Lending Agent may permit an Approved Borrower to substitute Collateral of any type specified in Section&nbsp;4
hereof during the term of any loan so long as the required margin in respect of such loan continues to be satisfied at the time of such substitution. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">4.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Return of Collateral. </B>Upon termination of the loan, the Lending Agent shall instruct the Approved
Borrower to return the loaned securities to the applicable Custody Account. The Lending Agent will instruct any custodian or <FONT STYLE="white-space:nowrap">sub-custodian</FONT> of the Client to accept such return delivery of loaned securities. The
Lending Agent shall monitor the return of loaned securities. Once the Lending Agent has confirmed settlement of the return of the loaned securities, the Lending Agent shall effect, on behalf of the Client, the redemption of any Permitted Investment,
if applicable, and effect the return of Collateral due the Approved Borrower in accordance with the Approved Borrower&#146;s transfer instructions with respect thereto, without obtaining any further approval from the Client. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">-&nbsp;5&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">5.&nbsp;&nbsp;&nbsp;&nbsp;<B>Investment of Cash Collateral. </B>Pursuant to the
SLA, the Client shall have the right to invest Cash Collateral received in respect of any loan, subject to an obligation, upon the termination of the loan, to return to the Approved Borrower the amount of cash initially pledged (as adjusted for any
interim <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">marks-to-market).</FONT></FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Cash Collateral Investment Direction. </B>The Client authorizes and directs the Lending Agent, subject to
oversight by the Advisor, to cause to be invested, on the Client&#146;s behalf and at the Client&#146;s sole risk, all Cash Collateral by effecting purchases and sales and/or subscriptions and redemptions of such Collateral in accordance with the
Securities Lending Guidelines. The Lending Agent shall, where applicable, send timely instructions to the transfer agent of the Permitted Investment with respect to any cash transfers required to be completed in conjunction with any subscription or
redemption in a Permitted Investment, and cause the Advisor and the Custodian to be notified of such investment. To facilitate the Lending Agent&#146;s ability to effect investments of Cash Collateral authorized by this Agreement, the Client
appoints the Lending Agent as its true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact,</FONT></FONT> with full power of substitution and revocation, in its name, place and stead to take action in the
Client&#146;s name to the extent necessary or desirable to fulfill the purposes of this Agreement, including, without limitation, (i)&nbsp;to establish trading accounts in a Client&#146;s name, (ii)&nbsp;to execute and deliver such contracts and
other documents on a Client&#146;s behalf as the Lending Agent, in its discretion, deems necessary or desirable to establish such trading accounts or otherwise to effect investments on the Client&#146;s behalf that are authorized by this Agreement,
and (iii)&nbsp;to act, in the Lending Agent&#146;s discretion, in the Client&#146;s name to enforce the Client&#146;s rights and remedies under such contracts or documents. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Cash Collateral Investment Risk. </B>Any investment of Cash Collateral shall be at the sole risk of the
Client. Any income or gains and losses from investing and reinvesting any Cash Collateral delivered by an Approved Borrower pursuant to an SLA shall be at the Client&#146;s risk, and the Client agrees that to the extent any such losses reduce the
amount of cash below the amount required to be returned to the Approved Borrower upon the termination of any loan (including any Cash Collateral Fee as defined in the SLA), the Client will, on demand of the Lending Agent, immediately pay or cause to
be paid to such Approved Borrower an equivalent amount in cash. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">6.&nbsp;&nbsp;&nbsp;&nbsp;<B>Borrower
Default. </B>In the event of default by a Borrower with respect to any loan entered into pursuant to an SLA, the Lending Agent will take such actions as agent for the Client as are set forth in the applicable SLA. In addition, the following
provisions shall apply. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">6.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Replacement of Loaned Securities. </B>If the Lending Agent declares an event of default pursuant to the
SLA with a Borrower (a &#147;Default Event&#148;), then the Lending Agent shall use the Collateral or the proceeds of the liquidation of </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">-&nbsp;6&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
Collateral to purchase for the affected Client&#146;s account, for settlement in the normal course, replacement securities of the same issue, type, class and series as that of the loaned
securities <FONT STYLE="white-space:nowrap">(&#147;Buy-In&#148;).</FONT> The Lending Agent shall purchase an amount of replacement securities having a value equal to the value of the securities on loan for which a Default Event has been declared. If
the cost of fully replacing the loaned securities is greater than the value of the Collateral (or liquidated damages calculated under Section&nbsp;6.2), the Lending Agent shall be responsible for using its funds, at its expense, to satisfy the
shortfall, but only to the extent that such shortfall is not due to any diminution in the value of the Collateral due to reinvestment risk that is borne by the Client pursuant to Section&nbsp;5 of this Agreement. For purposes of this Section, value
of the Collateral shall be calculated as follows: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">6.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Value of Cash Collateral. </B>In the case of loans collateralized solely by Cash Collateral, the value of
the Collateral shall be the market value of such Cash Collateral. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">6.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Value of Securities Collateral. </B>In the case of loans collateralized solely by securities Collateral,
the value of the Collateral shall be the market value of such Collateral. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">6.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Valuation Date. </B>The value of the Collateral shall be determined on the date of the <FONT
STYLE="white-space:nowrap">Buy-In</FONT> (or the payment made pursuant to Section&nbsp;6.2 below). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">6.1.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Market Value. </B>Market value shall be determined by the Lending Agent, where applicable, based upon the
valuation policies adopted by the Client&#146;s Board of Directors/Trustees. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">6.1.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Multiple Forms of Collateral. </B>Where a loan is collateralized by more than one type of Collateral, the
aggregate market value of Collateral securing such loan (for the purpose of computing the indemnity) shall be the sum of the market values for each relevant type of Collateral. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">6.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Impossibility of Replacement/Liquidated Damages. </B>If the Lending Agent determines that a <FONT
STYLE="white-space:nowrap">Buy-In</FONT> is commercially impracticable (for any reason other than price), the Lending Agent shall, in lieu of effecting a <FONT STYLE="white-space:nowrap">Buy-In,</FONT> pay to the affected Client an amount equal to
the market value of the loaned securities determined at the close of business on the date of the Default Event to be reduced by any shortfall diminution in the value of the Collateral due to reinvestment risk that is borne by the Client pursuant to
Section&nbsp;5. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">6.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Replacement of Distributions. </B>In addition to making the purchases or payments required above, the
Lending Agent shall pay from the proceeds of Collateral to the Client the value of all distributions on the Loaned Securities, the record dates for which occur before the date that the Lending Agent executes a
<FONT STYLE="white-space:nowrap">Buy-In</FONT> or makes the payments to the Client required pursuant to Section&nbsp;6.2 and that have not otherwise been credited to the Client&#146;s applicable account. For purposes of
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">-&nbsp;7&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
this Section, the value of such distributions shall be calculated net of taxes, expenses or other deductions that would normally accrue to such distributions. The Lending Agent shall use
Collateral or the proceeds of such Collateral to the extent available to make such payments of distributions. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">6.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Collateral not in Possession or Control of the Lending Agent. </B>If, on the date of the Default Event,
by reason of the Client&#146;s request or actions, the Lending Agent is not in possession or control of the Collateral allocated to the defaulted Loan, the Client shall promptly cause such Collateral to be transferred to the Lending Agent for
application against the cost of any <FONT STYLE="white-space:nowrap">Buy-In.</FONT> In such event, the replacement provisions of this Section&nbsp;6 shall not apply, and the compensation of the Client shall be limited to the value of the Collateral
on the date that <FONT STYLE="white-space:nowrap">Buy-In</FONT> or replacement payment may be affected. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">6.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Subrogation and Assignment of Rights in Collateral. </B>In the event that the Lending Agent is required
to perform or make any payment under this Section, the Client agrees that, to the extent of such performance or payment, the Lending Agent shall be subrogated to the Client, and the Client shall assign, and be deemed to have assigned, to the Lending
Agent all of such Client&#146;s rights in, to and against the Borrower in respect of the related loan, any Collateral pledged by such Borrower in respect of such loan and all proceeds of such Collateral to the extent permitted by applicable law. In
the event that the Client receives or is credited with any payment, benefit or value from or on behalf of the Borrower in respect of rights to which the Lending Agent is subrogated as provided herein, the Client shall promptly remit or pay to the
Lending Agent the same (or, where applicable, its United States dollar equivalent). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.&nbsp;&nbsp;&nbsp;&nbsp;<B>Income, Corporate Actions and Substitute Payments. </B>Income, corporate actions and Substitute
Payments (as defined in Sections 7.1 and 7.2) shall be dealt with as provided in this Section&nbsp;7. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">7.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Income and Related Payments to Borrower. </B>Payments to an Approved Borrower shall be made in accordance
with the terms of the applicable SLA. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">7.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Income and Related Payments to Client. </B>The Lending Agent shall instruct each Approved Borrower which
is a party to an SLA to remit any payment <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">in-lieu-of</FONT></FONT> the interest or other distribution on loaned securities (&#147;Loan Substitute Payment&#148;) for the account of the
Client. The Lending Agent shall also instruct each Approved Borrower which is a party to an SLA to remit any other fees payable on loaned securities to the Lending Agent for the account of the Client, and the Lending Agent shall receive, hold and
administer the same for the account of the Client. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">7.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Corporate Actions and Proxy Rights. </B>The Client acknowledges that, with respect to securities which
are out on loan over the applicable record date for such action, unless otherwise agreed hereto, it will not be entitled to participate in any dividend reinvestment program or vote any proxies; provided, however, that the Client may recall such
securities upon sufficient notice to exercise proxy rights. Corporate actions will otherwise be processed in accordance with the SLA. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">-&nbsp;8&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">8.&nbsp;&nbsp;&nbsp;&nbsp;<B>Reports and Statements. </B>The Lending Agent shall
furnish the Client with the reports and statements set forth in the Securities Lending Guidelines or as otherwise agreed from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">9.&nbsp;&nbsp;&nbsp;&nbsp;<B>SIPC Coverage. </B>THE PARTIES ACKNOWLEDGE THAT THE PROVISIONS OF THE SECURITIES INVESTOR
PROTECTION ACT OF 1970 (&#147;SIPA&#148;) OR THE DODD-FRANK ACT OF 2010 (&#147;DFA&#148;) MAY NOT PROTECT THE FUND WITH RESPECT TO THE SECURITIES LOAN TRANSACTION AND THAT, THEREFORE, THE COLLATERAL DELIVERED BY AN APPROVED BORROWER TO THE FUND MAY
CONSTITUTE THE ONLY SOURCE OF SATISFACTION OF THE OBLIGATION OF THE APPROVED BORROWER IN THE EVENT THE APPROVED BORROWER (OR ITS AGENT) FAILS TO RETURN THE SECURITIES. THE LENDING AGENT SHALL NOT BE RESPONSIBLE FOR ANY LOSSES INCURRED OR LIABILITIES
WHICH ARISE SOLELY DUE TO THE APPLICATION OF SIPA OR DFA TO THE SECURITIES LENDING TRANSACTIONS DESCRIBED HEREIN. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">10.&nbsp;&nbsp;&nbsp;&nbsp;<B>Client Information. </B>The Client covenants and agrees to promptly furnish to the Lending Agent
any information regarding the Client which is necessary to effect transactions on behalf of the Client, including, but not limited to, any limitations imposed pursuant to any applicable law, regulation, authority, charter, <FONT
STYLE="white-space:nowrap">by-law,</FONT> statute or other instrument. The Lending Agent agrees to comply with such restrictions and limitations. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">10.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">The Lending Agent may not disclose or supply any information regarding the Client or Fund unless required by
any law or governmental regulation now or hereafter in effect or requested to do so by the Client; provided that the Lending Agent may disclose or supply information regarding the Client and/or Fund and any transactions authorized by this Agreement
as necessary in the sole discretion of the Lending Agent in order to facilitate, effect or continue any securities loans hereunder or to assist in the analysis of the performance of the securities lending program. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">11.&nbsp;&nbsp;&nbsp;&nbsp;<B>Tax Treatment. </B>The Client acknowledges that the tax treatment of Substitute Payments may
differ from the tax treatment of the interest or dividend to which such payment relates and that the Client has made its own determination as to the tax treatment of any securities loan transactions undertaken pursuant to this Agreement and of any
dividends, distributions, remuneration or other funds received hereunder. The Client also acknowledges that, to the extent that either the Client or the Approved Borrower is a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> resident, the Lending
Agent may be required to withhold tax on amounts payable to or by the Client pursuant to a securities loan and may at any time claim from the Client any shortfall in the amount so withheld. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">12.&nbsp;&nbsp;&nbsp;&nbsp;<B>Responsibility of the Lending Agent. </B>Except as otherwise set forth herein, and subject to
the requirements of applicable law, the Lending Agent shall not be liable with respect to any losses incurred by the Client in connection with this securities lending program or under </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">-&nbsp;9&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">
any provision hereof, except to the extent that such losses result from the Lending Agent&#146;s willful misfeasance, bad faith, negligence or reckless disregard in the performance of its duties
under this Agreement. The Lending Agent shall not be liable for losses, costs, expenses or liabilities caused by or resulting from the acts or omissions of the Client or of any agent or third party custodian of the Client. The Lending Agent shall
not be responsible for any special, punitive, indirect or consequential damages, whether or not the Lending Agent has been apprised of the likelihood of such damages. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Standard of Care: Indemnification</B>. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">13.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">Subject to Section&nbsp;6, the Client shall indemnify and hold harmless the Lending Agent (which, for
purposes of this paragraph shall include its respective officers, directors, partners, managers, employees and agents) from and against any and all claims, damages, liabilities, losses, costs or expenses, including the reasonable fees and expenses
of counsel (each, a &#147;Loss&#148;) incurred, suffered or sustained by the Lending Agent, which arise from the Lending Agent&#146;s actions or failure to act, in either case taken in good faith in performance of this Agreement, except to the
extent that such claims, damages, liabilities, losses, costs or expenses were caused by the willful misfeasance, bad faith, negligence or reckless disregard of the Lending Agent, provided that the Client&#146;s indemnification obligation with
respect to the acts or omissions of the Lending Agent shall not exceed the indemnification provided by such Lending Agent to the Client. This indemnity shall survive the termination of this Agreement and the resignation or removal of the Lending
Agent as agent. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">13.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">The Lending Agent shall indemnify and hold harmless the Client and each Fund, its Board of
Directors/Trustees and the Advisor (which for purposes of this paragraph shall include its officers, directors, partners, managers, employees and agents) and any other investment advisor for the Clients and Funds from any and all Losses to the
extent that any such Loss arises out of the material breach of this Agreement by or the willful misfeasance, bad faith, negligence or reckless disregard of the Lending Agent, its officers, directors or employees in connection with the securities
lending activities undertaken pursuant to this Agreement, provided that the Lending Agent&#146;s indemnification obligation with respect to the acts or omissions of its subcustodians shall not exceed the indemnification provided by the applicable
subcustodian to the Lending Agent. This indemnity shall survive the termination of this Agreement and the resignation or removal of the Lending Agent. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">13.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B>Representations and Warranties. </B>Each party represents and warrants to the other that (i)&nbsp;it has
due authority to enter into and perform this Agreement and any transactions contemplated thereby; (ii)&nbsp;the execution and performance of this Agreement and any transaction contemplated thereby has been duly authorized by all necessary action,
corporate or otherwise, and does not violate any law, regulation, charter, <FONT STYLE="white-space:nowrap">by-law</FONT> or other instrument, restriction or provision applicable to it; and (iii)&nbsp;this Agreement constitutes such party&#146;s
legal, valid and binding obligation enforceable in accordance with its terms. In addition, the Client </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">-&nbsp;10&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
represents that: (a)&nbsp;any loan authorized hereunder and the performance of this Agreement in respect of such loan is authorized by the prospectus and other constitutive documents of the
Client (including any limits as to the aggregate amount of authorized lending under such documents); and (b)&nbsp;as to any securities lent at any time and from time to time on behalf of the Client, the Client shall be the owner thereof with clear
title thereto and no lien, charge or encumbrance upon such securities shall exist. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">13.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><B><FONT STYLE="white-space:nowrap">Non-Exclusivity</FONT> of Agency Service and Similar Matters. </B>The
Client acknowledges that the Lending Agent, acting on behalf of other lending clients, may effect transactions with or for the same Approved Borrowers to which loans of securities may be made hereunder, which transactions may give rise to potential
conflict of interest situations. Lending opportunities among Approved Borrowers shall be allocated at the discretion of the Lending Agent in an equitable manner. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">14.&nbsp;&nbsp;&nbsp;&nbsp;<B>Force Majeure. </B>The Lending Agent shall not be responsible or liable for any failure or delay
in the performance of its obligations under this Agreement arising out of, or caused directly or indirectly by, circumstances beyond its control, including without limitation, acts of God; earthquakes; fires; floods; wars; civil or military
disturbances; sabotage; epidemics; riots; interruptions, loss or malfunctions of utilities, transportation, computer (hardware or software) or communications service; accidents; labor disputes; acts of civil or military authority; governmental
actions; or inability to obtain labor, material, equipment or transportation. Without limiting the foregoing, but subject to Section&nbsp;6, the Lending Agent shall not be responsible for economic, political or investment risks incurred through the
Client&#146;s participation in this securities lending program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">15.&nbsp;&nbsp;&nbsp;&nbsp;<B>Reliance on Client
Communications. </B>The Lending Agent shall be entitled to conclusively rely upon any certification, notice or other communication (including by facsimile or email) reasonably believed by it to be genuine and correct and to have been signed or sent
by or on behalf of an approved person of the party sending such certification, notice or other communication. The Lending Agent reserves the right to notify the Client of any restrictions (self-imposed or otherwise) concerning its activities
worldwide. The Lending Agent and the Client shall each have the right to consult with counsel with respect to their respective rights and duties hereunder and shall not be liable for actions taken or not taken in reliance on such advice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">16.&nbsp;&nbsp;&nbsp;&nbsp;<B>Compensation. </B>In connection with the lending of Available Securities, a Fund shall pay to
the Lending Agent a percentage (the &#147;Lending Agent Fee Percentage&#148;) of the net amount earned from securities lending activities, consisting of income earned on the investment and reinvestment of Cash Collateral plus any Securities Loan
Fees otherwise paid by the Authorized Borrowers. For purposes of this Agreement, &#147;Securities Loan Fees&#148; shall mean the amount payable by an Authorized Borrower to the Lending Agent, as agent to the Fund, pursuant to the applicable SLA in
connection with the loan of Available Securities, if any, collateralized by collateral other than Cash Collateral. The net amount to be paid to the Lending Agent shall be computed after deducting (a)&nbsp;any applicable rebate due to the Authorized
Borrowers under the applicable SLA and (b)&nbsp;Cash Management Costs. &#147;Cash Management Costs&#148; shall mean the expenses incurred in connection with the management and investment of a Fund&#146;s Cash
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">-&nbsp;11&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">
Collateral in accordance with Section&nbsp;5 of this Agreement, including any fees payable to the Lending Agent, the Advisor or any other affiliate of the Lending Agent as a result of the
investment of Cash Collateral in any joint account, fund or similar vehicle. The Lending Agent, upon mutual agreement with the Client, may determine to cap the Cash Management Costs. Any such cap on the Cash Management Costs shall be set forth in
Appendix A or Appendix B hereto, as applicable, as each such Appendix may be amended from time to time. The Lending Agent Fee Percentage shall be such percentage as may from time to time be agreed upon by the Board of Directors/Trustees of the
Client and the Lending Agent and shall be set forth in writing. The Lending Agent Fee Percentage for each Fund is set forth in Appendix A or Appendix B hereto, as applicable, as each such Appendix may be amended from time to time. The Client
authorizes and directs the Lending Agent to deduct amounts equal to such compensation from the Custody Account and to retain such amounts as compensation. The Lending Agent shall notify the Client, on or about the 10th (tenth) day of each month, of
the amount of fees due the Lending Agent hereunder and, promptly upon receipt of such notice, the Client shall effect the requisite payment to the Lending Agent in immediately available funds of U.S. dollars. The Lending Agent shall be responsible
for all transaction fees and all other operational costs relating to securities lending activities, other than Cash Management Costs as described above and extraordinary expenses <I>(e.g., </I>litigation and indemnification expenses), each to be
borne by the respective Fund. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">17.&nbsp;&nbsp;&nbsp;&nbsp;<B>Termination. </B>This Agreement may be terminated at any time
upon mutual written agreement of the Lending Agent and the Client or upon sixty (60)&nbsp;days&#146; prior written notice to the other party; provided that the indemnification obligations in Section&nbsp;13 shall survive any such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">18.&nbsp;&nbsp;&nbsp;&nbsp;<B>Action on Termination. </B>It is agreed that (a)&nbsp;upon receipt of notice of termination, no
further loans shall be made hereunder by the Lending Agent and (b)&nbsp;the Lending Agent shall, as promptly as possible after termination of this Agreement, terminate any and all outstanding loans but continue to administer to any outstanding loans
as necessary to effect their termination and remit and deliver to the Custody Account all securities, earnings and other items due to the Client. The provisions hereof shall continue in full force and effect in all other respects until all loans
have been terminated and all obligations satisfied as herein provided. Both parties shall take all commercially reasonable steps to cooperate to provide a smooth transition in the event of a termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">19.&nbsp;&nbsp;&nbsp;&nbsp;<B>Notices. </B>All notices, demands and other communications hereunder shall be in writing and
delivered or transmitted (as the case may be) by registered mail, facsimile, email, courier, or be effected by telephone promptly confirmed in writing and delivered or transmitted as aforesaid, to the intended recipient as provided below. Notices
shall be effective upon receipt. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">19.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">Any notice or other instrument in writing, authorized or required by this Agreement to be given to the
Lending Agent, shall be sufficiently given if addressed to BlackRock Investment Management, LLC and received by it at its offices at 1 University Square Drive, Princeton, NJ 08540, Attention: Securities Lending Department, with a copy to BlackRock
Investment Management, LLC, 400 Howard Street, San Francisco, CA 94105, Attention: Securities Lending Department, or at such other place as the Lending Agent may from time to time designate in writing. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">-&nbsp;12&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">19.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">Any notice or other instrument in writing, authorized or required by this Agreement to be given to the
Client shall be sufficiently given if addressed to the Client and received by it at: Mutual Fund Administration, c/o BlackRock Advisors, LLC, 100 Bellevue Parkway, Wilmington, Delaware 19809, with a copy to: Legal Department, or at such other place
as the Client may from time to time designate in writing. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">20.<B>&nbsp;&nbsp;&nbsp;&nbsp;Governing Law
and Jurisdiction. </B>This agreement shall be governed by and construed in accordance with the laws of the State of New York without reference to conflict of law provisions thereof. The parties hereto hereby irrevocably consent to the exclusive
jurisdiction of (and waive dispute of venue in) the courts of the State of New York and the federal courts located in New York City in the Borough of Manhattan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">21.&nbsp;&nbsp;&nbsp;&nbsp;<B>Entire Agreement. </B>This Agreement supersedes any other agreement between the parties hereto
concerning loans of securities owned by the Client. This Agreement constitutes the entire understanding of the parties hereto with respect to the subject matter hereof. This Agreement together with any other written agreements between the parties
entered into in connection with this Agreement contain the entire agreement between the parties with respect to the transactions contemplated hereby and supersede all previous oral or written negotiations, commitments and understandings related
thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">22.&nbsp;&nbsp;&nbsp;&nbsp;<B>Assignment. </B>This Agreement shall not be assigned by any party without the
prior written consent of the other party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">23.&nbsp;&nbsp;&nbsp;&nbsp;<B>Capitalized Terms. </B>Capitalized terms not
otherwise defined herein shall have the meanings provided in the SLA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">24.&nbsp;&nbsp;&nbsp;&nbsp;<B>Amendment. </B>This
Agreement may not be amended or modified in any respect, without the written agreement of both parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">25.&nbsp;&nbsp;&nbsp;&nbsp;<B>Waiver. </B>No provision of this Agreement may be waived, without the written agreement of both
parties. No waiver by one party of any obligation of the other hereunder shall be considered a waiver of any other obligation of such party. The failure of a party to this Agreement to insist upon strict adherence to any term of this Agreement on
any occasion shall not be considered a waiver or deprive that party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">26.&nbsp;&nbsp;&nbsp;&nbsp;<B>Remedies. </B>All remedies hereunder shall survive the termination of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">27.&nbsp;&nbsp;&nbsp;&nbsp;<B>Severability. </B>In the event any provision of this Agreement is adjudicated to be void,
illegal, invalid, or unenforceable, the remaining terms and provisions of this Agreement shall not be affected thereby, and each of such remaining terms and provisions shall be valid and enforceable to the fullest extent permitted by law, unless a
party demonstrates by a preponderance of the evidence that the invalidated provision was an essential economic term of the Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">-&nbsp;13&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">28.&nbsp;&nbsp;&nbsp;&nbsp;<B>Further Assurances. </B>Each party hereto shall
execute and deliver such other documents or agreements as may be necessary or desirable for the implementation of this Agreement and the consummation of the transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">29.&nbsp;&nbsp;&nbsp;&nbsp;<B>Counterparts. </B>This Agreement may be executed in one or more counterparts, each of which
shall be deemed an original and all of which taken together shall be deemed one and the same instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">30.&nbsp;&nbsp;&nbsp;&nbsp;<B>Headings. </B>The headings of sections herein are included solely for convenience and shall have
no effect on the meaning of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">31.&nbsp;&nbsp;&nbsp;&nbsp;<B>Separate Agreement. </B>Execution of this
Agreement by more than one Client or on behalf of itself and more than one Fund shall not create any contractual or other obligation between or among such Clients or Funds, and this Agreement shall constitute a separate agreement between the Lending
Agent and each Client on behalf of itself and each respective Fund. Every reference to Client or Fund shall be construed to be a reference solely to the particular Client or Fund that is a party to the relevant transaction. Each of the parties
agrees that under no circumstances shall any rights, obligations, remedies or liabilities of a particular Client or Fund, or with respect to transactions to which a particular Client or Fund is a party, be deemed to constitute rights, obligations,
remedies or liabilities applicable to any other Client or Fund or to transactions to which other Clients or Funds are parties, and the Lending Agent shall have no right to set off claims of any Client or Fund against property or liabilities of any
other Client or Fund. All transactions are entered into in reliance on the fact that this Agreement constitutes a separate agreement between the Lending Agent and the Client or Fund. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">32.&nbsp;&nbsp;&nbsp;&nbsp;<B>Additional Parties. </B>The Lending Agent agrees that additional Clients may be added as parties
to this Agreement from time to time upon written notice to the Lending Agent and upon written consent of the Lending Agent to the addition of any such additional Client. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">33.&nbsp;&nbsp;&nbsp;&nbsp;<B>Business Trust. </B>With respect to a Client which is a business trust, the Lending Agent
acknowledges and agrees that this Agreement is executed by such Client on behalf of the trustees of such Client as trustees and not individually; and no trustee, shareholder, officer, employee or agent of such business trust shall be held to any
personal liability, nor shall resort be had to their property (other than the applicable trust property) for the satisfaction of the Client&#146;s obligations under this Agreement, and such obligations are binding only upon the applicable trust
property held by such trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">34.&nbsp;&nbsp;&nbsp;&nbsp;<B>Series Trusts. </B>The parties acknowledge that the Client
is an investment company, whose assets may be allocated to two or more series. In such case, the Lending Agent agrees to seek satisfaction of all obligations of such Client hereunder solely out of the assets of the series on whose behalf the
Transaction(s) giving to the obligations was entered into. If the Client establishes two or more series, the Client shall so indicate on Schedule A or otherwise give notice thereof and identify such series, and from such time the liability of such
series shall be limited as set forth above, as though and to the same extent as if such series was a separate and distinct Client hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">-&nbsp;14&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed
in its name and behalf as of the day and year first set forth above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BLACKROCK ADVISORS, LLC,</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">on
behalf of each investment company</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman">indicated on Schedule A</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: John Perlowski</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="40" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BLACKROCK INVESTMENT</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>MANAGEMENT, LLC,</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman"><B>as Lending Agent</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: Roland Villacorta</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: Managing Director</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">-&nbsp;15&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Schedule A: Clients and Funds </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B><U>Multi-Asset Complex <FONT STYLE="white-space:nowrap">Open-End</FONT> Funds &#150; Group A</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Advantage Global Fund, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock
Advantage SMID Cap Fund, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Capital Appreciation Fund, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Emerging Markets Fund, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Equity
Dividend Fund </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock EuroFund </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock
Financial Institutions Series Trust </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Summit Cash Reserves Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Fund<SUP STYLE="font-size:75%; vertical-align:top">SM</SUP> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Advantage Emerging Markets Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Advantage International Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Advantage Large Cap Growth Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Advantage Small Cap Core Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Advantage Small Cap Growth Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock China A Opportunities Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Commodity Strategies Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Defensive Advantage Emerging Markets Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Defensive Advantage International Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Defensive Advantage U.S. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Energy Opportunities Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Exchange Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Global Equity Absolute Return Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Global Equity Market Neutral Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Global Impact Fund </P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Health Sciences Opportunities Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock High Equity Income Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Infrastructure Sustainable Opportunities Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock International Dividend Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock International Impact Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Liquid Environmentally Aware Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock <FONT STYLE="white-space:nowrap">Mid-Cap</FONT> Growth Equity Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Real Estate Securities Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Short Obligations Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock <FONT STYLE="white-space:nowrap">SMID-Cap</FONT> Growth Equity Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Sustainable Advantage Emerging Markets Equity Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Sustainable Advantage International Equity Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Sustainable Advantage Large Cap Core Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Tactical Opportunities Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Technology Opportunities Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Total Factor Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock U.S. Impact Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Wealth Liquid Environmentally Aware Fund </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">Sch. A-1 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Funds II </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock 20/80 Target Allocation Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock 40/60 Target Allocation Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock 60/40 Target Allocation Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock 80/20 Target Allocation Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Dynamic High Income Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Global Dividend Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Managed Income Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Multi-Asset Income Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Retirement Income 2030 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Retirement Income 2040 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Funds VII, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock
Sustainable Emerging Markets Equity Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Sustainable International Equity Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Sustainable U.S. Growth Equity Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Sustainable U.S. Value Equity Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Global Allocation Fund, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Large
Cap Focus Growth Fund, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Large Cap Focus Value Fund, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Large Cap Series Funds, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Advantage Large Cap Core Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Advantage Large Cap Value Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Event Driven Equity Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock
Liquidity Funds </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">California Money Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Liquid Federal Trust Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">FedFund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">MuniCash </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">New York Money Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">TempCash
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">TempFund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">T-Fund</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">Treasury Trust Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock <FONT STYLE="white-space:nowrap">Mid-Cap</FONT> Value Series, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock <FONT STYLE="white-space:nowrap">Mid-Cap</FONT> Value Fund <B> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Natural Resources Trust </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Series
Fund, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Advantage Large Cap Core Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Capital Appreciation Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Global Allocation Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Government Money Market Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Sustainable Balanced Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Series, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock
International Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Sustainable Balanced Fund, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Unconstrained Equity Fund </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Variable
Series Funds, Inc. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">Sch. A-2 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock 60/40 Target Allocation ETF V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Advantage Large Cap Core V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Advantage Large Cap Value V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Advantage SMID Cap V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Basic Value V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Capital Appreciation V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Equity Dividend V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Global Allocation V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Government Money Market V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock International Index V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock International V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Large Cap Focus Growth V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Managed Volatility V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock S&amp;P 500 Index V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Small Cap Index V.I. Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>Managed
Account Series </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock GA Disciplined Volatility Equity Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock GA Dynamic Equity Fund </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B><U>Fixed-Income Complex <FONT STYLE="white-space:nowrap">Open-End</FONT> Funds &#150; Group B</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Allocation Target Shares </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BATS:
Series A Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BATS: Series C Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BATS: Series E Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BATS:
Series M Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BATS: Series P Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BATS: Series S Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BATS:
Series V Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Bond Fund, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Sustainable Total Return Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Total Return Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock
California Municipal Series Trust </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock California Municipal Opportunities Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Funds IV </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Global
Long/Short Credit Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Sustainable Advantage CoreAlpha Bond Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Systematic Multi-Strategy Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Funds V </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Core Bond
Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Floating Rate Income Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock GNMA Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock High Yield Bond Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Impact Mortgage Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Income Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock
Inflation Protected Bond Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Low Duration Bond Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Strategic Income Opportunities Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Sustainable Emerging Markets Bond Fund </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">Sch. A-3 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">
BlackRock Sustainable Emerging Markets Flexible Bond Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Sustainable High
Yield Bond Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Sustainable Low Duration Bond Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Multi-State Municipal Series Trust </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock New Jersey Municipal Bond Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock New York Municipal Opportunities Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Pennsylvania Municipal Bond Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Municipal Bond Fund, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock High Yield Municipal Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Impact Municipal Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock National Municipal Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Short-Term Municipal Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock
Municipal Series Trust </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Strategic Municipal Opportunities Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Series Fund II, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock
High Yield Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock U.S. Government Bond Portfolio <B> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Strategic Global Bond Fund, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock
Variable Series Funds II, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock High Yield V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Total Return V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock U.S. Government Bond V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>Managed Account Series II </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock U.S.
Mortgage Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>Master Bond LLC </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">Master Total Return Portfolio </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B><U>Fixed-Income Complex <FONT STYLE="white-space:nowrap">Closed-End</FONT> Funds &#150; Group B</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock 2037 Municipal Target Term Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock California
Municipal Income Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Capital Allocation Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Core Bond Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Corporate High Yield Fund,
Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Credit Allocation Income Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock
Credit Strategies Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Debt Strategies Fund, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Energy and Resources Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Enhanced Capital
and Income Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Enhanced Equity Dividend Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Enhanced Global Dividend Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Enhanced
Government Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Enhanced International Dividend Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock ESG Capital Allocation Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Floating Rate
Income Strategies Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Floating Rate Income Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Health Sciences Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Health Sciences Trust
II </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Hedge Fund Guided Portfolio Solution </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">Sch. A-4 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Income Trust, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Innovation and Growth Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Investment
Quality Municipal Trust, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Limited Duration Income Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Long-Term Municipal Advantage Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock
Multi-Sector Income Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Multi-Sector Opportunities Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Multi-Sector Opportunities Trust II </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock
MuniAssets Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Municipal 2030 Target Term Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Municipal Income Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Municipal Income
Quality Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Municipal Income Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock
Municipal Income Trust II </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock MuniHoldings California Quality Fund, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock MuniHoldings Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock MuniHoldings New
Jersey Quality Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock MuniHoldings New York Quality Fund, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock MuniHoldings Quality Fund II, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock MuniVest
Fund II, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock MuniVest Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock
MuniYield Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock MuniYield Michigan Quality Fund, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock MuniYield New York Quality Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock
MuniYield Pennsylvania Quality Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock MuniYield Quality Fund II, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock MuniYield Quality Fund III, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock MuniYield
Quality Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock New York Municipal Income Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Private Investments Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock
Resources&nbsp;&amp; Commodities Strategy Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Science and Technology Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Science and Technology Trust II </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Taxable
Municipal Bond Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Utilities, Infrastructure&nbsp;&amp; Power Opportunities Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BlackRock Virginia Municipal Bond Trust </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">Sch. A-5 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Schedule B: Forms of Securities Loan Agreement </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">Sch. B-1 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Appendix A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>Group A Funds </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">For the Funds in the Multi-Asset Complex identified on Schedule A as Multi-Asset Complex <FONT
STYLE="white-space:nowrap">Open-End</FONT> Funds &#150; Group A (the &#147;Group A Funds&#148;), the Lending Agent Fee Percentage shall be as set forth below: </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">With respect to a Group A Fund that is identified as a &#147;U.S. Equity Fund&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage is nineteen percent (19%). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">With respect to a Group A Fund that is identified as an &#147;International Equity Fund&#148; in accordance
with a methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage is eighteen percent (18%). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">With respect to a Group A Fund that is identified as a &#147;Fund of Funds&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage is eighteen percent (18%). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">With respect to a Group A Fund that is identified as a &#147;Fixed Income Fund&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage is eighteen percent (18%). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The &#147;Multi-Asset Complex&#148; refers to all of the Funds currently or in the future overseen by a board of
directors/trustees consisting of the same individuals who comprise the members of the boards of directors/trustees of the Group A Funds listed on Schedule A and the funds listed on Appendix C hereto. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">Notwithstanding the foregoing, if at any point during a calendar year, the aggregate gross revenues earned
by the funds in the Multi-Asset Complex prior to payment of compensation to the applicable lending agent exceed $29,780,000 (the &#147;Multi-Asset Complex Breakpoint&#148;), the Lending Agent Fee Percentage shall be equal to or reduced to, as
applicable, the following in allocating net income after the gross revenues for the calendar year equal the Multi-Asset Complex Breakpoint: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">With respect to a Group A Fund that is identified as a &#147;U.S. Equity Fund&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage shall be nineteen percent (19%). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">With respect to a Group A Fund that is identified as an &#147;International Equity Fund&#148; in accordance
with a methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage shall be fifteen percent (15%). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">With respect to a Group A Fund that is identified as a &#147;Fund of Funds&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage shall be fifteen percent (15%). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">App. A-1 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">With respect to a Group A Fund that is identified as a &#147;Fixed Income Fund&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage shall be fifteen percent (15%). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The adjusted allocation shall become effective on incremental gross income starting on the next business day after the
Multi-Asset Complex Breakpoint is reached. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">The Client and the Lending Agent agree and acknowledge that no advisory fee is payable with respect to
management and investment of a Group A Fund&#146;s Cash Collateral in any joint account, fund or similar vehicle. The Lending Agent has agreed to cap the Cash Management Costs in respect of the investment of Cash Collateral in Money Market Series on
an annualized basis at 0.04% of the daily net asset value of Money Market Series. The cap on the Cash Management Costs may be raised or reduced upon mutual agreement between the Lending Agent and the Client. In the event that a Group A Fund directly
or indirectly bears any Cash Management Costs, as computed at least monthly by the Lending Agent or its designee, in excess of such cap, then such excess shall, without limitation, be deemed a transaction fee or other operational cost for which the
Lending Agent shall be responsible. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">Notwithstanding any of the foregoing, if the fee calculated pursuant to paragraphs 1, 2 and 3 of this
Appendix A would result in an effective fee split for a Group A Fund of less than seventy percent (70%) of the sum of such Group A Fund&#146;s securities lending income (after deducting the rebate to the Approved Borrowers) and Cash Management Costs
for any day (the &#147;Group A Funds Effective Fee Split Floor&#148;), then the Lending Agent&#146;s fees for such day shall be reduced to the extent necessary to provide such Group A Fund with the Group A Funds Effective Fee Split Floor.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">App. A-2 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Appendix B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>Group B Funds </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">For the Funds in the Fixed-Income Complex identified on Schedule A as Fixed-Income Complex <FONT
STYLE="white-space:nowrap">Open-End</FONT> Funds &#150; Group B or Fixed-Income Complex <FONT STYLE="white-space:nowrap">Closed-End</FONT> Funds &#150; Group B (collectively, the &#147;Group B Funds&#148;), the Lending Agent Fee Percentage shall be
as set forth below: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">With respect to a Group B Fund that is identified as a &#147;U.S. Equity Fund&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage is nineteen percent (19%). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">With respect to a Group B Fund that is identified as an &#147;International Equity Fund&#148; in accordance
with a methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage is eighteen percent (18%). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">With respect to a Group B Fund that is identified as a &#147;Fund of Funds&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage is eighteen percent (18%). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">With respect to a Group B Fund that is identified as a &#147;Fixed Income Fund&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage is eighteen percent (18%). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The &#147;Fixed-Income Complex&#148; refers to all of the Funds currently or in the future overseen by a board of
directors/trustees consisting of the same individuals (or a subset thereof) who comprise the members of the boards of directors/trustees of the Group B Funds listed on Schedule A and the funds listed on Appendix D hereto. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">Notwithstanding the foregoing, if at any point during a calendar year, the aggregate gross revenues earned
by the funds in the Fixed-Income Complex prior to payment of compensation to the applicable lending agent exceed $3,700,000 (the &#147;Fixed-Income Complex Breakpoint&#148;), the Lending Agent Fee Percentage shall be equal to or reduced to, as
applicable, the following in allocating net income after the gross revenues for the calendar year equal the Fixed-Income Complex Breakpoint: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">With respect to a Group B Fund that is identified as a &#147;U.S. Equity Fund&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage shall be nineteen percent (19%). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">With respect to a Group B Fund that is identified as an &#147;International Equity Fund&#148; in accordance
with a methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage shall be fifteen percent (15%). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">App. B-1 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">With respect to a Group B Fund that is identified as a &#147;Fund of Funds&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage shall be fifteen percent (15%). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">With respect to a Group B Fund that is identified as a &#147;Fixed Income Fund&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage shall be fifteen percent (15%). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The adjusted allocation shall become effective on incremental gross income starting on the next business day after the
Fixed-Income Complex Breakpoint is reached. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">The Client and the Lending Agent agree and acknowledge that no advisory fee is payable with respect to
management and investment of a Group B Fund&#146;s Cash Collateral in any joint account, fund or similar vehicle. The Lending Agent has agreed to cap the Cash Management Costs in respect of the investment of Cash Collateral in Money Market Series on
an annualized basis at 0.04% of the daily net asset value of Money Market Series. The cap on the Cash Management Costs may be raised or reduced upon mutual agreement between the Lending Agent and the Client. In the event that a Group B Fund directly
or indirectly bears any Cash Management Costs, as computed at least monthly by the Lending Agent or its designee, in excess of such cap, then such excess shall, without limitation, be deemed a transaction fee or other operational cost for which the
Lending Agent shall be responsible. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">Notwithstanding any of the foregoing, if the fee calculated pursuant to paragraphs 1, 2 and 3 of this
Appendix B would result in an effective fee split for a Group B Fund of less than seventy percent (70%) of the sum of such Group B Fund&#146;s securities lending income (after deducting the rebate to the Approved Borrowers) and Cash Management Costs
for any day (the &#147;Group B Funds Effective Fee Split Floor&#148;), then the Lending Agent&#146;s fees for such day shall be reduced to the extent necessary to provide such Group B Fund with the Group B Funds Effective Fee Split Floor.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">App. B-2 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Appendix C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B><U>Multi-Asset Complex <FONT STYLE="white-space:nowrap">Open-End</FONT> Funds*</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock ETF Trust </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Future
Climate and Sustainable Economy ETF </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Future Financial&nbsp;&amp; Technology ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Future Health ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Future Innovators ETF BlackRock Future Tech ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Future U.S. Themes ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock U.S. Carbon Transition Readiness ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock U.S. Equity Factor Rotation ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock World ex U.S. Carbon Transition Readiness ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Fund<SUP STYLE="font-size:75%; vertical-align:top">SM</SUP> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">iShares Developed Real Estate Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">iShares Municipal Bond Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">iShares Russell <FONT STYLE="white-space:nowrap">Mid-Cap</FONT> Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">iShares Russell <FONT STYLE="white-space:nowrap">Small/Mid-Cap</FONT> Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">iShares Short-Term TIPS Bond Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">iShares Total U.S. Stock Market Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">iShares U.S. Long Credit Bond Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">iShares U.S. Intermediate Credit Bond Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">iShares U.S. Long Government Bond Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">iShares U.S. Intermediate Government Bond Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">iShares U.S. Securitized Bond Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Funds III </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Cash Funds:
Institutional </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Cash Funds: Treasury </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic Retirement Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic 2025 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic 2030 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic 2035 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic 2040 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic 2045 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic 2050 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic 2055 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic 2060 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic 2065 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index Retirement Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index 2025 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index 2030 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index 2035 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index 2040 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index 2045 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index 2050 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index 2055 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index 2060 Fund
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">App. C-1 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">
BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index 2065 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index Retirement Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index 2025 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index 2030 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index 2035 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index 2040 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index 2045 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index 2050 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index 2055 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index 2060 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index 2065 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">iShares MSCI Total International Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">iShares Russell 1000 <FONT STYLE="white-space:nowrap">Large-Cap</FONT> Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">iShares S&amp;P 500 Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">iShares U.S. Aggregate Bond Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Index Funds, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">iShares MSCI
EAFE International Index Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">iShares Russell 2000 <FONT STYLE="white-space:nowrap">Small-Cap</FONT> Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>Master Investment Portfolio </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">Diversified
Equity Master Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">International Tilts Master Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">Large Cap Index Master Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">Money Market Master Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">S&amp;P 500 Index Master Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">Total International ex U.S. Index Master Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">Treasury Money Market Master Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">U.S. Total Bond Index Master Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>Quantitative Master Series LLC </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">Master
Small Cap Index Series </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><I>* Funds have alternative securities lending agency arrangement. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">App. C-2 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Appendix D </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B><U>Fixed-Income Complex <FONT STYLE="white-space:nowrap">Open-End</FONT> Funds*</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock ETF Trust II </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock AAA CLO
ETF </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Floating Rate Loan ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock High Yield Muni Income Bond ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Intermediate Muni Income Bond ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>BlackRock Funds VI </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">BlackRock Advantage
CoreAlpha Bond Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>Master Investment Portfolio II </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:12pt; font-family:Times New Roman">Advantage CoreAlpha Bond Master Portfolio </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><I>*
Funds have alternative securities lending agency arrangement. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">App. D-1 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(L)(2)
<SEQUENCE>5
<FILENAME>d447340dex99l2.htm
<DESCRIPTION>OPINION AND CONSENT OF COUNSEL TO THE REGISTRANT
<TEXT>
<HTML><HEAD>
<TITLE>Opinion and Consent of Counsel to the Registrant</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g447340g27a00.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><B></B><B><I>Exhibit (l)(2)</I></B><B></B></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January&nbsp;13, 2023 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Debt Strategies Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">55 East 52nd Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10055 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have acted as special Maryland counsel to BlackRock Debt Strategies Fund, Inc., a Maryland corporation (the &#147;Company&#148;), in connection with the
offering and sale by the Company of up to an aggregate of 16,000,000 shares (the &#147;Shares&#148;) of the Company&#146;s common stock, par value $0.10 per share (&#147;Common Stock&#148;), pursuant to its Registration Statement on Form <FONT
STYLE="white-space:nowrap">N-2</FONT> filed with the Securities and Exchange Commission (the &#147;SEC&#148;) on September&nbsp;14, 2022 (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-267429,</FONT> together with all amendments and supplements
thereto through the date hereof, the &#147;Registration Statement&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In our capacity as special Maryland counsel to the Company and for the purposes
of the opinions expressed herein, we have examined originals or copies of the following documents: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Registration Statement (exclusive of the exhibits thereto), except that we have not examined the documents
incorporated by reference therein or otherwise deemed to be part of or included therein; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the prospectus supplement related to the Shares in the form to be filed with the SEC on the date hereof in
connection with the offering described herein (the &#147;Prospectus Supplement&#148; and together with the base prospectus referenced above, the &#147;Prospectus&#148;), except that we have not examined the documents incorporated by reference
therein or otherwise deemed to be part of or included therein; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">an executed copy of the Distribution Agreement, dated as of the date hereof, between the Company and BlackRock
Investments, LLC (the &#147;Distribution Agreement&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">an executed copy of the <FONT STYLE="white-space:nowrap">Sub-Placement</FONT> Agent Agreement, dated as of the
date hereof, between BlackRock Investments, LLC and UBS Securities LLC (together with the Distribution Agreement, the &#147;Agreements&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g447340g23w25.jpg" ALT="LOGO">
 </P>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Debt Strategies Fund, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January
13, 2023</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"> Page
 2
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g447340g72o91.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the charter of the Company as currently in effect (the &#147;Charter&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the bylaws of the Company as currently in effect (together with the Charter, the &#147;Governing
Documents&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a certificate of the State Department of Assessments and Taxation of the State of Maryland (the
&#147;SDAT&#148;), dated January&nbsp;11, 2023, to the effect that the Company is a corporation duly incorporated and existing under and by virtue of the laws of the State of Maryland and is duly authorized to exercise all the powers recited in its
charter and to transact business in the State of Maryland; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(viii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a certificate of the President of the Company, January&nbsp;13, 2023 (the &#147;President&#146;s
Certificate&#148;), certifying, among other things, as to the Company&#146;s compliance with the terms of the Distribution Agreement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ix)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a certificate of the Secretary of the Company, dated January&nbsp;13, 2023 (together with the President&#146;s
Certificate, the &#147;Officers&#146; Certificates&#148;), certifying, among other things, the records of proceedings and actions of the Company&#146;s board of directors relating to the transactions contemplated by the Agreements (the
&#147;Resolutions&#148;) and the Governing Documents. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purposes of the opinions expressed herein, we have relied as to factual
matters (other than facts constituting a legal conclusion) on the certificates of public officials, the Officers&#146; Certificates, and the representations and warranties of the Company contained in the Distribution Agreement and have made no
independent investigation or verification of the matters set forth therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In giving the opinions set forth herein, we have assumed (i)&nbsp;that all
documents submitted to us as originals are authentic, all documents submitted to us as copies conform to the original documents, and all signatures on all documents submitted to us for examination are genuine; (ii)&nbsp;that the form and content of
all documents submitted to us as unexecuted drafts do not differ in any respect relevant to this opinion from the form and content of such documents as executed and delivered; (iii)&nbsp;the power and authority of the parties to those documents
examined by us (other than the Company) to enter into the same and to perform the obligations of such parties thereunder; (iv)&nbsp;that all natural persons who executed any of the documents that were reviewed by us had legal capacity at the time of
such execution; (v)&nbsp;that all public records reviewed by us or on our behalf are accurate and complete; and (vi)&nbsp;that all documents examined by us are, under all applicable laws other than the laws of the State of Maryland, valid and
binding obligations of the parties thereto, enforceable in accordance with their respective terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on the foregoing and subject to the assumptions,
qualifications, and limitations set forth herein, we are of the opinion that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company is validly existing as a corporation in good standing under the laws of the State of Maryland.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Debt Strategies Fund, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January
13, 2023</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"> Page
 3
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g447340g72o91.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company has the corporate power to own, lease, and operate its properties and conduct its business as
described in the Registration Statement and the Prospectus. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The issuance and sale of the Shares by the Company is not subject to preemptive or other similar rights arising
under the Governing Documents of the Company or the Maryland General Corporation Law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Shares have been duly authorized, and, when issued and delivered by the Company in accordance with the
terms of the Registration Statement and the Agreements against payment of the consideration set forth therein, will be validly issued, fully paid, and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With respect to our opinion set forth in numbered paragraph 3 above as to the absence of any preemptive or similar rights, we point out that our opinion is
only as to preemptive rights or other rights to subscribe to or purchase stock that would be created as a matter of Maryland law or under the Charter. We do not express any opinion as to preemptive or similar rights of stockholders of the Company or
any other party that may exist under the terms of any contractual arrangement to which the Company may be a party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have assumed that, upon the
issuance of any Shares, (i)&nbsp;the Company continues to validly exist in good standing under the laws of the State of Maryland, and (ii)&nbsp;the proceeds to the Company from the sale of the Shares will be applied by the Company in the manner and
for the purposes specified in the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We express no opinion as to the laws of any state or jurisdiction other than, and our opinions expressed
herein are limited to, the laws of the State of Maryland, except that we express no opinion with respect to the &#147;blue sky&#148; or other securities laws or regulations of the State of Maryland or any other jurisdiction. We express no opinion
regarding the statutes, administrative decisions, rules, regulations or requirements of any county, municipality, subdivision or other local authority of the State of Maryland. We also assume that the Company has no assets, activities (other than
the maintenance of registered offices and resident agents in the State of Maryland and the filing of documents with the SDAT) or employees in the State of Maryland. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This letter is being furnished to you solely for your benefit in connection with the transactions contemplated by the Distribution Agreement and may not be
relied on, used, circulated, quoted from or otherwise referred to by any other person or for any other purpose without our prior written consent. We hereby consent to the use of our name and the discussion of this opinion under the heading
&#147;Legal Matters&#148; in the Prospectus Supplement and to the filing of this opinion as an exhibit to the Registration Statement. In giving our consent, we do not thereby admit that we are in the category of persons whose consent is required
under Section&nbsp;7 of the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 3 - </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Debt Strategies Fund, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January
13, 2023</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"> Page
 4
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g447340g72o91.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Miles&nbsp;&amp; Stockbridge P.C. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Emily Higgs</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Principal</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 4 - </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(S)(3)
<SEQUENCE>6
<FILENAME>d447340dex99s3.htm
<DESCRIPTION>CALCULATION OF FILING FEE TABLES (FINAL PROSPECTUS DATED JANUARY 13, 2023)
<TEXT>
<HTML><HEAD>
<TITLE>Calculation of Filing Fee Tables (Final Prospectus Dated January 13, 2023)</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit (s)(3) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Calculation of Filing Fee Tables </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">N-2</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Form Type) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BLACKROCK DEBT
STRATEGIES FUND, INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Exact Name of Registrant as Specified in its Charter) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The maximum aggregate amount of common shares being offered pursuant to the Prospectus Supplement dated January&nbsp;13, 2023 (the &#147;Prospectus
Supplement&#148;) and the accompanying Base Prospectus dated December&nbsp;28, 2022, as supplemented on January&nbsp;3, 2023, is 16,000,000 common shares (the &#147;Offering&#148;). The Base Prospectus and Prospectus Supplement, in the forms filed
with the Securities and Exchange Commission pursuant to Rule 424(b)(2) under the Securities Act of 1933, as amended, on January&nbsp;3, 2023 and January&nbsp;13, 2023, respectively, are the final prospectus relating to the Offering. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>cik0001051003-20230113.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 12-January-2023 [08:49:33] {PM}-->
<schema targetNamespace="http://www.blackrock.com/20230113" elementFormDefault="qualified" xmlns:cik0001051003="http://www.blackrock.com/20230113" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:cef="http://xbrl.sec.gov/cef/2022">
<annotation>
<appinfo>
<link:linkbaseRef xlink:type="simple" xlink:href="cik0001051003-20230113_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="cik0001051003-20230113_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="cik0001051003-20230113_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
<import namespace="http://xbrl.sec.gov/cef/2022" schemaLocation="https://xbrl.sec.gov/cef/2022/cef-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>cik0001051003-20230113_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 12-January-2023 [08:49:33] {PM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#SecurityOnly" roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" />
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#RiskOnly" roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
<definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllSecuritiesMember" xlink:label="loc_cef_AllSecuritiesMember_74" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_76" />
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>cik0001051003-20230113_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 12-January-2023 [08:49:33] {PM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link" />
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>cik0001051003-20230113_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 12-January-2023 [08:49:33] {PM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#N2" roleURI="http://xbrl.sec.gov/cef/role/N2" />
<presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllSecuritiesMember" xlink:label="loc_cef_AllSecuritiesMember_74" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_76" />
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g447340g23w25.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g447340g23w25.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M72-,FN3<RZ=:R3D@^8T*EN.G.,T 7*!D%K:BU$H#%O,D+G/;-2HV$3$!E*D
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MC%"$&FV8E9Q;KN;K_P#6';\*?)%/8!IMH8=1CDB38\I8N0?O$#O0XI.Z ?\
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MKWI<D1$8TNTB0LD;*T:G:1(W'ZT<D4)#S9V\\,2S1!U5< -S19/<H<^E64C
MM;J<=LD#KGD=Z'"/8+(N]L=JL!%4 8'%%K 0/:PLLB&,%9&W,#W/K2Y4!&VG
M6DCN[P[FD&&R2?R]/PI<B8@&G6B1E1 N""#G)SGKG-)10["P:=:PR)(D6&0;
M5^8D*/8=!2Y5%Z"L)_9=E^\'D "0Y89.,^H]/PJN1#L@_LVS2/8L"@8([]^>
MM')$0UM,LI$57MU(12HZY /49I<D0L)+I]LENX$9X7J6)/'(Y)S3Y(V'8<MM
M#+;VZR1AA'AESU!]:+)I7$21VL$)0QQA2@(4CK@T**6PR8\@$U0#9[>&Y@,<
MR!T/.#2:35F(B6QM5E:00(&8EB<=2>II<D>P#%TFQ4Y%N,^Y/'T]*.2/8"1[
M"U9V<PC<223S3Y4.Q$VEV3[P8 -[;R02#N]>*EPB%D2?8;;RS'Y*E"GEX/3;
MZ4U%"$BTZTB7"PCO]XDDY&.2?:H22=@L0VUE;@7=H(\6_P J[,G &.GZTU%*
MZ E73K2.,QK"-ASD$DYSUSZT^5 20V<%MCRD(QTRQ/\ ,TXI+8>Q9'2K __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g447340g27a00.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g447340g27a00.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1  (! @0$ P0'!00$  $"=P ! @,1
M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_  !$( #P!) ,!$0 "$0$#$0'_V@ ,
M P$  A$#$0 _ .5^)\.K>&O'=_;)J-VEM<-]H@ F8#:QS@<]CD?A0,X_^V]6
M_P"@I>?]_P!O\: #^V]6_P"@I>?]_P!O\: #^V]6_P"@I>?]_P!O\: /2?@O
M9:GK_BTWMQJ%R]IIR^8RM*Q#N<A1U^I_"@1W?Q!OKA/$"PQ32(L<*\*Q')S_
M /6KS,3)J>ARUY-.R.3^W7?_ #]3?]]FN;FEW.=29Z#\-)Y9EO\ S97?!3&Y
MB<=:[<*VWJ==!MK4] KO-SG/'7B*;PMX2N]5MHTEN(RBQ(^<,S,!V^M #O!7
MB5?%?ABUU,A4G(*3QK_!(/O#^OXT 0^-_&%OX/T*6[8"2Z93]GA/\;9 _++"
M@!O@#Q-<^*_"T6HWD*0W0E>*6-,@*RG'?VQ0!D>'_'-_J[>,1+! @T21D@V@
M_.!O^]S_ +(H VO /B&Z\4^#[/6+R*..:<OE8\[1ARO?Z4 6_%^L3^'_  GJ
M.K6R(\UK%O57SM)R.N* .0T?6_B5K>CVFIVMEH0@NHQ(@=Y V#ZT ;?B3Q7>
M^$_"%O?ZA:Q3ZM,R0+!"QV-,W8$\XXH S8S\4(XA?.-%F)&38_,I7V#],T =
MY;-*]M$T\8CE* NBMD*<<C/>@#(\2Z\N@V23>5YLLC;$7.!GU-8U:GLU8F4N
M5%:;_A(;7R+EKFWF0NHDB6/& 2!P<]LU'[S1BU.C4\5T(L=3 * "@ H * "@
M H * "@ H * "@ H * /*/CEX634_#"ZW#&3=:>1N('6(GG\B<_G0,^;J "@
M H ^G?@MHJZ/X%AN9%"7&I.9N>I4<+^@S^-2VK@9GQ"4CQ2Y(ZQ(1^M>9B?C
M.*O\1RE<QSH]%^%_W=0^J?UKNPFYUX?8]$KT#I/.OBA<BYO/"V@@Y-_J4;NO
MJB$9_F* (/!\;^&/B9X@\/.-EI?C[?9CMR?G _/_ ,=H J:KIA\=?%E$<[])
M\/E%D Z-(P+D>_*H#]*!FG\+C]DN_%FD]!:ZM(ZKZ*_3^5 CF?!@*0?%&0'G
MSI/T$O\ C0!UWP;_ .27:3]9?_1K4 7_ (GG;\-==/\ T[_U% ''>#O&?B"Q
M\'Z3:VW@G4+N&*W54GC<;9!ZB@#JO%^@7GC;P5;B.-K#4T,=W#'(?]7*!]UO
MS(H P]'^(^I:)<1Z9X^TYM-G;Y8[U5S#*?<C('X<?2@9Z:KJ\:NC J1D$'@B
MDQ'&^,A_;4\.BV2"6]3]\3NP(QC^N:XZ[Y]%N95/>T19\*^(1>VXTZ^(CU&#
MY&1^"V._UJJ-2_NL<)=&:&G:ZUWK-UI<EJ8I;==S,&!4^G\ZTA5O)Q*4O>L;
M@K<H* "@ H * "@ H * "@ H * "@ H * *6KZ?'JNCWNGRDA+F%XB1V# C^
MM 'Q?J>GSZ5J=S872;)[>0QN/<'% RI0!H:#I4NMZ]8Z7#]^ZF6,'TR>3^ Y
MHV ^JS<06/BC1]$M\^7;6Y')R?NX _(5S3G:HD0Y:V.>^)5DRW]K>C[CIY?T
M(Y_K7/BU[USGKJSN<)7$<R/1?A?]W4/JG]:[L)N=6'V/1*] Z3RWQ&?[0^/'
MABR7I96KSM[9#?\ Q(_.@"S\2Y_^$=UOPYXO*,\-C,]O<*HR=DBXR/R/YT 7
MOA9:2_\ "-7&LW"[9]9NY+TK_=5CA1^0S^- &9X9G_L[XU^*M-;I>0QW*'Z*
MN?\ T(T 8/@QL:=\3RQ_Y;2_RDH U_A;XQ\.:5\.M*LK[6;2WN8_,WQR2 $9
MD8C]"* -CQ[K>F:S\+->N--O8KJ%8MA>)L@-E>/U% %;P-XV\,6/@;1;6ZUR
MSAN(K9%>-I "IQT- '67GBS0M/TZTO[G4H8[.[<)#-G*N3GOZ<=: //_ (RZ
M]HE_X)_L^WOH;J^N)HS;QPN&.0W)..V,C\10!Z+X=MI[/PSI=M<C;<16L:2#
MT8* 1^=(#D9+P>'_ !_<W.H?);W:823' Z?X5P<RA5NS#FY:EV,\56]H;^'6
M--OXFO,J1"#N+GMBBJE?FBPFNJ+7@[5[6?4M0ENI/*U&Y<$Q,,  =A54)Q3U
MW*IR3>IW:G*UVHU%I@% !0 4 % !0 4 % !0 4 % !0 4 5K&]AU"RBNK=P\
M4HRIH \ ^/?AT66O6>N01;8KQ/+E(''F+T/XC^5 SQ^@#U7X%Z,MUXGN]:G7
M]QIL!*L>@=N/_0=U)NVH/34[.QU@WOQ AOV.$DG"KGLOW17DQG>I=G$I7J'H
MGB?1EUO19;<#]\OSQ'_:%>A6I\\3JG!26IXO<6\UI.\$\;1RH<,K#!%>2X\K
ML>>URNQZ!\,/NZA]4_K7;A-SIP^QZ)7H'29_]B:;_;(UC[''_:/E^7]HQ\VW
MTH FU#3;+5;1K2_M8KFW8@F.50RDCIP: );>WAM;:.WMXEBAC4*B*,!0.@ H
M J#1--76&U<6<0U%D\LW&/FV^F?2@!(-"TNU2[2#3[>-+PDW 5 !*3UW>O4T
M 9W_  @?A/\ Z%W3_P#P'7_"@"[#X:T6WTV;38=+MH[&8YD@6(!'/'4?@* *
M7_"!^$_^A=T__P !U_PH OS>'](N-+32YM-MY+&,82!HP47Z#M0!0TWP+X7T
MFZ%U8Z':0SKT<)DCZ9Z4 =%^% %2[T^TOD"75M',HZ!U!Q42A&6Z%9/=$%KH
M6F64@DMK&&-QT8(,BDJ45T#E2'RZ/I\TOFRV4#R?WB@S^=#IQO>P65[ER*-8
MHPBKM5> !VJTK#'TP"@ H * "@ H * "@ H * "@ H * /+_ (.^(Q?6FJZ'
M-(//L;N1HP3R8V8G]&S^8H Z#XF>&SXG\$7MI$FZZA'GP8'.]>WXC(_&@9\D
M,I5BI!!'&#0!]%>'=+3P=\(8R 5O=5 DD)Z_..!^"USXF7+#0SJNT3EX)F@N
M(YD.&C8,/J*\I.S3//B];GO5A=QWUC!<QD%94#\>]>U!\T;GI)W1B>)/"-IK
MO[Y28;L# D X;V(K&M04]41.FIF;X#TRZTFZU.VNHRC*4P<<,.>16>'@X-ID
MTH..AW%=IL<!XO\ %^KV_BS3O"7AZ.$:C>Q^:US,-RPISSM[GY30!>T^R\<V
M&J6OVS6++4[!VQ/FV\EXQ@\K@\\\4 0WEG\1VO)VL]6T9+8NQB62W8L%SP#[
MXH YWPMK7Q&\56%U=6NI:1"EO<O;,)+9LDKC)&#[T ;?B'QGJ?A/2-.L)X(M
M5\3WA*QP6X*HW/WL=<8Q0!'!IWQ-O8%NI=?TZPE8;OLJV@=5]BQ.?YT 1^'_
M !WK%OXH7PSXOT^*TO90?LUS%D1SD>F?7_ZV* -3QQX[C\)):VEM:M?:M>G;
M;6J'D]LGOC- %"WTWXF7L"W4WB#3K"1AN^RK9[POL6)S0!M:7=>);7P_J<OB
M 6@N[8.89+<';(H7(8@^_;VH 9X(\13ZSX#LM<U66)))$=Y7 VH K,,^W H
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MHJ "@ H * /DSPCX@_X1KXI)?.Q6W-V\4W/\#,02?IP?PH&?6(Y6@1\T^)O
MDA^-,>D1)BUU&<7*X' C))?\L-2&CT/XA:DDVH0:=#Q':KR!TW'_  %>=B9W
ME8XZ\NAQ=<:1RG?> O$JV[+I%TV%8_N6)Z$_PUVT*MO=9V4:BM9GI(Z5Z!T@
M% .10DD ZF!Y[XX\&:O?>(+#Q5X<N8X]6L4\OR9>%F7)XS^)'X]J )_#GQ%-
M]KB^']=TJ;2-9*Y2-SN27']UOP_^O0!W6?ES0!YS\&#N\+ZJ?75I_P"2T 5M
M* O?C]K+W7+V>GHMN&[ [<D?]]'\Z /4* /*_CI&D?A;3;]#MN[>_3RG'WAD
M-D#\@?PH C\/(NJ?'#4[B_4-/9Z=$8%;^$E4R1_WT?SH&>L=*!&;K_\ R+FJ
M?]>LO_H!H \!TJ^N[WP[X2\-ZNS:;X:N2S/=*<BY;>QV''W1GCGZT#/H>RL[
M:PM([:T@2"",;41!@ 4"/'? VH^*+1_%']@Z%!?PMJT[&26Y$>UL],=^U RU
M\/2DFM^*[O5995\421DW-L\>T0H.RG)W#[O/TH RO 7CN?PI\.D9_#M_=6L4
MLC&ZCQY62W<]1^5 CLO &AWEQK6I>-M0FMS+JZ+Y,5N^]8X^."W<_*/R- $=
MCG_A?^IX[:0G_H2T 1?"7!U#QDP&,ZM)_-J /0]1MX+O3KFWN%5X9(V5PPR"
M"* /G?[3/<_#+PCID['^SYM7:)V)X*!^!]/F;\J!GT?&BQH$0!548 '84",'
M6?%]EHGB/2-$GAF>XU1BL3(!M7!'WN<]Z /,-"U76--^*WC-]'T(ZL[S .HG
M6+RQGWZT >H^'-7US4WN!K'AYM)$8'EDW"R^9G.>G3''YT +KFO7>FZGI^G6
M.GI>7%Z)&7?/Y2J$ )YP?6@!FD>*[?4--U&ZNH'L'TV1X[N.4AO+*J&)!'48
M.: (M/U[6]4%O=6^@+'ITQ4J\UT%E*'^/8%...<9S0!TU 'Q'JQQK5\?^GA_
M_0C0,^IOA9XH;Q1X*MIIG#7=L?L\WJ2!P?Q&/UH$=%?Z=IRW\>N7$*_:K*%U
M24]54]1^E1-\JN#=D>)7UT]]?SW4ARTKEC^->--W=SS9.\BO4DBJS(P9200<
M@CM33L"NMCT+PGXX(VV.K2CTCG;^3?XUVT<1;21V4JR>C/1%964%3D'H17>G
M=71T#J8'+ZYX[TOPYJZV.J0W4,;('%R(&:+G/&0.O'ZT <5?:C#X_P#B+X;F
MT*":2STF5IKF],11<<$*"0,YQ^M SUO^#\*!'G_P>ADA\*7RRQ/&6U*=L.I!
M(^7F@"MX[T;6M)\3V?C3PU:F[NHH_(N[4=98^QQU/X>@]* +EO\ %[PT;8&]
M-U9W8'SVTEL^]3Z<#% &&MOJWQ/\465Q?Z7-8^%M/D,T:3J5:Z?MD'M_3/K0
M!=\=^'=;T_Q19>,_"\!GNH$\N[ME/^MC'H._''X"@#0M_B[X9-L/MC7=I=@?
M/;26KEPWIP,4 :*:^?$O@[6KF+3KRT00RI$+B+8THV?> ^N1^% &%X-\,VGB
M'X.Z9I&K6S!61\$C#QMO;##T- P\"ZCXBT/79?"'B-);E40R65\%+!XQV9O\
M?\*!&+X%\6:;X5'B&UU1+N.6;59I4"6DC@J2 #D#':@"QX?AU+7?&_B#Q=)I
ML]EIYL6M[99DV/-TY(Z]OY4#-CX2:>'^&,-I?6^4EDF#Q2KU4L1@@T",KPY%
MJ7P[\<CPY-YL_A[4V8V#\OY+?W3Z>A_ ^M &II\4P^.^K3F)Q%_92*'VG:3N
M7C- SG? _BK3?"NH>)XM4CNXY)]3EDCV6LC[EW'G(&*!&OKGBKQ!XPMSI/A#
M2KNWAG&V?4+R(PJBG@[<]3B@#2UKX=6UQ\-X?#=@VVXLE$EM*>/WHR23]23^
M= S.T'XFR:7;"P\<65SINH1?+YWD,T<P'<$ \_I0(Q]3UB'QI\4O"UYH=O=7
M-G8.?/G^SLJ+DYZD>U R+0/$%IX4^)_C&YU2"[6*ZFQ$T=L[AL,?04"/3/#_
M (QTOQ-<30Z>+D-"H9O.MVC&#Z$CF@#-\46-Q?>,_#J6]U-9D1W.9X54D?*O
M'S CF@"KJ6@62>'=<\*Z7/.^J7=NUU(\Q+-*S< E\8Y*XQ0!HZ)XST:6RLK2
M:?[)J&U(FM)499$?@;<8]>_2@#8L]>T^^-R+>5F-M,T$F8V&'7&1R.>O6@#C
MI_@KX-N+B2>2VNM\C%VQ<,.2<F@#H/"O@C1O!OVD:.DR+<8\P22EQQG'7ZT
M;6H6<5_92VDV[RI5VMM.#BHFDXV8-71S?_" :%_SSF_[^5S>P@8JE$7_ (5_
MH7_/.;_OY1["'8?LHB?\(!H7_/.;_OY1["'8/91#_A -"'/ES?\ ?RDZ$$'L
MHHZ.PM([&SBMHBQCB&U=QR<?6NN,4EH:VLBW5 -8!A@@$>AH $4*,* !Z 4
M.H !0 4 1F-"VXHI([D4 2#I0 4 ,,:%LE%)'?% #A0 "@ % !B@!>U  * &
ML 2"0,CI[4 +^% !B@!: "@!KHK##*"/0C-  BA1A0 /04 +0 N* $[T +B@
..!NT9S@9H 7 '84 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g447340g72o91.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g447340g72o91.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M1'YS#*I_]>L*D^5I$N21;TU-0B>=+Z=)E#?NG"A25QW JH7CI(HT:U * "@
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M:VF&+N.3Y95 /RGW/%+G;:BP4FG9G?1L&4$'(]:[KFH^F 4 % !0 4 % !0
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<3M,CL&CTZ46T0CBG,S@N!@+N39QQUPQYH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139662920322080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>N-2<br></strong></div></th>
<th class="th"><div>Jan. 13, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001051003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">333-267429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyActFileNumber', window );">Investment Company Act File Number</a></td>
<td class="text">811-08603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">N-2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreEffectiveAmendment', window );">Pre-Effective Amendment</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PostEffectiveAmendment', window );">Post-Effective Amendment</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PostEffectiveAmendmentNumber', window );">Post-Effective Amendment Number</a></td>
<td class="text">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyActRegistration', window );">Investment Company Act Registration</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendment', window );">Investment Company Registration Amendment</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendmentNumber', window );">Investment Company Registration Amendment Number</a></td>
<td class="text">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BlackRock Debt Strategies Fund, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 Bellevue Parkway<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Wilmington<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">882-0052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic', window );">Approximate Date of Commencement of Proposed Sale to Public</a></td>
<td class="text">From time to time after the effective date of this Registration Statement.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DividendOrInterestReinvestmentPlanOnly', window );">Dividend or Interest Reinvestment Plan Only</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DelayedOrContinuousOffering', window );">Delayed or Continuous Offering</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PrimaryShelfFlag', window );">Primary Shelf [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EffectiveUponFiling462e', window );">Effective Upon Filing, 462(e)</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AdditionalSecuritiesEffective413b', window );">Additional Securities Effective, 413(b)</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EffectiveWhenDeclaredSection8c', window );">Effective when Declared, Section 8(c)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NewEffectiveDateForPreviousFiling', window );">New Effective Date for Previous Filing</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AdditionalSecurities462b', window );">Additional Securities. 462(b)</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NoSubstantiveChanges462c', window );">No Substantive Changes, 462(c)</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ExhibitsOnly462d', window );">Exhibits Only, 462(d)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ExhibitsOnly462dFileNumber', window );">Exhibits Only, 462(d), File Number</a></td>
<td class="text">333-267429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RegisteredClosedEndFundFlag', window );">Registered Closed-End Fund [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_BusinessDevelopmentCompanyFlag', window );">Business Development Company [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_IntervalFundFlag', window );">Interval Fund [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PrimaryShelfQualifiedFlag', window );">Primary Shelf Qualified [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_NewCefOrBdcRegistrantFlag', window );">New CEF or BDC Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">55 East 52nd Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">John M. Perlowski, President<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BusinessDevelopmentCompanyFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BusinessDevelopmentCompanyFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_IntervalFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_IntervalFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_NewCefOrBdcRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_NewCefOrBdcRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfQualifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfQualifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RegisteredClosedEndFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RegisteredClosedEndFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AdditionalSecurities462b">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AdditionalSecurities462b</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AdditionalSecuritiesEffective413b">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 413<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AdditionalSecuritiesEffective413b</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ApproximateDateOfCommencementOfProposedSaleToThePublic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:dateOrAsapItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DelayedOrContinuousOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DelayedOrContinuousOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DividendOrInterestReinvestmentPlanOnly">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DividendOrInterestReinvestmentPlanOnly</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveUponFiling462e">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection e<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveUponFiling462e</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveWhenDeclaredSection8c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Section 8<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveWhenDeclaredSection8c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ExhibitsOnly462d">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection d<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ExhibitsOnly462d</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ExhibitsOnly462dFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection d<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ExhibitsOnly462dFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendmentNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendmentNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NewEffectiveDateForPreviousFiling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NewEffectiveDateForPreviousFiling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoSubstantiveChanges462c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoSubstantiveChanges462c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PostEffectiveAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PostEffectiveAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PostEffectiveAmendmentNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PostEffectiveAmendmentNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreEffectiveAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreEffectiveAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>d447340dposex_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cik0001051003-20230113.xsd" xlink:type="simple"/>
    <context id="P01_13_2023To01_13_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001051003</identifier>
        </entity>
        <period>
            <startDate>2023-01-13</startDate>
            <endDate>2023-01-13</endDate>
        </period>
    </context>
    <context id="P01_13_2023To01_13_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001051003</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-13</startDate>
            <endDate>2023-01-13</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="P01_13_2023To01_13_2023">0001051003</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="P01_13_2023To01_13_2023">false</dei:AmendmentFlag>
    <dei:EntityFileNumber contextRef="P01_13_2023To01_13_2023">333-267429</dei:EntityFileNumber>
    <dei:InvestmentCompanyActFileNumber contextRef="P01_13_2023To01_13_2023">811-08603</dei:InvestmentCompanyActFileNumber>
    <dei:DocumentType contextRef="P01_13_2023To01_13_2023">N-2</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="P01_13_2023To01_13_2023">true</dei:DocumentRegistrationStatement>
    <dei:PreEffectiveAmendment contextRef="P01_13_2023To01_13_2023">false</dei:PreEffectiveAmendment>
    <dei:PostEffectiveAmendmentNumber contextRef="P01_13_2023To01_13_2023">1</dei:PostEffectiveAmendmentNumber>
    <dei:PostEffectiveAmendment contextRef="P01_13_2023To01_13_2023">true</dei:PostEffectiveAmendment>
    <dei:InvestmentCompanyActRegistration contextRef="P01_13_2023To01_13_2023">true</dei:InvestmentCompanyActRegistration>
    <dei:InvestmentCompanyRegistrationAmendmentNumber contextRef="P01_13_2023To01_13_2023">10</dei:InvestmentCompanyRegistrationAmendmentNumber>
    <dei:InvestmentCompanyRegistrationAmendment contextRef="P01_13_2023To01_13_2023">true</dei:InvestmentCompanyRegistrationAmendment>
    <dei:EntityRegistrantName contextRef="P01_13_2023To01_13_2023">BlackRock Debt Strategies Fund, Inc.</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1 contextRef="P01_13_2023To01_13_2023">100 Bellevue Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="P01_13_2023To01_13_2023">Wilmington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="P01_13_2023To01_13_2023">DE</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="P01_13_2023To01_13_2023">19809</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="P01_13_2023To01_13_2023">800</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="P01_13_2023To01_13_2023">882-0052</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName contextRef="P01_13_2023To01_13_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">John M. Perlowski, President</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="P01_13_2023To01_13_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">55 East 52nd Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="P01_13_2023To01_13_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="P01_13_2023To01_13_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="P01_13_2023To01_13_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">10055</dei:EntityAddressPostalZipCode>
    <dei:ApproximateDateOfCommencementOfProposedSaleToThePublic contextRef="P01_13_2023To01_13_2023">From time to time after the effective date of this Registration Statement.</dei:ApproximateDateOfCommencementOfProposedSaleToThePublic>
    <dei:DividendOrInterestReinvestmentPlanOnly contextRef="P01_13_2023To01_13_2023">false</dei:DividendOrInterestReinvestmentPlanOnly>
    <dei:DelayedOrContinuousOffering contextRef="P01_13_2023To01_13_2023">true</dei:DelayedOrContinuousOffering>
    <cef:PrimaryShelfFlag contextRef="P01_13_2023To01_13_2023">true</cef:PrimaryShelfFlag>
    <dei:EffectiveUponFiling462e contextRef="P01_13_2023To01_13_2023">false</dei:EffectiveUponFiling462e>
    <dei:AdditionalSecuritiesEffective413b contextRef="P01_13_2023To01_13_2023">false</dei:AdditionalSecuritiesEffective413b>
    <dei:EffectiveWhenDeclaredSection8c contextRef="P01_13_2023To01_13_2023">true</dei:EffectiveWhenDeclaredSection8c>
    <dei:NewEffectiveDateForPreviousFiling contextRef="P01_13_2023To01_13_2023">false</dei:NewEffectiveDateForPreviousFiling>
    <dei:AdditionalSecurities462b contextRef="P01_13_2023To01_13_2023">false</dei:AdditionalSecurities462b>
    <dei:NoSubstantiveChanges462c contextRef="P01_13_2023To01_13_2023">false</dei:NoSubstantiveChanges462c>
    <dei:ExhibitsOnly462d contextRef="P01_13_2023To01_13_2023">true</dei:ExhibitsOnly462d>
    <dei:ExhibitsOnly462dFileNumber contextRef="P01_13_2023To01_13_2023">333-267429</dei:ExhibitsOnly462dFileNumber>
    <cef:RegisteredClosedEndFundFlag contextRef="P01_13_2023To01_13_2023">true</cef:RegisteredClosedEndFundFlag>
    <cef:BusinessDevelopmentCompanyFlag contextRef="P01_13_2023To01_13_2023">false</cef:BusinessDevelopmentCompanyFlag>
    <cef:IntervalFundFlag contextRef="P01_13_2023To01_13_2023">false</cef:IntervalFundFlag>
    <cef:PrimaryShelfQualifiedFlag contextRef="P01_13_2023To01_13_2023">true</cef:PrimaryShelfQualifiedFlag>
    <dei:EntityWellKnownSeasonedIssuer contextRef="P01_13_2023To01_13_2023">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityEmergingGrowthCompany contextRef="P01_13_2023To01_13_2023">false</dei:EntityEmergingGrowthCompany>
    <cef:NewCefOrBdcRegistrantFlag contextRef="P01_13_2023To01_13_2023">false</cef:NewCefOrBdcRegistrantFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>39</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d447340dposex.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="N-2" original="d447340dposex.htm">d447340dposex.htm</File>
    <File>cik0001051003-20230113.xsd</File>
    <File>cik0001051003-20230113_def.xml</File>
    <File>cik0001051003-20230113_lab.xml</File>
    <File>cik0001051003-20230113_pre.xml</File>
    <File>d447340dex99h1.htm</File>
    <File>d447340dex99h2.htm</File>
    <File>d447340dex99k7.htm</File>
    <File>d447340dex99l2.htm</File>
    <File>d447340dex99s3.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="6">http://xbrl.sec.gov/cef/2022</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d447340dposex.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/cef/2022": 6,
    "http://xbrl.sec.gov/dei/2022": 37
   },
   "contextCount": 2,
   "dts": {
    "definitionLink": {
     "local": [
      "cik0001051003-20230113_def.xml"
     ]
    },
    "inline": {
     "local": [
      "d447340dposex.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cik0001051003-20230113_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cik0001051003-20230113_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cik0001051003-20230113.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/cef/2022/cef-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022_lab.xsd"
     ]
    }
   },
   "elementCount": 189,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 39,
   "memberCustom": 0,
   "memberStandard": 1,
   "nsprefix": "cik0001051003",
   "nsuri": "http://www.blackrock.com/20230113",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d447340dposex.htm",
      "contextRef": "P01_13_2023To01_13_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityFileNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "true",
     "longName": "995470 - Disclosure - N-2",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "shortName": "N-2",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d447340dposex.htm",
      "contextRef": "P01_13_2023To01_13_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityFileNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 1,
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AllRisksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "localname": "AllRisksMember",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "cef_AllSecuritiesMember": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Securities:"
       }
      }
     },
     "localname": "AllSecuritiesMember",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "localname": "AnnualCoverageReturnRatePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AnnualDividendPayment": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "localname": "AnnualDividendPayment",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_AnnualDividendPaymentCurrent": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "localname": "AnnualDividendPaymentCurrent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_AnnualDividendPaymentInitial": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "localname": "AnnualDividendPaymentInitial",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_AnnualExpensesTableTextBlock": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "localname": "AnnualExpensesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "localname": "AnnualInterestRateCurrentPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AnnualInterestRateInitialPercent": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "localname": "AnnualInterestRateInitialPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AnnualInterestRatePercent": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "localname": "AnnualInterestRatePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_BdcFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "localname": "BdcFileNumber",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "localname": "BusinessDevelopmentCompanyFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_CapitalStockTableTextBlock": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "localname": "CapitalStockTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_DistributionServicingFeesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "localname": "DistributionServicingFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "localname": "EffectsOfLeverageTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_EffectsOfLeverageTextBlock": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "localname": "EffectsOfLeverageTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ExpenseExampleTableTextBlock": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "localname": "ExpenseExampleTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ExpenseExampleYear01": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "localname": "ExpenseExampleYear01",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_ExpenseExampleYears1to10": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "localname": "ExpenseExampleYears1to10",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_ExpenseExampleYears1to3": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "localname": "ExpenseExampleYears1to3",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_ExpenseExampleYears1to5": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "localname": "ExpenseExampleYears1to5",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_FeeTableAbstract": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "localname": "FeeTableAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_FinancialHighlightsAbstract": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "localname": "FinancialHighlightsAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_HighestPriceOrBid": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "localname": "HighestPriceOrBid",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_HighestPriceOrBidNav": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "localname": "HighestPriceOrBidNav",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "localname": "IncentiveAllocationMaximumPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "localname": "IncentiveAllocationMinimumPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveAllocationPercent": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "localname": "IncentiveAllocationPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveFeesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "localname": "IncentiveFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "localname": "InterestExpensesOnBorrowingsPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IntervalFundFlag": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "localname": "IntervalFundFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LatestNav": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest NAV"
       }
      }
     },
     "localname": "LatestNav",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "localname": "LatestPremiumDiscountToNavPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_LatestSharePrice": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Share Price"
       }
      }
     },
     "localname": "LatestSharePrice",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LoanServicingFeesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "localname": "LoanServicingFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtPrincipal": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "localname": "LongTermDebtPrincipal",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtStructuringTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtTableTextBlock": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "localname": "LongTermDebtTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtTitleTextBlock": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LowestPriceOrBid": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "localname": "LowestPriceOrBid",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LowestPriceOrBidNav": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "localname": "LowestPriceOrBidNav",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ManagementFeesPercent": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "localname": "ManagementFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_NetExpenseOverAssetsPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "localname": "NetExpenseOverAssetsPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "localname": "NewCefOrBdcRegistrantFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_NoPublicTradingTextBlock": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "localname": "NoPublicTradingTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_NoTradingHistoryTextBlock": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "localname": "NoTradingHistoryTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherAnnualExpense1Percent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": 1.0,
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpense1Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherAnnualExpense2Percent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": 2.0,
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpense2Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherAnnualExpense3Percent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": 3.0,
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpense3Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherAnnualExpensesAbstract": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherAnnualExpensesAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_OtherAnnualExpensesPercent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherExpensesNoteTextBlock": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "localname": "OtherExpensesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherFeederFundExpensesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "localname": "OtherFeederFundExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherMasterFundExpensesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "localname": "OtherMasterFundExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "localname": "OtherSecuritiesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "localname": "OtherSecurityDescriptionTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherSecurityTitleTextBlock": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "localname": "OtherSecurityTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherTransactionExpense1Percent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": 1.0,
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpense1Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionExpense2Percent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": 2.0,
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpense2Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionExpense3Percent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": 3.0,
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpense3Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionExpensesAbstract": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherTransactionExpensesAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_OtherTransactionExpensesPercent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "localname": "OtherTransactionFeesBasisMaximum",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "localname": "OtherTransactionFeesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "localname": "OutstandingSecuritiesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "localname": "OutstandingSecurityAuthorizedShares",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sharesItemType"
    },
    "cef_OutstandingSecurityHeldShares": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "localname": "OutstandingSecurityHeldShares",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sharesItemType"
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "localname": "OutstandingSecurityNotHeldShares",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sharesItemType"
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "localname": "OutstandingSecurityTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_PrimaryShelfFlag": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "localname": "PrimaryShelfFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "localname": "PrimaryShelfQualifiedFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_ProspectusLineItems": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "localname": "ProspectusLineItems",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "xbrltype": "stringItemType"
    },
    "cef_ProspectusTable": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "localname": "ProspectusTable",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RegisteredClosedEndFundFlag": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "localname": "RegisteredClosedEndFundFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_ReturnAtMinusFivePercent": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "localname": "ReturnAtMinusFivePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtMinusTenPercent": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "localname": "ReturnAtMinusTenPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtPlusFivePercent": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "localname": "ReturnAtPlusFivePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtPlusTenPercent": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "localname": "ReturnAtPlusTenPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtZeroPercent": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "localname": "ReturnAtZeroPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RiskAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "localname": "RiskAxis",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_RiskFactorsTableTextBlock": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "localname": "RiskFactorsTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RiskTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "localname": "RiskTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SalesLoadPercent": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "localname": "SalesLoadPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_SecurityAxis": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security [Axis]"
       }
      }
     },
     "localname": "SecurityAxis",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_SecurityDividendsTextBlock": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "localname": "SecurityDividendsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "localname": "SecurityLiabilitiesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "localname": "SecurityLiquidationRightsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityTitleTextBlock": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "localname": "SecurityTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityVotingRightsTextBlock": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "localname": "SecurityVotingRightsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesAmount": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "localname": "SeniorSecuritiesAmount",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesCoveragePerUnit": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "localname": "SeniorSecuritiesCoveragePerUnit",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "auth_ref": [
      "r47",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "auth_ref": [
      "r48",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Involuntary Liquidating Preference per Unit"
       }
      }
     },
     "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "auth_ref": [
      "r46",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SharePriceTableTextBlock": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "localname": "SharePriceTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_TotalAnnualExpensesPercent": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "localname": "TotalAnnualExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_UnderwritersCompensationPercent": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "localname": "UnderwritersCompensationPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "localname": "WarrantsOrRightsCalledAmount",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateItemType"
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "localname": "WarrantsOrRightsExercisePrice",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "dei_AdditionalSecurities462b": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "localname": "AdditionalSecurities462b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "localname": "AdditionalSecurities462bFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "localname": "AdditionalSecuritiesEffective413b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.",
        "label": "Approximate Date of Commencement of Proposed Sale to Public"
       }
      }
     },
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateOrAsapItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r2",
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DelayedOrContinuousOffering": {
     "auth_ref": [
      "r4",
      "r5",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "localname": "DelayedOrContinuousOffering",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "auth_ref": [
      "r4",
      "r5",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EffectiveAfter60Days486a": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "localname": "EffectiveAfter60Days486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnDate486a": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnDate486b": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnSetDate486a": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnSetDate486b": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling462e": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "localname": "EffectiveUponFiling462e",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling486b": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "localname": "EffectiveUponFiling486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "localname": "EffectiveWhenDeclaredSection8c",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityInvCompanyType": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).",
        "label": "Entity Inv Company Type"
       }
      }
     },
     "localname": "EntityInvCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "invCompanyType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_ExhibitsOnly462d": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "localname": "ExhibitsOnly462d",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "localname": "ExhibitsOnly462dFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_InvestmentCompanyActFileNumber": {
     "auth_ref": [
      "r5",
      "r72",
      "r73",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "localname": "InvestmentCompanyActFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_InvestmentCompanyActRegistration": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "localname": "InvestmentCompanyActRegistration",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "auth_ref": [
      "r5",
      "r72",
      "r73",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "localname": "NewEffectiveDateForPreviousFiling",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462c": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "localname": "NoSubstantiveChanges462c",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "localname": "NoSubstantiveChanges462cFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_PostEffectiveAmendment": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "localname": "PostEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PostEffectiveAmendmentNumber": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective.",
        "label": "Post-Effective Amendment Number"
       }
      }
     },
     "localname": "PostEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_PreEffectiveAmendment": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "localname": "PreEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreEffectiveAmendmentNumber": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective.",
        "label": "Pre-Effective Amendment Number"
       }
      }
     },
     "localname": "PreEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sequenceNumberItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "3",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "4",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "5",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "6",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "Instruction 2",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "1",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "2",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Form N-2",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Form N-2",
   "Paragraph": "d",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r20": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r21": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r22": {
   "Name": "Form N-2",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r23": {
   "Name": "Form N-2",
   "Paragraph": "e",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r24": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r25": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r26": {
   "Name": "Form N-2",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r27": {
   "Name": "Form N-2",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r28": {
   "Name": "Form N-2",
   "Paragraph": "3",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r29": {
   "Name": "Form N-2",
   "Paragraph": "4",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r30": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r31": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 1",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r32": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 10",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "a",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r33": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 10",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "a, g, h",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r34": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 10",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "f",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r35": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 10",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "g",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r36": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 10",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "i",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r37": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 11",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r38": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 4",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r39": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 5",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Form F-3",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r40": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 6",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r41": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 7",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "a",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r42": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 7",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "b",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r43": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 8",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r44": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 9",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r45": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 4",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r46": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 2",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r47": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 3",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r48": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 8",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r49": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r50": {
   "Name": "Form N-2",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r51": {
   "Name": "Form N-2",
   "Paragraph": "3",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subparagraph": "Instruction 2",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r52": {
   "Name": "Form N-2",
   "Paragraph": "4",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subparagraph": "Instruction 3",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r53": {
   "Name": "Form N-2",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r54": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 1",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r55": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 4",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r56": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 5",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r57": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 8",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r58": {
   "Name": "Form N-2",
   "Paragraph": "b, d",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r59": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 10",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r60": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r61": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "1",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r62": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "2",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r63": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "3",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r64": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r65": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "4",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r66": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "Instruction 2",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r67": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "Instruction 3",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r68": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "Instruction 4",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r69": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "Instructions 4, 5",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r70": {
   "Name": "Form N-2",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r71": {
   "Name": "Form N-2",
   "Paragraph": "e",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r72": {
   "Name": "Form N-3",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r73": {
   "Name": "Form N-4",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r74": {
   "Name": "Form N-6",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r75": {
   "Name": "Form S-3",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r76": {
   "Name": "Investment Company Act",
   "Number": "270",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r77": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "313",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r78": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r79": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "413",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "1",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r80": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r81": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r82": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r83": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "e",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r84": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r85": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r86": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r87": {
   "Name": "Securities Act",
   "Publisher": "SEC",
   "Section": "8",
   "Subsection": "c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "2",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001193125-23-008474-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-008474-xbrl.zip
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M$5+FKRCG9Z>[CM\(K>#F\2C5"]'\[.,.B/[Y!N%P^#J7OP%02P,$%     @
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M@!DLEP7<#=V(8*=WB;MT"^_U%A#UMM=M^_DU=OW+37>]D6Q&)\WDGX(7N$7
MJ 6+F6F1LQ@06@;RLPJQ+W6!*Z#2RZ>M.L@*UY+"QTLXYC1= F$2M[@$*@3,
MQ/<L086E14'PG"&PY@4SDP#A?)F!>P5902@,',EGK@F2NY/G)RK/HPW8Q\S,
MT]R@<@Y8LFDE24 ./1(G9%$G;7%F293I%4&$4$A 5T)2S#(6:E'5 $'RKQ$H
M1%\^H% "5B;+MJ/3-@AES2)J*E18D@ID\P2DB)D#K&KZ)D4,2.>KJ("+*.LF
M9YZKL*R 42,(^?UQ! OW\?F\ %R=9.D9@(W C!N*4&T1,3N-\H88L+)W/@^
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M7Q^^.ST\_@R?T^UN?4JWS@A-7*T![@'_1EX$X@54M)I)S>>\!&K 6J7IFI[
MN]V._ES"?0)O2J=XX5T2$F;$L@LO!3&?WXIWXK^8;KS]>Z94W29^V]Z9["IE
M7E#.0,DTS&WH7?QF8!%IYF@9-SQ/35<D$M+3[X+7B D$[VD69K:+.@3ITV &
M(MG'@ 9_[IT7EP:L>?K 6VCPL'(V9.P)O @U;^!K8(JFI:]#L9*G2B*8D"H&
M2/ZW%4B/\Q.!.B,4: G?SX^<I1<"/MHC7^!:+>>.V-",$1()W9"I2IMW#'IF
M&&(H;U:^FG%FG +=OD5XLC3(J?(ILZ$RF1GR&^@"JCG#>^%(P/J-F#?;8'X
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M%R83OBIT&;1S*3 2MJ)X0VULNP*;2=%:":5X:0D7F67?+@9^?0]2^'P3,R?
M8 &&G62QE;4,X_$('5G*XJ2H /\M:3 V7#<W,W06QNQ\ D6TF+(QHFK;60%"
M(\=[XL]+U[W+U9W%T:0 Z.%_9JO8TV^I60XPI17'8.8<"]10H<GF6]YZ17F6
MY.H\4-9\C6@0BF]_FRK O:7=CC:N@9SAY7+\2"&M".'[G<->2.@%4U1,,B#]
MV8H-C&+"W#L.HJW]05U@MQTO1XL@M"E37C4+";3YN5<:3O::\'45^@E>#$E
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MYBD_FII'KE=^.\%N?H"FS_3D2& Y@P]48:Z2?X W@%W]>?Z1I'2K42;7;M-
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MH(]A3X.:!U';;UE&%T.QUU@=8K;X2/UN/&&[I_YY/&%O]" >>,O$'0ONH-E
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M#]R7!%.(0- * A8 G&Q)1_IS^V1;[I<'J*?H[R;':F-KO6M*_$HK=G MBMP
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MX3:OBSQ%015=C5&N[*FW=*^-V7;6.,/.LM$P!1#3;+R8]7@T34IL:"F.Z.M
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MSM 88:_E43[==FYF\K(Z<T;'5OWPZOW!/^"FWYS^\7;O_P!02P,$%     @
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MOUH#QL'1R<71^5?8OQ[&]$;"]$[R"A&NK #CB<Q>$4F*+W/XU+R!N:*V+-7
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M)3!.;&72#R1Q# G506)">9PM+OV>;Z/ >2R@?"$9D'I1$-I/2($=L>A&JY[
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M1R.@&]52O(+6G EZ!YR($6SVT);J@X C,(Q$0P)E9 5;M(,;VT'CD&>S>)(
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M-AP,D5- 9EF(Q]\ZZ%3FX;0(5EA *>-5N/NIN1SB&6DC$:$X=GRV&;XN*)O
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M5+[#J7L]QWBH%_(CT6!B? HEV6S8C!JWYQ/[HT>)Y)3@BS")A,(WEF #!:S
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M L9;2H ;4"/8;E/F')C6*?MV>#)C^2,/!O,,=%BX:"06UN#3R5[+3#A<<?B
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MEI..<H!OR&91R#Q:V*OPM CW ^QCV""TIQ=6/WJU_Z_')B8TGYH]526N,XL
MUMYPI8'LL((Q0OF3:R=_*@?HJE>N=&P#FUQ0GX$T11Q[]IB&6RDHF@T:",PJ
M:B_+D'I!Q\P ZH,]FH'W49*DKHN]0N#I 8VE\GG3D/%5SC;67G86A3]R)"Z6
M*%H$G(:X># >8.OR?/'96 Z(+25W#]C[H5FD#Z4?^%TAJ@_6C*@^V"*J_PF(
MZLHBF:L@U2NJ:MX64WV RM-]5NT,=H:@C[,,C1;L%W#/A8.;(KA!A;\VA'N[
MD?Z1T<R#7R^:N45P;^.8MV?MFL<QMTC7;0CSSN1WC4*86[[>ANONCJ_K%:[[
M51'<5;9-C2#<.^3\R^8#M&30ARV3\>,[!'8?W K8?;0%=F^!W7<)[*[T--P9
MLOMYZ]5^"=A=^<H'@>R^8F1;9\C6&?)K.T.VT.ZM2^0?XA+YAZ%?:UV]Z1^_
M\;=NHCKN]>VIMO45_1J^HBVT^]K0[BMLN"VV>XOMOD]L]\$6V_U+8[L/MMCN
M+;9[B^U>-[;[X";8[H/;8[L/ZHGM/J@KMON@$MM]);D/#]M]L,5V%[#=AVO#
M=K_]\FYY3>2?1>_^G[=/OKQ;&^E.?][^>],NH 1.O\:RW<98<WOA4@R^V0#-
M:(K"#"56#Z@284Q:<&>8Q,ET0>1NF,C@/= 4#T,1N>T@G+X9FL8EB[@>(E5C
MW5K0HCJ@)J"R(CVEWW'NZD$IA<G )L#K-DL047(HT@$URP;5.23-^4R*$?L;
M:D">#K((:L]YEK#:OV'*OB4I*' @A^]K!F\N:U'0O^U]J3!*7KV$ 5_(- ]!
M@=T%^_8\?DWZ=N_3VR=PQY4GP[U,:MB;"-"$@R-09B,PTT8X>5'0 ;%,#9U&
M,,NFE=,F""NTO:D!16=ST 5 L[U2"?@4CG8/Q4SK +\2Z;TIZ.Y/ZC> WB1)
M<^[DW.]^[M6&)_H)NI))'/5RZA''/J@:D$9$80/LX! ,,3"3ZC)G1!B%]*=
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M D.<'OT%(_K8_W3\[O\!4$L#!!0    ( *.(+5:]IUP%H0\  %]4   2
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MW^;C5OCL&P?>-SK_[.L;_R D:4%)D-((I)/QJ-V:\#3%X+N6KQ"/Z2;)#5*
M-"/!<A:)D$=XD3K!*E[/^V,5K;2KF7F1]+$E)G%#@UON)6K3+82L!1(/LN5V
MZ?#ZE&O<A%G9G9"G,KBPG/I8+A%8[#!I%)+ A ?8 ,/6<R 2$5-8D 2]RM E
M8YK!.EO**LE9+B4C4FP:6IM!\7Z7K2*AO"/EKJYS24ESG;DQ&?;EUN2Z-7O*
M 2'7:K?*7I_)O(E,76,T,P15%_M!<&,2IFSPI/2[E*8M?=-M'H'UR!NJ1*H;
MKWS7+C0.9V08\S3#5BQNQ%TZ 6YVL1U+NR1(72CB#%9^GV$[NL)ET=2U&VC
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M @ 1    9#0T-S,T,&1P;W-E>"YH=&WM??M3ZSBR\.];M?^#BOWF7K@50EY
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MLDT3]5QGP((XK+<IT)+W:9["!Y"CT,&I@[[19=P7JH6'6P"/>WT_Z*-?%F
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M"KNETJHCP"?@#$9(#_H&21/44G'UL:16**T^EJP/,ER)1^ZL(Q[42^N ")^
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M3O6\@-"!;9KM*3W-EUI\I"8XO(\>@&B%8<?W^H\=FI]"UL#KBI"(RNQ!U?4
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M,RTR,#(S,#$Q,RYX<V102P$"% ,4    " "CB"U6HY8*1>\!  #"!0  '@
M            @ 'Z @  8VEK,# P,3 U,3 P,RTR,#(S,#$Q,U]D968N>&UL
M4$L! A0#%     @ HX@M5A$]9O2I 0  PP8  !X              ( !)04
M &-I:S P,#$P-3$P,#,M,C R,S Q,3-?;&%B+GAM;%!+ 0(4 Q0    ( *.(
M+5:A=/,:IP$  -H#   >              "  0H'  !C:6LP,# Q,#4Q,# S
M+3(P,C,P,3$S7W!R92YX;6Q02P$"% ,4    " "CB"U6$+<MB7 R  !O^
M$@              @ 'M"   9#0T-S,T,&1E>#DY:#$N:'1M4$L! A0#%
M  @ HX@M5E3RU=5C.0  JA$! !(              ( !C3L  &0T-#<S-#!D
M97@Y.6@R+FAT;5!+ 0(4 Q0    ( *.(+5:)<#W)4U   "!H @ 2
M      "  2!U  !D-#0W,S0P9&5X.3EK-RYH=&U02P$"% ,4    " "CB"U6
MO:=<!:$/  !?5   $@              @ &CQ0  9#0T-S,T,&1E>#DY;#(N
M:'1M4$L! A0#%     @ HX@M5GE; ZRG @  ] 8  !(              ( !
M=-4  &0T-#<S-#!D97@Y.7,S+FAT;5!+ 0(4 Q0    ( *.(+5:U%2MZ,D
M !5+ @ 1              "  4O8  !D-#0W,S0P9'!O<V5X+FAT;5!+!08
1    "@ * *L"  "L& $    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
